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ABSTRACT 
 Antenatal depression occurs in about 20% of all pregnancies and gestational 
diabetes occurs in up to 14% of all pregnancies.   Although there is sufficient information 
on (1) depression during pregnancy and (2) depression and diabetes, there is little 
information about depression and gestational diabetes.  This comparative, longitudinal 
research study was done to better understand the relationship between gestational 
diabetes and depression.  The study aims were the following: (1) to determine whether 
women with gestational diabetes had more depression than women without gestational 
diabetes, (2) to determine whether factors predictive of depression in pregnant women 
with gestational diabetes were different from women without gestational diabetes, and (3) 
to determine if minorities were more at risk for depression during pregnancy than 
Caucasians.  The sample included 135 pregnant women between 24 and 40 weeks’ 
gestation, of which 65 had gestational diabetes (GDM) and 70 had no gestational diabetes 
(NGDM).  Depression, anxiety, stress, and social support were measured using self-
report questionnaires completed during a prenatal care visit.  Delivery outcomes were 
collected from the electronic medical record.  Using the CES-D, 28% of the entire sample 
had depression and 32% of women with GDM had depression compared to 24% of 
women with NGDM, although the difference was not statistically significant.  However, 
women with GDM were 2.7 times more likely to have depression (OR=2.72, 95% CI, 
1.04, 7.13, p =.041).    
 xv 
 
 Also, women with GDM were 3.07 times as likely to have a history depression 
(OR=3.07, 95% CI, 1.01, 9.49, p = .05).  Trait anxiety was found to be a significant 
predictor of prenatal depression (p<.001).  No significant difference was found between 
race and depression.  There were no clinically significant findings in delivery outcomes 
between women with and without GDM or between women with and without depression.  
This study may improve the prenatal care of women with depression and gestational 
diabetes during pregnancy.   
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CHAPTER ONE 
 
PROBLEM STATEMENT 
 
Depression affects approximately 121 million people and is the leading cause of 
disability worldwide (World Health Organization, 2009).  Depression is more common in 
women than in men and is the leading cause of disease burden in developed and 
developing countries for women between the ages of 15 and 44 (World Health 
Organization, 2009).  Since these are the childbearing years for women, the risk of 
depression for women during pregnancy and the postpartum period increases.  
Although many people believe that women are resistant to becoming depressed during 
pregnancy, at least 20% of women are depressed during pregnancy (Bonari et al., 2004).  
Some studies have reported depression rates as high as 45% during pregnancy (Lindgren, 
2001; S. Orr, Blazer, & James, 2007; S. T. Orr, Blazer, & James, 2006).  Depression 
during pregnancy is often called antenatal depression or prenatal depression.  An increase 
in the percentage of antenatal depression has been reported in women with low social 
support (C. Anderson, Roux, & Pruitt, 2002; Glazier, Elgar, Goel, & Holzapfel, 2004; 
Records & Rice, 2007; Sleath et al., 2005; Westdahl et al., 2007), low socioeconomic 
status (C. Anderson et al., 2002; T. Field et al., 2002; Glazier et al., 2004; Lindgren, 
2001), lower education levels (Glazier et al., 2004; Lindgren, 2001; Marcus, Flynn, 
Blow, & Barry, 2003; Rubertsson, Waldenstrom, Wickberg, Radestad, & Hildingsson,
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 2005; Westdahl et al., 2007), and younger age (Glazier et al., 2004; Lindgren, 2001; S. 
T. Orr et al., 2006; Rubertsson et al., 2005).  During pregnancy, there is a heightened 
inflammatory response and an increase in stress hormones, such as, cortisol (Dayan et al., 
2006).  Interestingly, increased cortisol and inflammation markers are also found in 
persons with depression (Black, 2006), suggesting a possible physiological mechanisms 
for antenatal depression.    
Depression is defined and diagnosed clinically according to the DSM-IV.     To 
make this diagnosis, at least five of the following symptoms must be present during the 
same two week period: (1) depressed mood most of the day, nearly every day; (2) 
markedly diminished interest or pleasure in all or almost all activities; (3) significant 
weight loss when not dieting or significant weight gain, or decrease or increase in 
appetite nearly every day; (4) insomnia or hypersomnia; (5) psychomotor agitation or 
retardation; (6) fatigue or loss of energy; (7) feelings of worthlessness or excessive or 
inappropriate guilt; (8) diminished ability to think or concentrate, or indecisiveness; and 
(9) recurrent thoughts of death, suicidal ideation without a specific plan, or suicide 
attempt or a specific plan for committing suicide (American Psychiatric Association, 
1994).  Also, one of the two symptoms, (1) depressed mood or (2) loss of interest or 
pleasure must be included in the five symptoms (American Psychiatric Association, 
1994).  The symptoms of depression are similar among pregnant and non-pregnant 
women.  However, pregnant women with depression are less likely to report intense 
feelings of suicide and guilt, have less difficulty falling asleep, and are more likely to 
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have slowed movement or speech (Manber, Blasey, & Allen, 2008).  Although it is 
necessary to use the DSM-IV criteria to make a diagnosis of depression, many research 
studies use self-report measures to classify participants as depressed. 
Postpartum Depression 
Postpartum depression is common and occurs in 13% of postpartum women 
(O'Hara & Swain, 1996).  A meta-analysis of 141 articles on postpartum depression 
indicated that low social support, low self-esteem, life stress, fatigue, and a history of 
prenatal depression are risk factors for developing postpartum depression (C. T. Beck, 
2008a).  Another meta-analysis of 59 studies found similar risk factors, but had poor 
marital relationship as an additional risk factor (O'Hara & Swain, 1996).  Postpartum 
depression was found to have a negative effect on mother-infant interactions during the 
first year of life (C. T. Beck, 2008b).   Also, postpartum depression has a negative effect 
on cognitive and emotional development in children (C. T. Beck, 2008b).  Postpartum 
depression and prenatal depression occur at different points during the birth process and 
although related, they are different concepts.  Postpartum depression has been extensively 
studied and thus, is not the focus of this study (C. T. Beck, 2008a).   
Gestational Diabetes 
Gestational diabetes is a significant problem in the United States, occurring in 
about 7% of all pregnancies (American Diabetes Association, 2010b).  However, 
gestational diabetes has been found in up to 14% of all pregnancies (Jovanovic & Pettitt, 
2001).  Recently, it has been documented that there are more than 200,000 pregnancies 
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which are complicated by gestational diabetes each year (American Diabetes Association, 
2010b).  Also, there was a 122%  increase in the prevalence of gestational diabetes 
between 1989 and 2004 (Getahun, Nath, Ananth, Chavez, & Smulian, 2008).  Other 
studies have shown an increase in gestational diabetes between 16% and 127% in 
different races over the past 20 years (Ferrara, 2007).  The increase in gestational diabetes 
may be attributed to a modification in the diagnosis standards.  These modifications 
include an increase in the number of women screened for gestational diabetes and the 
lowering of the plasma glucose threshold needed to make a diagnosis of gestational 
diabetes (Ferrara, 2007).  However, with such a large increase in the prevalence of 
gestational diabetes, the increase in obesity has been suggested as a valid reason for the 
increase in gestational diabetes (Ferrara, 2007).    
Gestational diabetes is defined as glucose intolerance found for the first time 
during pregnancy (Buchanan, Xiang, Kjos, & Watanabe, 2007).  During pregnancy, the 
maternal body goes through many changes.  Increased maternal adiposity in early 
pregnancy  and increased insulin resistance in late pregnancy are physiological reasons 
for a woman developing gestational diabetes  (Barbour et al., 2007).   In gestational 
diabetes, the pancreatic β-cells are not able to increase insulin secretion to meet the 
demands of the insulin resistant pregnant woman (Buchanan et al., 2007).  Gestational 
diabetes is diagnosed based on the result of an oral glucose tolerance test.  Criteria to 
interpret elevated results of the glucose tolerance test are used to diagnosis gestational 
diabetes (O'Sullivan, 1980; O'Sullivan & Mahan, 1964).  
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  Parity, maternal obesity, advanced maternal age, and race are risk factors for 
developing gestational diabetes (Casey, Lucas, McIntire, & Leveno, 1997; Ferrara, 2007; 
Getahun et al., 2008).  Women with gestational diabetes are more likely to deliver a baby 
with macrosomia and have an increased risk of a shoulder dystocia during delivery 
(Jovanovic & Pettitt, 2001).  Also, stillbirth and infant hypoglycemia are increased in 
women with gestational diabetes (Getahun et al., 2008). 
Women with gestational diabetes were more likely to have a cesarean section 
(46%) compared to women without gestational diabetes (32%) (Wier, Witt, Burgess, & 
Elixhauser, 2010).  Also, the hospital costs related to delivery of infants were 18% more 
expensive (about $4,500) for women with gestational diabetes than for women without 
gestational diabetes (Wier et al., 2010).  
The increased state of insulin resistance in pregnancy that contributes to the 
diagnosis of gestational diabetes may also predispose a woman to develop depression.  
Lower insulin sensitivity was found in depressed patients, and insulin resistance 
improved with depression treatment indicating that increased insulin resistance may be 
connected to depression (Lustman, Penckofer, & Clouse, 2007; Okamura et al., 2000).  
Hyperglycemia, a complication that occurs with gestational diabetes, has also been found 
to be related to depression (Lustman, Anderson, Freedland, de Groot, & Carney, 2000).  
Therefore, the combination of increased insulin resistance and hyperglycemia that occurs 
with gestational diabetes may increase the chance of depression occurring in women with 
gestational diabetes. 
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The combined effects of gestational diabetes and depression in pregnant women 
increases the chance of multiple complications in mothers and infants.  Although there is 
potential for increased risk, there has been limited research to study the relationship 
between gestational diabetes and depression.   
Purpose 
The purpose of this study was to determine if women with gestational diabetes are 
more likely to suffer from depression.  Depression and gestational diabetes are common 
occurrences during pregnancy; however, the relationship between the two has not been 
extensively studied.  Depression occurs in 25% of persons with type 1 and type 2 diabetes 
(Lustman et al., 2000).  Whether there is more depression in women with gestational 
diabetes is unknown.  If women with gestational diabetes have more depression, it would 
seem that they would be at even greater risks for complications because of their co-
morbid depression.  The factors that predict depression (anxiety, stress, age, income, and 
marital status) in both women with and without gestational diabetes were also assessed to 
determine if women with gestational diabetes have different predictive factors of 
depression than women without gestational diabetes.  Lastly, a potential difference in the 
prevalence of depression between White and minority women was investigated.  
Theoretical Framework 
The biopsychosocial model developed by George Engel (1977) was used to guide 
the study.  This model includes the biological, psychological, and sociological effects 
incorporated with disease.  In the biopsychosocial model, the biological, psychological, 
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and sociological components of a person are all equally important when treating an 
illness (Engel, 1977).  The biopsychosocial model is holistic in that it explains how a 
person can be understood as a whole including the interaction between the components 
(Molina, 1983).   
The components of the biopsychosocial model are (1) the concept of 
multicausality of illness, (2) illness as a dynamic process, (3) holistic understanding of 
the human being, and (4) the concept of vulnerability of systems (Molina, 1983).  The 
concept of multicausality of illness is the idea that an illness is caused by the interaction 
of several factors.  For example, depression is caused by both biological factors 
(neurotransmitters dysfunction) and psychological (learned helplessness or negative 
thinking) (Molina, 1983).  Illness is a dynamic process rather than a steady state and 
changes constantly as biological, psychological, and sociocultural factors interact with 
each other and the environment (Molina, 1983).  Holistic understanding of the human 
being is the belief that body and mind are not separate entities, and that there is complex 
interaction between body and mind.  These complex interactions need to be considered 
when caring for the person as a whole (Molina, 1983).   The human being is considered 
an open system of complex relationships with the internal and external environment, 
which defines the concept of vulnerability.  The biological and psychosocial systems 
interact with each other and can be affected by a change in the internal or external 
environment (Molina, 1983). 
8 
 
 
A benefit of the biopsychosocial model is that it allows the researcher or clinician 
to consider the person as a whole including quality of life, social role performance, and 
emotional status during evaluation of a patient (Fava & Sonino, 2008).   The 
biopsychosocial model has been used to study depression (Covinsky & Landefeld, 1996) 
and diabetes (Peyrot, McMurry, & Kruger, 1999).  The factors examined in this study 
include psychological, sociological, and biological variables and will be thoroughly 
described in Chapter 2.  The psychological variables were as follows: depression, history 
of depression, anxiety, stress and social support.  The sociological variables were as 
follows: socioeconomic status, race, ethnicity, and marital status.  The biological factors 
were as follows: body mass index (BMI), oral glucose tolerance test results, gravida and 
parity, presence of delivery complications, type of delivery (vaginal or cesarean section), 
gestational age at delivery, Apgar (Appearance, Pulse, Grimace, Activity, Respiration) 
scores, and infant weight.   
Figure 1 illustrates the biopsychosocial model used for this study.    
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Psychological
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-Anxiety
-Stress
-Social Support
Sociological
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-Delivery Complications
-Apgars
-Gestational age
-Birth Weight
Health
 
Figure 1: The Biopsychosocial Model for the Study of Depression and Gestational 
Diabetes 
 
Specific Aims 
The primary aims for this study were (1) to determine whether women with 
gestational diabetes had more depression than women without gestational diabetes and 
(2) to determine whether factors predictive of depression in pregnant women with 
gestational diabetes were different from women without gestational diabetes.  
Hispanic and African American women are at greater risk for developing 
gestational diabetes than Caucasians.  One study has found African Americans are more 
likely to be depressed during pregnancy (S. T. Orr et al., 2006).  However, other studies 
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have not shown race to be a significant risk factor for depression during pregnancy 
findings (Diego, Field, & Hernandez-Reif, 2005; Marcus et al., 2003; Sleath et al., 2005; 
Westdahl et al., 2007).  If women with gestational diabetes have more depression, race 
may be a significant factor.  Therefore, it is important to study these minority populations 
in order to determine if a health disparity exists.  Thus, an exploratory aim for this study 
was to determine if minorities were at more at risk for depression than Caucasians.   
In summary, depression and gestational diabetes are common during pregnancy.  
There is a known link between type 1 and type 2 diabetes and depression.  A possible 
relationship between gestational diabetes and depression exists due to the increased 
insulin resistance and occurrence of hyperglycemia.  However, the relationship between 
gestational diabetes and depression has not been extensively studied.  The 
biopscyhosocial model was the theoretical framework used to guide the study.  The study 
had three aims: (1) to determine whether women with gestational diabetes had more 
depression than women without gestational diabetes, (2) to determine whether factors 
predictive of depression in pregnant women with gestational diabetes were different from 
women without gestational diabetes, and (3) to determine if minorities were at more at 
risk for depression than Caucasians. 
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CHAPTER TWO 
 
LITERATURE REVIEW 
 
This chapter addresses the biopsychosocial variables that contribute to depression 
and gestational diabetes.  In order to gain an understanding of these variables, a literature 
search was completed.   Using CINAHL, Medline, and PsychInfo, articles studying 
depression during pregnancy were examined.  The time frame from 2002 onward was 
selected as this was the time that most literature on depression during pregnancy was 
published.  The keywords used in the search were as follows: depression, pregnancy, 
antepartum, and prenatal.  A librarian was also consulted to aid in the search to insure 
that the most relevant articles were found.  Approximately 120 articles were found in the 
search, about 45 articles were included in this literature review.  Articles not included 
were (1) not written in English, (2) editorials, or (3) focused on postpartum depression.  
Most articles excluded were those that focused on postpartum depression which was not 
the intent of this study.  Eight literature review papers were found on the topic of 
depression during pregnancy.  The articles included in the review will be summarized and 
organized according to risk factors for developing depression during pregnancy, factors 
related to maternal health, and factors related to infant health.  Evidence from the 
literature suggests that depression is a common problem during pregnancy and has an 
impact on the health of the mother and infant.  It is important that this evidence be 
known, so practice can change and the care given to pregnant women improved.
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Risk Factors 
The literature review revealed four risk factors most often associated with 
depression during pregnancy: (1) decreased social support, (2) low income or 
socioeconomic status, (3) low education, and (4) younger age.  Race as a risk factor was 
found to be inconclusive and will be discussed as well. 
The relationship of social support, emotional distress, and stress were examined in 
a large cross-sectional, descriptive study (n=2052)  (Glazier et al., 2004).  Healthy 
pregnant women between 15 and 18 weeks’ gestation were requested to complete the 
following tools: Perceived Social Support, the Center for Epidemiologic Studies 
Depression Scale (CES-D), and the State-Trait Anxiety Inventory (STAI).  Results 
showed that depression was inversely correlated with education (r=-.21, p<.01) and 
income (r=-.24, p<.01), and similar relationships were found with anxiety.  Low social 
support was related to depression (r=-.32, p<.01) and anxiety (r=-.27, p<.01).  Stress was 
also significantly related to low social support and having more symptoms of anxiety and 
depression.  Limitations to this study were the lack of information regarding the racial 
distribution of the sample and the cross-sectional design.    
Social support and social conflict have been examined as predictors of prenatal 
depression (Westdahl et al., 2007).  One prospective, longitudinal study examined social 
support and social conflict as it relates to depression in women during their second 
trimester of pregnancy and followed them to one year postpartum.  Social conflict and 
social support were found to account for 34% of the variance for depression during 
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pregnancy.  Although education and relationship status with the infant’s father were the 
only socio-demographic variables found to be significant, they accounted for only 5% of 
the variance for depression.  Women with less education, who were not in a relationship 
with the father of the baby, were more likely to be depressed.  Low social support and 
high social conflict predicted depression and social conflict was more strongly related to 
depression (r=.58, p<.01) than social support (r=-.45, p<.01).  The finding that social 
conflict was a greater predictor of depression suggests that social support may be an 
important risk factor when studying depression. One strength of the study included a 
diverse sample (80% African American and 13% Hispanic participants); however, its 
generalizability to White participants was limited. 
Depression and social support have been examined relative to ethnicity (Sleath et 
al., 2005).  In a study of 73 pregnant women (23 Hispanic, 25 Black, and 25 White) 
between 12 and 32 weeks’ gestation, women with lower quality of social interactions as 
measured by the Quality of Social Interactions Scale had significantly more depression 
(Mean=11.64 ) than those who did not have low social interactions (Mean= 5.53, 
p<.001).  No significant difference in the incidence of depression (moderate or severe 
depression measured by the Beck Depression Inventory-II (BDI-II)) among the ethnic 
groups of African Americans (24%), Hispanics (13%), and Whites (20%) was found.  
Limitations of the study included the small sample and the lack of an operational 
definition of quality of social interactions which made the results difficult to interpret.  
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 Depression and support were also studied by Anderson, Roux, & Pruitt (2002).  
In a sample of 31 women between 32 and 39 weeks’ gestation, 29% of the sample scored 
higher than a 12 on the Edinburgh Postpartum Depression Scale (EPDS) which indicated 
depression.  Significant relationships between depression and marital dissatisfaction 
(r=.378, p=.02), partner satisfaction (r=-.584, p=.001), partner support (r=-.578 p=.001), 
partner closeness (r=-.663, p=.000) and partner love (r=-.506, p=.004) were found.  
Researchers also found that women with lower education levels (Tau=-.290, p=.027) and 
lower socioeconomic status (Tau=-.362, p=.019) were also found to have higher 
depression scores.  A limitation to this study was the small and predominately White 
(84%) sample.  Another potential limitation was the use of a tool developed by the 
researchers to measure social support; although the Cronbach’s alpha of .85 indicated it 
was a reliable measure.  
Records & Rice (2007) conducted a study focusing on depression and social 
support in 139 women during the third trimester of pregnancy.   Thirty-eight percent of 
the sample was found to have depressive symptoms (CES-D≥16).  Intermittent negative 
mood states, social support, marital satisfaction, and gravida accounted for 46% of the 
variance in depression during the third trimester.  In this model, social support accounted 
for 6% of the variance of depression and brief, intermittent negative mood states 
accounted for 24% of the variance.  Although this study was unique in that it focused on 
women in the third trimester, the Postpartum Depression Predictor Inventory-Revised 
Scale (which includes 12 items to measure social support) was used to measure social 
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support.  In addition, the reliability of this tool was not reported, which is a limitation of 
this study. 
Depression in relation to life circumstances was studied in a large, cross-sectional 
study of 1,321 women between 16 and 26 weeks’ gestation (Holzman et al., 2006).   Life 
circumstances were defined as life stressors relating to physical or sexual abuse, 
economic problems, substance abuse in a loved one, and legal problems.  For the 
analysis, the participants were divided into three groups: teenagers, women older than 20 
years and on Medicaid (disadvantaged), and women older than 20 years and not on 
Medicaid (advantaged).  Depression was found in 46% of the teens, 47% of the 
disadvantaged group, and 23% of the advantaged group.  Depression was higher in 
women who had problems with abuse, economics, and illegal substance use in someone 
close in the past six months for all three groups of women.  Overall, disadvantaged 
women and teens consistently had higher depression scores when compared to 
advantaged women.    
Another study was conducted in which the primary aim was to determine risk 
factors associated with prenatal depression (Leigh & Milgrom, 2008).  Depression, 
anxiety, self-esteem, and social support were measured in a sample of 367 pregnant 
women (between 26 and 36 weeks’ gestation).  Depression was measured using the Beck 
Depression Inventory (BDI) and anxiety was measured using the Beck Anxiety Inventory 
(BAI).  To measure social support, the Social Provisions Scale was used and the 
Rosenberg Self-Esteem Scale was used to measure self-esteem.  Using a cutoff score of 
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16.5 of the BDI to determine depression, 16.9% of the sample had prenatal depression.  
Multiple regression analysis indicated that the significant predictors of prenatal 
depression were as follows: low self-esteem (β= -.34, p<.001), antenatal anxiety (β= .32, 
p<.001), social support (β= -.18, p<.001), income (β= -.05, p=.04), history of abuse (β= 
.06, p=.03), major life events (β= .07, p=.01), and negative cognitive style (β= .11, 
p<.001).  The regression model explained 78% of the variance in prenatal depression.  
Interestingly, age, education, and depression history were not found to be significant 
predictors.  However, these factors were reported to be significantly correlated with 
antenatal depression (although the correlation coefficients and corresponding p values 
were not provided).  Limitations to this study include that only 1.6% (n=6) reported being 
without a partner, all other participants were married or with a significant other.  Also, 
87.5% of the sample was from Australia (where the study was conducted) which 
decreases generalizability of findings.       
Social support, education, and income were found to be significant factors related 
to perinatal depression (C. Anderson et al., 2002; Glazier et al., 2004; Marcus et al., 
2003; Records & Rice, 2007; Westdahl et al., 2007).  However, race as a risk factor was 
inconclusive.  In a study with a sample of 3,472 women (73% White and 13.3% Black) 
the CES-D was used to measure depression, but race was not related to depression 
(Marcus et al., 2003).  Only 20% of the sample was found to be depressed.  The sample 
was largely White which may have affected the findings regarding race.  This study did 
find that women with a history of depression were 4.9 times more likely to have antenatal 
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depression (p<.05). Also, poorer health (β=.39, p<.001), greater alcohol use (β=.211, 
p<.001), smoking (β=.13, p<001), lower education achievement (β=-.10, p=.04), 
unemployment (β-.30, p=.01), and not being married (β=-.56, p<.001) were significant 
predictors of depression during pregnancy.  A limitation of this study was the cross-
sectional design, and the large variability of gestational age (3 to 41 weeks, Mean=25 
weeks).   
Another study of 112 minority women in the second trimester of pregnancy (54% 
Hispanic, 46% Black) did not find a relationship between race and depression (T. Field et 
al., 2002).  However, differences were found in depression and socioeconomic status: the 
women with higher socioeconomic status had lower levels of depression.  Women in the 
low socioeconomic status group had a mean CES-D score of 13.78 and women in the 
higher socioeconomic status group had a mean score of 9.16 (p=.006). Because this study 
only included minority women, a true comparison by race was not able to be examined. 
Another study of minority women compared Latina women in the United States 
(n=108) to Latina women in Mexico (n=117) and did not find significant racial 
differences (Lara, Le, Letechipia, & Hochhausen, 2009).  This study reported that 32.4% 
of Latinas from the U.S with depression compared with 36.8% of Latinas from Mexico 
using the cutoff score of 16 on the CES-D.  Also, the mean CES-D score for U.S. Latinas 
was 12.9 and it was 14.7 for Latinas in Mexico; however, these differences were not 
statistically significant.     
A similar study, which also used the CES-D, but had a sample size of 252 
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women between 20 and 40 weeks’ gestation (77% White, 13% Black, 10% other) and 
reported that minority women had higher depression scores than White women 
(Lindgren, 2001).  However, it was not reported if the differences in depression scores 
between races were statistically significant.  This study also found that younger women 
(r=-.26, p<.05), less education (r=-.34, p<.05), and lower income (r=-.38, p<.05) were 
related to depression.  Perhaps the larger sample accounted for the ability to detect race as 
a factor related to depression. 
Orr, Blazer, and James (2006) reported differences between races and incidence 
of depression in 1,163 pregnant women in their first or second trimester of pregnancy 
(70% Black and 30% White).  Although the age range of patients was not provided, 
21.8% of the sample was younger than 20 and 78.2% was older than 20.  The CES-D was 
used to measure depression and 44% of the sample had depression based on a CES-D 
score of greater than or equal to 16.  The mean CES-D score for Black women was 17.37 
and was 13.65 for White women—which was significantly different, indicating Blacks 
were more depressed than Whites.  Black women had a 50% greater prevalence rate of 
depression even after adjustment for age, education, and marital status.  However, 
socioeconomic status, which has been associated with depression, was not controlled for 
(T. Field et al., 2002; Marcus et al., 2003).  Also, approximately 67% of the sample was 
enrolled in Medicaid (of which 72% of were Black).  Because Blacks were more likely to 
be on Medicaid, the difference found in depression scores between races may be more 
attributable to socioeconomic status instead of race. 
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Social support was found to be related to depression in all of the articles 
reviewed.  All of the articles that had a cross-sectional design measured social support 
and depression during the pregnancy, but the time was quite variable (between 3 to 41 
weeks’ gestation).  Only one study included pregnant women during the first trimester 
and all other studies focused on the second and third trimesters of pregnancy.  Regardless 
of the time when depression and social support were measured, women with more social 
support had less depression.  Many of these studies also included measurements of age, 
socioeconomic status and education.  Overall, it was noted that pregnant women who 
were younger had lower socioeconomic status, and those with less education were more 
likely to be depressed.  Although all studies agreed on the risk factors of age, low social 
support, education, and socioeconomic status, race as a risk factor to depression was not 
conclusive.  Race as it relates to depression needs to be studied further while controlling 
for the risk factors of age, low social support, education, and socioeconomic status in 
order to determine if it is a risk factor to depression.  
Maternal Health Factors 
Overall Health 
Pregnant women with depression are more likely to report having poor health.  
Women with a poor health status may require more complex prenatal care or they may 
elicit poor self-care behaviors which would suggest they are less likely to adhere to a 
complex prenatal care plan.  Women with a psychiatric diagnosis were reported to have 
poor prenatal care (Kelly et al., 1999).  Orr, Blazer, James, and Reiter (2007) studied 
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depression and maternal health status during pregnancy in a cross-sectional study of 
1,163 women in their second trimester (70% White, 30% Black).  Forty-four percent of 
the sample was found to have a score greater than 16 on the CES-D, indicating 
depression.  A total of 16.9% of the sample reported fair or poor health.  It was found that 
women with higher depression scores had twice the risk of poorer health (OR=1.74, CI= 
1.27-2.39) even when age, marital status, smoking, education, type of insurance, 
trimester, and race were accounted for.  The large, diverse sample size was a strength of 
the study.  However, with a 68% of the sample on Medicaid, the results may not be 
generalizable. 
Marcus et al., (2003), also found a relationship between overall health status and 
depression in a large, cross-sectional study (n=3742) of women between 3 to 41 weeks’ 
gestation.  Approximately twenty percent of the sample was found to be depressed.  As 
discussed earlier in this paper, there was a significant relationship between depressive 
symptoms and marital status, education level, employment status, history of depression, 
self-rated overall health, smoking, and alcohol and substance abuse.  A strength of this 
study was the large sample size.    
Anxiety 
 Many women with depression also report feelings of anxiety.  This relationship 
has also been reported in pregnancy (Breitkopf et al., 2006; Hart & McMahon, 2006).  
Hart & McMahon (2006) analyzed relationships between depression, anxiety, and 
psychological adjustment in 53 women between 20 and 38 weeks’ gestation using a 
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cross-sectional design.  Psychological adjustment was described as including two 
concepts:  maternal representation of herself as a mother and a positive relationship with 
the fetus.  Maternal representation of self was described as the mother being competent 
and confident in mothering behaviors and her role as a mother (Hart & McMahon, 2006).  
Relationship with the fetus was defined as the attachment developed between mother and 
fetus.  This attachment is represented by maternal behaviors such as healthy eating, 
talking to the fetus, stroking the belly, abstaining from cigarettes and alcohol, buying 
baby clothes and furniture, reading about child development, and attending antenatal 
classes.   Nine percent of the sample was found to score above 13 on the EPDS indicating 
depression.  Scores on the EPDS and the STAI were significantly correlated (r=.77 and 
.63, respectively, for state and trait anxiety, p<.001).  Relationship with the fetus and 
maternal fetal attachment was measured using the Maternal Antenatal Attachment scale.  
Mean STAI scores were significantly higher for women with low attachment scores 
(p=.015 for state anxiety and p=.038 for trait anxiety).  However, mean EPDS scores 
were not significantly different between women with high and low attachment scores 
(Mean EPDS 7.52 for women with low attachment scores and 5.57 for women with high 
attachment scores, p=.078).  Although depression was not found to be significantly 
related to maternal-fetal attachment, there was a trend indicating exploration of this 
relationship is needed.  However, the significant relationship between anxiety and 
depression suggests that it may be beneficial to measure anxiety when researching 
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antenatal depression.   Because this study was conducted in Australia, there may be 
limitations in the generalizability of the findings to U.S. women. 
Breikopf et al. (2006), examined the relationship between anxiety and depression 
symptoms in a group of pregnant, postpartum, and non-pregnant women.  The sample 
consisted of 807 women (36% pregnant, 23% postpartum, and 41% non-pregnant).  The 
measurements were done between 24 and 36 weeks’ gestation for the pregnant women 
and between 2 and 8 weeks postpartum for the postpartum group.  Twenty-eight percent 
of the sample was found to have depression symptoms. The Beck Depression Inventory 
(BDI-II) was administrated (recommended cutoff score of 16 for use in pregnant 
women), but the cutoff score was 14 because the sample included non-pregnant women 
(Holcomb, Stone, Lustman, Gavard, & Mostello, 1996).  Pregnant women had the highest 
depression scores with a mean value on the BDI-II of 11.5.  The mean values on the BDI-
II were 8.1 and 10.6 for postpartum and non-pregnant women, respectively.  A significant 
difference in mean scores was found between pregnant and postpartum women (p<.001), 
but not between pregnant and non-pregnant women (p=.66).  Depression scores were 
found to increase as anxiety scores increased.  Regression analysis suggested that anxiety 
scores would increase by 5.81 points (p<.001) in women reporting mild depression 
compared with women reporting minimal depression symptoms.   Anxiety scores would 
increase by 17.53 points (p<.001) for women reporting severe depression symptoms 
compared with women reporting minimal depression symptoms.  A history of depression 
and anxiety, as well as current depressive symptoms, were found to be significant 
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predictors of anxiety.  The strengths of this study were the diverse (50% Hispanic, 25% 
African American, 21% White, and 3% other) and large sample as well as use of a non-
pregnant comparison group.  A limitation of this study was the use of a lower cutoff 
value to determine depression which may have increased the number of women classified 
as depressed and potentially biased the results. 
Obstetric Complications 
Women with depression have been reported to have an increase in obstetric 
complications.   Larsson et al. (2004), reported that in a sample of 518 participants, 
women who were depressed (17.4% of the sample) were more likely to be multiparous 
and single.  The multiparous women in the depressed group were more likely to have had 
a previous pregnancy with complications when compared with the multiparous women 
without depression.  Complications of pregnancy (acute or elective cesarean sections, 
instrument delivery, perineal tears, excessive bleeding, premature contractions, back pain, 
or preeclampsia) were more often found in the depressed group.  Depressed women were 
also more likely to have premature contractions, back pain, and shorter gestational length 
by one week.  A limitation to this study was that only p values were reported in the 
analysis section making it difficult to interpret the strength of the relationships found in 
the study. 
Another study, which also analyzed obstetric complications, used medical records 
and a much larger sample of 32,156,438 deliveries between the years of 1998 and 2005 
(Bansil et al., 2010).  This study found that women with a depression diagnosis were 1.2 
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to 2.8 more times likely to experience maternal and fetal complications including: 
preterm labor, preeclampsia, diabetes, cesarean section, anemia, placental abnormalities, 
urinary tract infections, infections during labor, fetal growth restriction, fetal 
abnormalities, fetal distress, and fetal death.  This study was a cross-sectional study and 
so it is impossible to determine causality.  Although the use of medical records allowed 
for a very large sample size, the use of diagnosis codes to determine cases of depression 
may have resulted in some cases of depression being missed.  The researchers believed 
that only the most severe cases of depression would be coded because it is the most 
severe cases that would be likely to interfere with the routine care of a pregnant woman 
(Bansil et al., 2010); therefore the less severe cases of depression may not have been 
coded and included in the analysis.   
Preeclampsia is a serious obstetric complication that usually occurs during the 
third trimester of pregnancy where delivery of the infant is the only cure.  A prospective 
study of 623 Finnish women enrolled in the study between 8 and 17 weeks’ gestation 
found that depression (OR 2.5, CI 1.2-5.3) and anxiety (OR 3.2, CI 1.4-7.1) in early 
pregnancy increased the risk of preeclampsia (Kurki, Hilesmaa, Raitasalo, Mattila, & 
Ylikorkala, 2000).  This study also reported that 30% of the sample was found to be 
depressed and that older age (greater than 30 years) was another risk factor (OR 3.4, CI 
1.3-8.8) in developing preeclampsia.  The BDI was modified for this study; no 
information was provided on its reliability or validity.  Another limitation was the use of 
one item to measure anxiety.  
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Recurrent spontaneous abortions are another obstetric complication that can be 
challenging for health care providers to treat.  Two studies reviewed this complication 
and reported conflicting results (Bergant et al., 1997; Sugiura-Ogasawara et al., 2002).  
Depression was found to be related to recurrent spontaneous abortions in a prospective 
study of 61 women (Sugiura-Ogasawara et al., 2002).  This study recruited women who 
had a history of two recurrent spontaneous abortions and followed them longitudinally to 
see if there were differences in women that had another abortion and women that were 
able to conceive.  The participants entered the study at an average of ten months after 
their last miscarriage.  Out of the 61 women included in the study, 45 became pregnant 
again and ten of them had another subsequent spontaneous abortion.  Using the Symptom 
Checklist-90 to measure mental status, only the depression subscale was found to be a 
significant predictor of the subsequent pregnancy outcome, where women with 
depression were more likely to have a subsequent spontaneous abortion.  However, no 
specific statistics were reported, which is a limitation of this study.  The study was done 
in Japan with a small sample size which may decrease the generalizability of the findings. 
Bergant et al. (1997), compared women with a history of two recurrent 
spontaneous abortions (n=36) to women without a history of recurrent spontaneous 
abortions (n=36).  Women with recurrent spontaneous abortions all desired children and 
entered the study at six to eight weeks after their last miscarriage.  These women were 
followed for two years.  Those without a history of recurrent abortions were randomly 
selected from a sample of women that attended a hospital for a preventive checkup.  
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Their desire for children was unknown.  There was no difference between groups in 
depression scores on the BDI.  The sample size may be the reason for the non-significant 
findings.  This study was done in Germany and may decrease the generalizability of the 
findings to U.S. women.  
Poor Prenatal Care 
Women with a psychiatric diagnosis are more likely to have poor prenatal care.  
Kelly et al. (1999), used five psychiatric disorders to study this relationship: (1) 
substance-related disorder, (2) schizophrenic disorders, (3) mood disorders, (4) anxiety 
disorders, and (5) other psychiatric disorders.  Women were determined to have a 
psychiatric diagnosis by International Classification of Diseases, 9th Revision (ICD-9) 
codes documented in the California Health Information for Policy Project (CHIPP) 
database.  Poor prenatal care was defined as initiating prenatal care after the fourth month 
of pregnancy and/or attending less than 50% of recommended visits.  Women with a 
psychiatric diagnosis were 2.3 times (CI 2.23-5.50, p<.001) more likely to delay initiation 
of prenatal care and 2.18 times (CI 2.06-2.31, p<.001) more likely to receive inadequate 
prenatal services after controlling for potential confounding demographic variables.   Chi 
square analysis indicated that women without private insurance, of single marital status, 
of lower educational status, having one previous delivery, at a younger age, and of 
Hispanic and Native American race were more likely to receive poor prenatal care.  
Although this study suggests that Hispanics and Native Americans are more likely to 
have a diagnosis of psychiatric disorder, it did not provide any specific information about 
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the number of participants with depression compared to the other psychiatric diagnosis 
which limits the interpretation of the findings. 
In another study, poor prenatal care was not found to be significantly related to a 
psychiatric disorder (H. G. Kim et al., 2006).  Similar to the study discussed above, poor 
prenatal care was defined as initiating prenatal care after the fourth month of pregnancy 
and/or attending less than 50% of recommended visits.  This Primary Care Evaluation of 
Mental Health Disorder Patient Health Questionnaire was used to determine the 
psychiatric diagnosis of 154 participants.  Participants were given the questionnaire while 
attending prenatal care visits; the mean gestational age when interviewed was 28 weeks.  
After the women had delivered the infant, the medical chart was reviewed to determine 
the number of prenatal care visits attended.  A benefit of this study is that it indicated that 
of the 29% of participants who had a psychiatric disorder, 26% had major or minor 
depression.  Inadequate prenatal care was significantly related to domestic abuse in the 
past year, but not with current psychiatric disorder, alcohol abuse, age, primiparity, 
marital status, government assistance, or unplanned pregnancy.  Another difference with 
this study was the use of a questionnaire instead of ICD-9 codes to determine a 
psychiatric diagnosis.  A limitation of this study is that all women were interviewed 
during a prenatal care visit which may confound the results since these women were 
already receiving prenatal care. 
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Postpartum Depression 
Postpartum depression is serious and may lead to postpartum psychosis, a serious 
mental illness where suicide, infanticide, and homicide may result. Suicide is a risk of 
untreated depression and 86% of maternal deaths were related to psychiatric illness where 
68% of deaths were due to suicide (Oates, 2003).  Women with prenatal depression are 
more likely to suffer from postpartum depression.  Heron et al. (2004), conducted a large 
(n=8,323), prospective, longitudinal study.  Women were assessed for depression using 
the EPDS at 18 and 32 weeks’ gestation and 8 weeks and 8 months postpartum.  Women 
who had depression at 32 weeks’ gestation were found to be six times (OR=6.55, CI 
4.68-9.17) more likely to have postpartum depression.  Also, 43.7% of women with 
postpartum depression reported elevated depression symptoms during pregnancy.  The 
strengths of this study were the large sample and the longitudinal design to examine the 
relationship between prenatal and postpartum depression.  This study was done in 
England, which may decrease the generalizability of the findings because of socialized 
medicine. 
Another longitudinal study reported that 39% of women (n=2,674) who had 
depression during pregnancy also had postpartum depression (Rubertsson et al., 2005).  
Women were assessed for depression using the EPDS sometime during their prenatal care 
(16 weeks’ gestation was the average gestational age) and then at two months 
postpartum. A significant positive correlation (r=.52, p<.01) between antenatal 
depression and postpartum depression was reported.  Unemployment (RR 2.8, CI 2.6-
29 
 
 
5.8), younger age (RR 1.7, CI 1.2-2.5), single marital status (RR 3.9, CI 2.6-5.8), and less 
education (RR 2.1, CI 1.3-3.3) were associated with antenatal depression.  Although the 
study had a large sample and used the EPDS to determine the relationship between 
prenatal and postpartum depression, it was conducted in Sweden, which may decrease its 
generalizability.    
Infant Health Factors 
 Depression has been found to be related to many infant factors including: preterm 
birth (A. Beck & Steer, 1996; Dayan et al., 2006; Steer, Scholl, Hediger, & Fischer, 
1992), maternal-fetal attachment (Lindgren, 2001), negative infant reactivity (Davis et 
al., 2007; Davis et al., 2004; Diego et al., 2005; Huot, Brennan, Stowe, Plotsky, & 
Walker, 2004; Steer et al., 1992), fetal heart rate (Allister, Lester, Carr, & Liu, 2001), 
infant colic (Sondergaard et al., 2003) and developmental delay (Deave, Heron, Evans, & 
Emond, 2008).  It is important for health care providers to be aware and understand the 
impact of depression on the fetus and infant, and more importantly to recognize and treat 
depression to prevent poor infant outcomes.   
Preterm Birth 
Dayan et al. (2006), examined the relationships between depression, anxiety, and 
spontaneous preterm birth in a prospective cohort study (n=681).  The EPDS was used to 
assess for depression and the STAI to assess for anxiety between 20 and 28 weeks’ 
gestation. Preterm birth (defined as birth before 37 weeks’ gestation) was assessed using 
medical records.  Depression was found to be significantly related to preterm birth, where 
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9.7% of women with high depression scores had a preterm delivery compared to 4.0% of 
non-depressed women (p=.023).  There was not a significant relationship found between 
anxiety and preterm birth.  This study took place in France, which may limit the 
generalizability of the findings to U.S. women. 
 Steer et al. (1992), also found a relationship between preterm birth and 
depression.  This prospective study used the BDI to measure depression at 28 weeks’ 
gestation in 389 adults (greater than 18 years of age) and 323 teens.  In this study, low 
birth weight was defined as a baby weighing less than 2500 grams, small for gestational 
age was defined as having a birth weight below the tenth percentile for that gestational 
age, and preterm delivery was defined as delivering before the 37th week gestation.  For 
adult participants with a score higher than 16 on the BDI, indicating depression, there 
was an increased risk for delivery of a low birth weight infant (OR 2.86, CI 2.73-2.99), a 
small for gestational age infant (OR 2.32, CI 2.21-2.43), or delivering a preterm infant 
(OR 2.53, CI 2.42-2.65).  All odds risk ratios were adjusted for ethnicity, low pre-
pregnancy body mass index, inadequate pregnancy weight gain, smoking, and history of 
complications.  The risk of a low birth weight infant rose approximately 5% to 7% for 
each point the total score on the BDI increased (p <.05).  This study did not find a 
relationship between depression and low birth weight, preterm delivery, or small for 
gestational age infants in the teen population, which may suggest that the BDI may not be 
an appropriate tool for the teen population.  
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Maternal-Fetal Attachment 
Lindgren (2001) examined the relationship between depression, maternal-fetal 
attachment, and health practices in 252 pregnant women between 20 and 40 weeks’ 
gestation, in which 44% had depression defined as scoring 16 or higher on the CES-D.   
Women who had more children (r=.14, p<.05), were younger (r=-.26, p<.05), less 
educated (r=-.34, p<.05), lower income (r=-.38, p<.05), single (.r=30, p<.05), and from 
the inner city (r=.25, p<.05) had higher depression scores.  After controlling for age, 
income, and education there was a significant relationship between increased depression 
and less maternal-fetal attachment (measured by the Maternal Fetal Attachment Scale).  
However, depression explained only three percent of the variance in maternal-fetal 
attachment. 
Negative Infant Reactivity 
Depression and anxiety during pregnancy have been found to have negative 
effects on the infant (Davis et al., 2004).  Maternal depression and anxiety were measured 
in women at 32 weeks’ gestation and 8 weeks postpartum.  Forty-two percent of the 
sample was found to have scores greater than 16 on the CES-D indicating depression at 
32 weeks’ gestation.  Infant behavioral reactivity was assessed at four months of age 
using the Harvard Infant Behavioral Reactivity Protocol.  To measure infant behavioral 
reactivity, various stimuli were used to elicit a response.  The type of response such as 
movement and crying are recorded as a negative response.  The measures of anxiety and 
depression were highly correlated (r =.74, p=.0001) at 32 weeks’ gestation.  Prenatal 
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anxiety accounted for 20% and prenatal depression accounted for 27% of the variance in 
negative infant behavioral reactivity.  Postnatal measurements of anxiety and depression 
did not contribute significantly to infant behavioral reactivity.  This finding suggests that 
it is important to intervene during prenatal care to detect and treat depression symptoms, 
in order to prevent negative infant reactivity.   
Maternal depression during pregnancy has been found to impact infant 
temperament at six months (Huot et al., 2004).  This study included 123 mother-infant 
pairs.  Women were assessed for depression using the BDI sometime during pregnancy 
and postpartum; however, exact times of measurement were not reported and this is a 
limitation of the study.  Women who were assessed during the first or second trimester 
were combined into one group for analysis because there was a smaller number of 
women during these times compared to women assessed in the third trimester.  Higher 
BDI scores during the first two trimesters of pregnancy (but not the third trimester) were 
significantly related to negative infant affect (R2=0.11, p=.02).  There was no significant 
relationship found between postpartum scores on the BDI and negative infant affect.  The 
results indicate the importance of detecting and treating antenatal depression to improve 
infant health outcomes.  
 The effects of depression during pregnancy and cortisol levels on infant 
temperament were studied by Davis et al. (2007), in a longitudinal study of 247 mother-
infant pairs.   Maternal assessments of depression using the CES-D and anxiety using the 
STAI were done between 18 and 20 weeks’ gestation, 24 and 26 weeks’ gestation, 30 and 
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32 weeks’ gestation, and 2 months postpartum.  Depression scores on the CES-D and 
cortisol levels were found to be higher during pregnancy compared to the postpartum 
period.  At 30 to 32 weeks’ gestation, higher cortisol levels were found to be significantly 
related to negative infant reactivity (r=.20, p<.01).  However, postpartum cortisol levels 
were not found to be significantly related to negative infant reactivity.  Prenatal anxiety 
(r=.17, p<.01) and depression (r=.18, p<.01) were also found to be related to negative 
infant reactivity.  The effects of prenatal depression and cortisol levels on negative infant 
reactivity remained significant after controlling for postpartum depression and anxiety.  
These findings indicate that anxiety and depression during pregnancy have an impact on 
infant behavior regardless of postpartum depression and anxiety; and again, this supports 
the importance of diagnosing and treating prenatal depression and anxiety.  This study 
was unique because cortisol levels to determine a relationship between stress, depression, 
and anxiety were measured, and few studies have included physiologic markers.  Future 
studies may want to include measures of stress hormones to confirm the findings of this 
study. 
Diego et al. (2005), also reported a relationship between infant behavior and 
maternal depression.  This prospective, longitudinal study of 80 women used the CES-D 
to measure depression between 23 and 27 weeks’ gestation and then 2 weeks postpartum.  
When infants of mothers with prenatal depression were compared to infants of mothers 
without prenatal depression, women with prenatal depression had infants who spent more 
time crying and fussing (14% compared to 3%, p<.05), exhibited more stress behaviors 
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(9% compared to 5%, p<.05), and spent less time awake and alert (5% compared to 16%, 
p<.05) than infants of women without prenatal depression.  Also, women with both 
prenatal and postpartum depression had infants with lower mean motor scores (3.45 
compared to 4.59, p <.05) and mean orientation scores (3.36 compared to 4.99, p<.05) as 
measured by Brazelton Neonatal Behavior Scale.  Similar to the other studies on infant 
behavior, this study reported findings that are consistent with the need to treat prenatal 
depression to improve infant outcomes.  
Fetal Heart Rate 
Fetal heart rate is a measure of fetal well-being.  Allister et al. (2001), reported a 
relationship between fetal heart rate and prenatal depression in a cross-sectional study of 
20 women (10 with depression, 10 without depression) between 32 and 36 weeks’ 
gestation.  Depression was measured using the BDI and fetal heart rate was measured 
using a fetal heart monitor.  After a baseline fetal heart rate was obtained, a vibroacoustic 
stimulus was given.  Vibroacoustic stimulation applies an auditory stimulus to the 
maternal abdomen to stimulate the fetus.  Women with depression had higher baseline 
fetal heart rates (Mean FHR 145 bpm compared to 136 bpm), had smaller heart rate 
accelerations after the stimulus (Mean acceleration 6 bpm compared to 12.5 bpm), and 
required a longer amount of time to return to baseline after the stimulus (6 min. compared 
to 2.5 min.) than women without depression.  For the depressed group, a smaller 
acceleration suggested a slower response to the environment, and a longer time period to 
return to baseline suggested an inability to adjust to the external stimuli (Allister et al., 
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2001).  The inability to adjust to external stimuli may be related to an immature 
autonomic nervous system or an abnormality in the overall well-being of the fetus 
(Allister et al., 2001).  A weakness of this study is the small sample size and the use of a 
cutoff score of ten on the BDI, which is lower than the recommended cutoff score of 16 
for the pregnant population (Holcomb et al., 1996), which may have classified more of 
the women as depressed. 
Developmental Delay 
Depression during pregnancy has been found to be related to child developmental 
delay at 18 months of age (Deave et al., 2008).  Women (n=14,062, 96% White) were 
screened four times for depression (18 and 32 weeks’ gestation and 8 weeks and 8 
months postpartum).  Fourteen percent of women were found to be depressed at least 
once during pregnancy (but not postpartum), 4.8% were depressed at least once during 
postpartum (but not during pregnancy), and 1.4% were found to be depressed at least 
once both during pregnancy and postpartum.  Nine percent of children were reported to 
be developmentally delayed.  For women who had depression during both prenatal 
measurements, their child was 1.24 times (CI 1.04-1.49) more likely to be delayed.  Once 
smoking, maternal age, and life events were adjusted for, the risk of delay for their child 
increased to 1.34 times (CI 1.11-1.62).  This relationship between depression and delay 
remained significant after controlling for postpartum depression.  A limitation of the 
study was the small number of women reported to have depression during pregnancy and 
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postpartum.  A strength of the study was the large sample size; however, the sample was 
predominately White, limiting the generalizability of the findings. 
Sudden Infant Death Syndrome (SIDS) 
SIDS is the most common cause of infant death in the first year of life (Howard, 
Kirkwood, & Latinovic, 2007).  A retrospective, case control study (n=831) was 
conducted to determine if there was relationship between antenatal depression and SIDS 
(Howard et al., 2007).  Antenatal depression was defined as a diagnosis of depression by 
an ICD-9 code during the year before birth.  Women who had an infant death related to 
SIDS (n=169) were compared to women without an infant death (n=662).   There were 
no differences in substance use or alcohol consumption between groups.  However, 
smoking was more common in the women with cases of SIDS.  Also, depression during 
the year before birth was found to be associated with SIDS (OR=4.93, 95% CI 1.10-
22.05).  Postpartum depression was not associated with SIDS, indicating the importance 
of diagnosis of depression during pregnancy.  A limitation to this study was that women 
in the depression group were determined to have depression at some point during the year 
before birth but not necessarily during pregnancy.   The racial distribution of the sample 
was not reported and the study was done in England, which may also make 
generalizability of the findings problematic. 
Antenatal Depression Treatment 
 Only one research article was found studying a treatment program for depressed 
women during pregnancy (Spinelli & Endicott, 2003).  A review paper on treatments for 
37 
 
 
depression during pregnancy cited the Spinelli & Endicott paper as the only intervention 
study to meet the criteria to be included in the paper (Dennis, Ross, & Grigoriadis, 2007).  
Spinelli & Endicott (2003) conducted a controlled clinical trial in a sample of 50 pregnant 
women to compare a 16 week Interpersonal Therapy (IPT) treatment to a parenting 
education control.  Women began the IPT treatment or the parenting education class at 
about 21 weeks’ gestation.  Depression was measured by the Hamilton depression scale 
(HDS), the BDI, the EPDS, and the Structured Clinical Interview for DSM-IV Axis I 
Disorder.  Mood improved in both groups; however, mood improved significantly more 
in the IPT treatment group compared to the parenting education group on all 
measurements of mood (HDS: p<.03, BDI: p<.02, EPDS: p=.005).  This study was 
unique in testing an intervention treatment for prenatal depression. A strength of the 
study was that it included minority women with more than half having an annual income 
of less than $25,000 a year.  Another strength of the study was the use of a structured 
interview for depression and the randomized study design.   
Synthesis of the literature indicates there are multiple health risks to the mother 
and infant when the mother has depression during pregnancy.  Many of the longitudinal 
studies found that depression during pregnancy, but not in the postpartum period, had a 
significant impact on the health of the infant, indicating the importance of continued 
research in the area of antenatal depression.  Almost all of the studies used self-report 
measures to determine depression, which is a limitation to this body of research.  The 
results of the studies using only self-report measures would be strengthened if there had 
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been a diagnostic interview to validate the findings of the self-report questionnaires.   
Many of the studies included women in the second or third trimester, so it may be 
beneficial for future studies to include women in early pregnancy to determine when 
depression is most prevalent and its impact on the health of the mother and infant. 
Most studies used a sample of women that were already receiving prenatal care.  
Because depressed women may be more likely to receive poor prenatal care and miss 
prenatal care visits, many of the studies could be missing a large population of depressed 
women.  Also, many studies did not have diverse samples.  Future studies should target 
women who are at risk for receiving poor prenatal care and include racially diverse 
samples. 
Depression and Diabetes 
There is a known link between diabetes and depression.  Depression is more 
commonly found in women with type 2 diabetes (28%) than in men with type 2 diabetes 
(18%) (R. Anderson, Freeland, Clouse, & Lustman, 2001).  Whether the neuroendocrine 
changes in depression cause hyperglycemia or the effects of hyperglycemia cause 
depression is yet to be determined.  However, three meta-analyses have indicated that 
depression may predispose the onset of type 2 diabetes (Lustman et al., 2000; Lustman et 
al., 2007; Musselman, Betan, Larsen, & Phillips, 2003).  It has been shown that 
depression-induced changes in neurotransmitter functions may negatively affect glycemic 
control by causing hyperglycemia (Von Kanel, Mills, Fainman, & Dimsdale, 2001).  
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Also, depression has been found to be significantly related to hyperglycemia in both type 
1 and type 2 diabetes (Lustman et al., 2000).   
The effects of hyperglycemia have been known to cause depression because 
insulin resistance has been related to depression.  Insulin sensitivity was found to be 
significantly lower in depressed patients when compared to non-depressed people and 
insulin resistance improved with treatment of depression (Lustman et al., 2007).  Also, 
the pathophysiological relationship between insulin resistance and psychological stress 
may be due to the exposure to the stress hormones, the catecholamines and 
corticosteroids, the proinflammatory cytokines, and the free fatty acids acting in 
combination to cause increased insulin resistance (Black, 2006). 
Although the hyperglycemia and insulin resistance that occur during diabetes has 
been related to depression, the relationship between gestational diabetes and depression 
has not been extensively researched.  Hyperglycemia is also a complication of gestational 
diabetes and is related to increased stillbirths and increased infants born with macrosomia 
(Dudley, 2007; Metzger et al., 2008).  Whether hyperglycemia during pregnancy is 
associated with increased incidence of depression is unknown and is an area for future 
research. 
Gestational Diabetes and Depression 
Despite the association between depression and type 1 and 2 diabetes, there is 
little known about gestational diabetes and depression.  During the literature review, only 
five studies were found that examined depression and gestational diabetes. 
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 A cross-sectional, descriptive study of 90 high risk pregnant women between 34 
and 36 weeks’ gestation to determine if a high risk pregnancy was associated with 
depression and maternal fetal attachment was conducted by Chazotte, Freda, Elovitz, & 
Youchah (1995).  The CES-D was used to compare the following groups: (1) women 
with gestational diabetes (n=30), (2) women at risk for a preterm delivery (n=30), and (3) 
women with an uncomplicated pregnancy (n=30).   Fifty-seven percent of the gestational 
diabetics, 70% of the women at risk for preterm delivery, and 33.3% of the 
uncomplicated pregnant women were found to be depressed (≥ 16 on the CES-D).  
Although the pregnant women with gestational diabetes had a greater incidence of 
depression than women with an uncomplicated pregnancy, this difference was not 
statistically significant.  The researchers suggested that this lack of difference may have 
been due to the small sample size, thus insufficient power necessary to find significant 
differences between the groups.  Most of the sample consisted of minority women (94%), 
therefore, it is unknown if these findings would be generalizable to White women. 
 A similar study examined health-related quality of life and depressive symptoms 
in pregnant women (n=90).  Here a prospective, longitudinal study compared women 
with hypertension (n=18), gestational diabetes (n=11), preterm birth (n=32), and healthy 
pregnant women (n=29) (Mautner et al., 2009).  The EPDS was used to measure 
depression at three times throughout the perinatal period (24-37 weeks’ gestation, 2-5 
days postpartum, and 3-4 months postpartum).  No significant differences in depression 
scores were found between women with gestational diabetes and women without 
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gestational diabetes.  However, the highest rates of depressive symptoms occurred during 
late pregnancy (24-37 weeks’ gestation).  In addition, women with preterm delivery 
followed by women with hypertensive disorder reported the greatest number of 
depressive symptoms.  The only significant difference in depressive symptoms was found 
between women with preterm delivery and women with healthy pregnancies.  Limitations 
to this study included the small sample of women with gestational diabetes who were 
from one hospital located in Austria.  
The diagnosis of gestational diabetes and its impact on emotional adjustment was 
studied by Langer & Langer (1994).  In this study, 206 women with gestational diabetes 
and 95 non-diabetic pregnant women between 37 and 38 weeks were assessed for 
depression using the Profile of Mood States-Bipolar (POMS-B).  No differences in 
depression scores were noted between gestational diabetics and non-diabetics.  However, 
the study reported that the mean score on the POMS-B was in the normal range for both 
groups with the mean score of 45 for the women with gestational diabetes and 44 for the 
women without diabetes on the elated-depressed subscale (Langer & Langer, 1994).   
This study was unique because it classified the women with gestational diabetes by the 
type of treatment (diet or insulin therapy) and by their level of glycemic control (good 
control or poor control).  In this study, good control was defined as a mean glucose <105 
mg/dL and poor control was a mean glucose ≥ 105 mg/dL.   Also, the target range was 
defined as an overall mean blood glucose of 90-100 mg/dL, fasting blood glucose of 60-
90 mg/dL, and postprandial blood glucose less than 120 mg/dL.  Participants were 
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classified as having good control if their average blood glucose was less than 105 mg/dL 
and women were said to have poor control if their average blood glucose was greater than 
105 mg/dL.   Intense treatment for gestational diabetes (insulin therapy and close 
monitoring of blood glucose) was not related to increased depression symptoms.  
However, women with good control of their diabetes were less distressed than women in 
poor control.  Twenty-one percent of the variance in the average mood disturbance score 
was explained by the number of glucose readings in the normal range, number of glucose 
readings above the target range, marital status, and maternal age.  A limitation of this 
study is that the number of women with depression was not reported, and there may have 
not been a sufficient number of women with depression to find differences between 
women with and without depression.  Finally, the use of the POMS-B has not been 
widely used in pregnancy and the reliability and validity of the tool was not reported for 
this study.   
   Kim, Brawarsky, Jackson, Fuentes-Afflick, & Haas (2005) examined health status 
in pregnant women with gestational diabetes (n=64), pregnancy induced hypertension 
(PIH) (n=148), or uncomplicated pregnancy (n=1233).   Although the focus of this cohort 
study was not depression, it was assessed using the CES-D between 12 and 20 weeks’ 
gestation and between 8 and 12 weeks postpartum.  Although women were measured 
between 12 and 20 weeks’ gestation, they were asked to answer questions regarding the 
month prior to conception.  Therefore, perceived depression before pregnancy was 
assessed rather than actual antenatal depression.  Depression was present in 7.8% of 
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women with gestational diabetes, 10.1% of women with PIH, and 11.6% of unaffected 
women.  Group differences were not significant for depression; however, researchers 
reported that women with gestational diabetes had poorer self-rated health in the third 
trimester (20%) compared to women without gestational diabetes (9.2%).  The 
researchers suggested the study may not have been powered sufficiently to detect 
significant differences for depression.  Differences in self-rated health during the third 
trimester were reported but it is unclear how this was measured.  A weakness of this 
study is that women were asked to recall feelings of depression and health the month 
prior to conception at 12 to 20 weeks’ gestation which may have measurement error due 
to recall bias.  
 A recent study reported that women with diabetes during pregnancy were more 
likely to have depression (Backes Kozhimannil, Pereira, & Harlow, 2009).  A large 
sample (n=11,024) using a retrospective cohort design used medical records from New 
Jersey’s Medicaid administrative claims database and ICD-9 codes to determine women 
with diabetes and depression.  After controlling for age, race, and preterm birth, 15.2% of 
women with diabetes during pregnancy had depression compared to 8.5% of women 
without diabetes (OR 1.85, 95% CI 1.45-2.36).  This study also reported that women with 
diabetes but no depression during pregnancy were more likely to develop postpartum 
depression (OR 1.69, CI 1.27-2.23).  The strength of this study was the large sample size.  
However, one weakness was that women with gestational diabetes, type 1 diabetes, and 
type 2 diabetes were grouped together in the study.    
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 These five studies were the only studies found that examined depression and 
gestational diabetes.  Four studies did not show that pregnant women with gestational 
diabetes are at greater risk for depression; however, all four of the studies had small 
sample sizes and inadequate power (Chazotte, Freda, Elovitz, & Youchah, 1995; C. Kim, 
Brawarsky, Jackson, Fuentes-Afflick, & Haas, 2005; Langer & Langer, 1994; Mautner et 
al., 2009).  One large study reported a difference in depression between women with 
diabetes compared to women without diabetes.  However, this large study studied women 
with type 1, type 2, and gestational diabetes making it difficult to make conclusions 
specifically about gestational diabetes.  Therefore, a gap in the literature exists and the 
need for a study with a large sample and adequate power to determine if women with 
gestational diabetes are more at risk for depression is needed.   
A relationship between depression and poor self-care in people with diabetes has 
been established (Lin et al., 2006).  Women who are depressed during pregnancy were 
more likely to smoke, use alcohol, miss prenatal care visits, or delay initiation of prenatal 
care (Kelly et al., 1999; Marcus et al., 2003).  Pregnant women with depression and 
gestational diabetes may find it difficult to perform all the self-care behaviors necessary 
to effectively manage the diabetes.  Future studies may want to include measurements of 
self-care to determine if women with depression and gestational diabetes are more at risk 
for complications. 
The relationship between hyperglycemia, increased insulin resistance, and 
depression has been documented in type 2 diabetes and suggests that depression may 
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cause gestational diabetes.  However, this has not been established through research in 
the area of gestational diabetes.  Future studies may find it beneficial to measure insulin 
resistance, hyperglycemia, and depression in a prospective study beginning in the first 
trimester of pregnancy before the diagnosis of gestational diabetes is made later in the 
third trimester.  This study would provide evidence as to whether depression is a risk 
factor for developing gestational diabetes.    
Electronic Medical Record 
  The electronic medical record (EMR) is defined as a digital collection of patient 
data that is accessible to multiple authorized users and is exchanged and stored securely.  
It includes retrospective, current, and prospective information and has the primary 
purpose of providing efficient and high quality health care (Hayrinen, Saranto, & 
Nykanen, 2008).  Although the EMR is primarily used for clinical purposes, it may also 
be used for research.  When using the EMR for research, it is important to consider the 
quality of the retrieved data information.  Information quality includes the concepts of 
completeness, accuracy, and reliability. 
 A review paper analyzed the information quality in 299 studies using the EMR as 
a data source (Hayrinen et al., 2008).  This paper reported that of the 299 studies 
reviewed, 55 reported on the completeness of the data in the EMR.  Completeness is a 
measure of the amount of missing data.  Many of the studies (n=31) found that 
documentation by the health care provider was more complete and included more details 
in the EMR than in another data source.   Data accuracy is a measure of how accurate the 
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data in the EMR is compared to another data source.  A review of data accuracy was 
included in 29 of the papers and it was found that data in the EMR was accurate.  
Another study involving respiratory illness in an emergency department compared 
electronic data to data retrieved from a paper chart and found the electronic data to be 
accurate (Townes et al., 2004).  When the electronic data was compared to a dictated 
clinical note, it was found that 95% of the notes included a history of one respiratory 
symptom or an objective sign of a respiratory tract infection on physical examination.   
Reliability is a measure of how often the data shows the same results over 
multiple measurements.  Electronic medical records have been found to produce reliable 
data (Hayrinen et al., 2008).  Reliability and accuracy of EMR’s were analyzed in a study 
on the amount of prescribed medication to the elderly for osteoarthritis in general 
practitioners’ offices (Vandenberghe et al., 2005).  In this study, the general practitioner 
had the option of using a semi-automatic data extraction system from an EMR or data 
collection with paper registration sheets.  Semi-automatic data extraction was completed 
by the EMR software developers creating a data extraction software program to extract 
the necessary data for the study.  Once the necessary data was extracted from the chart, 
the general practitioner had the ability to review the data and modify data or add missing 
data.  This step allowed the general practitioner to improve the quality of the data.  The 
data collected from the charts included age, sex, diagnosis and location of osteoarthritis, 
treatment type (medication, physiotherapy, diet, surgery, other, or none), and prescribed 
medications for osteoarthritis (paracetamol, NSAID, or other painkillers).  The analysis 
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included 222 general practitioners who collected data on 4,231 patients using paper 
sheets and 146 general practitioners who collected data on 3,055 patients using EMR.  
Although there were fewer practitioners using EMR, they were able to collect data on 
more patients indicating the ease and timely manner in which data can be collected using 
EMR.  This study also found that the proportion of patients who were prescribed drugs to 
treat osteoarthritis was almost twice as high for the general practitioners recording data 
on paper sheets (64%) when compared to the general practitioners using EMRs (36%).  
One possible explanation for this difference is that the general practitioners wrote the 
prescriptions on paper and did not record them in the EMR.  Another possibility is that 
the prescriptions were recorded in a different place in the EMR and the semi-automatic 
extraction was not able to capture the total number of patients on medications.   
 Missing data and problems with data entry are two weaknesses that may be found 
when using EMR as a data source.  Missing values can be found in any large database 
(Cios & Moore, 2002).  The missing value may be due to an oversight or intentionally 
due to a technical, economic, or ethical reason (Cios & Moore, 2002).  Missing values 
may be substituted with the most likely value, with all possible values, or with a likely 
range of possible values (Cios & Moore, 2002).  A statistician who is familiar with large 
data sets may be needed to assist in methods to replace missing data.  Data entry 
problems can also occur because many terms are used to describe the same conditions 
(Cios & Moore, 2002).  An example of this would be terms for high blood pressure 
during pregnancy which include the following: hypertension, pregnancy induced 
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hypertension, and preeclampsia.  All three diagnoses include high blood pressure 
occurring during pregnancy, so when studying the complication of high blood pressure 
during pregnancy, it is important to search the EMR for all three terms.  Similarly, when 
health care providers document this problem in the chart, they may use one or all three of 
these terms, also creating a challenge for accurate data extraction for research. 
 One of the strengths of using EMR as a data source is the ability to collect a large 
amount of data on many people in a short time.  For example, a large study using EMR as 
a data source found that hypertension was under-diagnosed in the pediatric population 
(Hansen, Gunn, & Kaelber, 2007).  This study had a sample size of 14,187 patients and 
data was collected for 53,911 patient visits over seven years.  The author reported that the 
study took about 100 hours of work time, and was completed without significant 
resources as compared to a study of this magnitude that did not use EMR that would have 
required many hours and cost hundreds of thousands of dollars.  Another strength of 
using the EMR as a data source is that preliminary data can be generated to provide 
support for a possible intervention study.   
Use of the electronic medical record systems has the ability to transform research 
and may change the way research is conducted in the future.   However, it will be 
important to assess and understand the data quality issues (completeness, accuracy, and 
reliability) that may occur or may be inherent with electronic documentation so that these 
can be controlled in study design.  Assurances of high quality data is essential for 
research to be conducted using new and different methods of automated data captured at 
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the point of care and aggregated across patient populations (Thiru, Hassey, & Sulllivan, 
2003).    
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CHAPTER THREE 
METHODOLOGY 
This chapter addresses the study design, sampling criteria, recruitment strategies, 
enrollment procedures, and data collection methods (including all measurements).  As 
stated previously, the purpose of the study was to determine if women with gestational 
diabetes were more likely to suffer from depression.  Although depression and gestational 
diabetes are common occurrences during pregnancy, the relationship between the two has 
not been extensively studied.  The study aims were as follows: (1) to determine whether 
women with gestational diabetes had more depression than women without gestational 
diabetes, and (2) to determine whether factors predictive of depression in pregnant 
women with gestational diabetes were different from women without gestational 
diabetes.  An exploratory aim to determine if minorities were more at risk for depression 
during pregnancy than Caucasians was also examined. 
Design 
 This study used a comparative, longitudinal design.  It was comparative because 
women with gestational diabetes were compared to women without gestational diabetes 
(Nieswiadomy, 1998).  It was longitudinal because data was collected in the antepartum 
period from the mother and information regarding infant and maternal outcomes was 
collected following delivery.   The study explored whether having depression or 
gestational diabetes impacts 
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health outcomes in the mother and infant when compared to pregnant women who do not 
have depression or gestational diabetes.  The psychological factors (depression, history of 
depression, anxiety, perceived stress, and social support), biological factors (body mass 
index (BMI)), oral glucose tolerance test results, type of delivery, complications during 
delivery, Apgar scores, gestational age at delivery, and infant birth weight), and 
sociological factors (socioeconomic status, race, marital status, and medical history) were 
studied.  
Setting  
The study was conducted primarily in outpatient clinics of a large, urban, 
Midwestern medical center (99% women).  Because data collection was slower than 
anticipated, another outpatient clinic approximately five miles from the primary site was 
also used (1% women).  Data collection occurred over a period of one year (January 2010 
to 2011).  Both data collection sites serve the ethnically and economically diverse 
population of the greater Chicago area.   
Sample 
The sample was a convenience sample of pregnant women who met selected 
inclusion and exclusion criteria.  The sample inclusion criteria were as follows: women 
who received prenatal care at the research sites, between 24 and 40 weeks’ gestation, 
spoke and read English, and older than 18 years.  The exclusion criteria were as follows: 
women under the age of 18 because expression of symptoms of depression varies with 
developmental stage and some adolescents may have difficulty identifying and describing 
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mood states (Bhatia & Bhatia, 2007).  Also, women who did not read or speak English 
were excluded because of insufficient funds to pay for translation.  In order to classify 
women as having gestational diabetes, the results of the three-hour oral glucose tolerance 
test, an ICD-9 code of gestational diabetes, and/or a one-hour OGT greater than 200 
mg/dL (see measurement section for how women with gestational diabetes was defined) 
were used.   
To determine the sample size needed for statistical significance, a power analysis 
was conducted.  Using the data from Chazotte et al. (1995), there was an incidence of 
significant depressive symptoms (CES-D ≥ 16) in women with gestational diabetes of 
57% and of 33% in women without gestational diabetes.  Using G-Power, in order to 
detect a difference between groups using these percentages with an alpha of 0.05, power 
of .80, and one-sided tail distribution, 58 women per group are needed.  Thus, 120 
women were needed to determine whether women with gestational diabetes had more 
depression than women without gestational diabetes.  To determine whether 
psychological (anxiety, stress), biological (gestational diabetes, age), and sociological 
(social support, marital status, socioeconomic status) factors were predictive of 
depression in pregnant women with and without gestational diabetes, a conservative rule 
of 10 to 15 subjects per major variable, or a total of 80 to 120 subjects, was required.  
Thus, a sample of 147 women was recruited in order to account for missing data. 
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Recruitment of Study Participants 
Participants were recruited from outpatient obstetrics offices.  The investigator 
approached pregnant women while they were attending a routine prenatal care visit.  
After the nurse or technician had completed the patient vital signs and the patient was in 
the exam room, the nurse or technician asked the patient for permission for the 
investigator to come in and discuss the study.  If the patient agreed, the investigator went 
in the room to explain the study and determine if the patient was interested.  If the patient 
agreed to participate, the investigator explained the informed consent document and the 
self-report questionnaires (Appendix A).  The participant had the option of signing the 
informed consent document and completing the self-report questionnaires while at the 
visit or take them home and return them in a pre-paid envelope or at another scheduled 
visit.  The investigator also recruited gestational diabetics who had a scheduled visit with 
the dietician.    The process was the same: the dietician would ask permission for the 
investigator to talk about a study and if the patient agreed, the investigator would 
approach the patient and explain the study, the informed consent document, and the self-
report questionnaires.  All participants were made aware that by signing the consent they 
were giving the investigator permission to access their electronic medical record.  A flyer 
(Appendix B) was also posted around the clinics and institution regarding participation; 
however this method of recruitment did not lead to any participants. 
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Collection of Data  
Data was collected using self-report questionnaires and medical records.  
EpicCare (Epic) is a common type of EMR and was used at the institution where most of 
the data was collected.  The use of Epic began in the ambulatory care setting in 2004 and 
in the inpatient setting in 2007 and has been successfully used in documenting patient 
information and providing quality care.  At the other data collection site, information was 
collected using paper medical records.  These records were only from the outpatient 
obstetric clinic; the inpatient hospital records were not accessed.  
 The self-report questionnaire included the following: the depression score 
measured by the CESD and the EPDS, the anxiety score, the perceived stress scale, the 
social support scale, and demographic and health information (including age, race, 
marital status, socioeconomic status, depression history, other chronic conditions, 
estimated date of delivery, list of current medications, gravida, and parity) (Table 1).  
Data taken from the EMR included the following: weight, height, gravida, parity, 
ethnicity, race, results of oral glucose tolerance test, gestational age at delivery, type of 
delivery, complications during delivery, perineal tears, infant birth weight, and Apgar 
scores (at one, five, and ten minutes) (Table 1).   
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Table 1: Data Collection Methods 
Variable Data Collection Method 
Depression (CESD and EPDS scores) 
Anxiety (STAI score) 
Stress (Perceived Stress Scale) 
Social Support (MSPSS score) 
Age 
Race & Ethnicity 
Marital Status 
Socioeconomic Status 
Depression History 
Chronic Conditions 
Current Medications 
Estimated Date of Delivery 
Gravida & Parity 
Self-report questionnaire 
Result of OGT test 
Infant Birth Date 
Infant weight 
Infant Length 
Apgar Scores 
Gestational Age at Delivery 
Type of Delivery 
Delivery complications 
EPDS Scores 
Maternal Height 
Maternal Weight 
Perineal Tears & Episiotomy 
Maternal Height & Maternal Weights 
Infant Hypoglycemia 
Electronic Medical Record 
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Other variables extracted from the EMR for a possible secondary analysis 
included the following: past medical history, current medical diagnoses, depression 
scores measured by the EPDS (done at four time points: 28 weeks’ gestation, time of 
delivery, two weeks postpartum, and six weeks postpartum), history of tobacco, alcohol 
or illegal substance, type of anesthesia used during delivery, occurrence of induction, 
plan to breastfeed, infant size (average for gestational age (AGA), small for gestational 
age (SGA), or large for gestational age (LGA)), and infant blood glucose levels to 
determine episodes of hypoglycemia. 
The self-report questionnaire booklet (Appendix A) took participants about 15 to 
30 minutes to complete.  Upon successful completion, the participants were given a $10 
gift card.  Participants who took the self-report questionnaire booklets home were sent the 
$10 gift card once the booklet was received in the mail.  The phone number and address 
of patients who took the questionnaire booklet home was obtained and the gift card was 
mailed once the completed booklet was received.  If patients had not returned the booklet 
within a couple of weeks, the investigator called the patient to remind them to complete 
and mail back the booklet.  
After the patient had completed and returned the self-report questionnaire booklet, 
data was collected from the EMR (electronic medical record) of both the mother and the 
infant.  Data extracted from the EMR of the mother included the following: weight, 
height, gravida, parity, ethnicity, race, results of oral glucose tolerance test, gestational 
age at delivery, type of delivery, complications during delivery, and perineal tears.  The 
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data to be extracted from the infant EMR included the following:   infant birth weight and 
Apgar scores (at one, five, and ten minutes).  See Appendix C for variables collected 
from the EMR.   
Data collection from the EMR occurred in two stages.  The first stage entailed the 
investigator accessing the EMR to obtain the participant OGTT results, gravida, and 
parity.  The second phase was done using a template to extract variables from the EMR.  
The template was created specifically for the study by an informatics specialist.   This 
template was created as a way to expedite data retrieval from the EMR.  To create the 
template, the investigator worked with the informatics specialist to determine what 
variables should be extracted from the chart.  The medical record numbers of the 
participants were given to the informatics specialist.  The informatics specialist then 
entered the numbers into the template and the variables collected from the EMR were 
automatically pulled and provided in a word document.  The template for this research 
study included the following maternal variables: maternal height and weight, past 
medical history, gravida, parity, type of delivery, perineal tears, episiotomy, and 
substance abuse.  The template included the following infant variables: date of birth, 
Apgar scores (at one, five, and ten minutes), birth weight, birth length, and any results for 
a blood glucose level for the infant.   
Only information which could be documented as a discrete variable in the EMR 
was provided on the template.  Therefore, to collect information which was only 
contained in physician notes (such as complications during delivery), the investigator 
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accessed the EMR of all participants.  The information provided in the template was also 
checked to ensure that accurate information was being recorded.  This check was done by 
reading four notes in the maternal EMR: the history and physical admission note when 
the participant began prenatal care, the history and physical admission note when the 
participant was admitted to the hospital for delivery, the delivery summary note, and the 
discharge note.  Also, two notes were read in the infant EMR: the admission note to the 
nursery and the discharge summary note.     
Measurements 
The measurements were organized using the biopsychosocial model previously 
discussed in Chapter 1 (see Table 2).    See Appendix A for a copy of all the 
measurement tools used. 
 The psychological factors assessed included depression, social support, anxiety 
and stress.  For depression, the CESD and EPDS instruments were used to measure 
depression and were included in the self-report questionnaire booklet. The EPDS is a ten-
item tool in which each item is scored on a four-point scale (0-3).  The score from each 
item is then summed to give a total score ranging from 0-30.   
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Table 2: Variables and Measurements of Study 
 Variable Measurement 
Psychological Factors 
Depression EPDS score 
CESD scores 
History of Depression 
Social support MSPSS 
Anxiety STAI 
Stress PSS 
Biological Factors 
Maternal Health 
Factors 
BMI 
OGTT Results 
Gravida and Parity 
Current medications 
Type of Delivery 
Delivery Complications 
Infant Health 
Outcomes 
Apgar scores 
Gestational age  
Birth weight 
 
Sociological Factors 
Socioeconomic Status Income 
Demographic Maternal Age 
Race 
Ethnicity 
Marital Status 
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Higher scores indicate more depressive symptoms in the individual.  The 
recommended cutoff score to indicate prenatal depression is 12/13 resulting in a 
sensitivity of 64% and specificity of 95% (Murray & Cox, 1990).  In the study, a cutoff 
score of 12 was used to indicate depression.  The EPDS was developed for use in the 
postpartum population but has been validated for use during pregnancy (Murray & Cox, 
1990).  In addition, reliability has been established (Cox, Holden, & Sagovsky, 1987).  
The EPDS for the current study had a Cronbach’s alpha of .91.  
The CES-D was developed by Radloff (1977) and is a 20-item tool that has items 
scored on a scale of 0 to 3 and then summed to give a total score ranging from 0 to 60.  A 
higher score indicates more depressive symptoms.  A score equal to or greater than 16 
indicates depression (Radloff, 1977).  Similar to the EPDS, the CES-D asks the 
individual to answer the items based on his or her feelings in the past week.  The CES-D 
has established reliability in pregnancy (Maloni, Seunghee, Anthony, & Musil, 2005).  In 
the current study the Cronbach’s alpha of the CES-D was found to be .90.      
For anxiety, the Speilberger State Trait Anxiety Inventory (STAI) scale is a 40-
item tool which measures both a person’s current level of anxiety (state anxiety) and a 
person’s general and long standing anxiety (trait anxiety).  The measure of state anxiety 
includes 20 items using a four point Likert scale (1=not at all to 4=very much so), with a 
total score ranging from 20-80.  Another four point Likert scale (1=not at all to 4=almost 
always) is used to measure trait anxiety in 20 items, again with the total score ranging 
from 20-80.  Higher scores on the STAI indicate higher levels of anxiety.  The STAI has 
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been frequently used in pregnant populations (Allister et al., 2001; Bergant et al., 1997; 
Breitkopf et al., 2006; Davis et al., 2004; Dayan et al., 2006; Glazier et al., 2004; Hart & 
McMahon, 2006) with acceptable reliability for state and trait anxiety (Dayan et al., 
2006).  In the current study, the Cronbach’s alpha for the state anxiety was .93 and .94 for 
trait anxiety.  
The Multidimensional Scale of Perceived Social Support (MSPSS), a 12-item 
tool, was used to measure social support (Zimet, Dahlem, Zimet, & Farley, 1988).   Each 
item is scored on a 7-point Likert scale (1=very strongly disagree to 7=very strongly 
agree).  To compute a total social support scale, the mean of all items are used with 
higher scores indicating more social support (with total scores ranging from 1-7).  There 
are three subscales to the tool including significant other support (item numbers 1, 2, 5, 
10), family support (item numbers 3, 4, 8, 11), and friend support (item numbers 6, 7, 9, 
12).  The tool has established reliability and validity in the pregnant population (Zimet, 
Powell, Farley, Werkman, & Berkoff, 1990).  In the current study, the Cronbach’s alpha 
was .94 for the total scale and for the subscales, .95 for significant other support, .90 for 
family support, and .97 for friend support. 
To measure stress, the Cohen’s Perceived Stress Scale (PSS) was used.  This is a 
commonly used 10-item tool to measure a person’s amount of stress.  Each item is scored 
on a 5 point Likert scale (0=never to 4=very often) and then scores are summed with 
higher scores indicating higher levels of stress.  This tool has established reliability 
(Cohen & Williamson, 1988).  In the current study, the Cronbach’s alpha was .92.  
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For the history of depression and chronic conditions, the self-report questionnaire 
asked women if they had a history of depression by the question: “Have you ever been 
diagnosed with depression?”  The women were also asked if they had a current diagnosis 
of asthma, diabetes, hypertension, depression, bipolar disorder, or schizophrenia.  
Women had the option to write in any other current diagnosis.  Women who had a 
positive history of depression were not excluded.   Women with type 1 or type 2 diabetes 
were excluded.  
The biological factors assessed included maternal health and infant factors.  For 
the mother, body mass index (BMI), gravida and parity, oral glucose tolerance test 
results, current medications, type of delivery, and complications of delivery were 
assessed.  For BMI, weight (lbs) and height (in) at the time of the prenatal care visit when 
the patient filled out the self-report questionnaire was extracted from the EMR.  To 
calculate BMI, the formula 703 times the weight divided by the height squared was used.  
Gravida was recorded as the number of times a woman has been pregnant.  Parity 
consisted of the results of those pregnancies and included full term deliveries, preterm 
deliveries (infants born between 20 and 37 weeks’ gestation), abortions (including 
spontaneous and miscarriages), and current living children.  In the self-report 
questionnaire, women were asked to report their gravida and parity.  This information 
was also extracted from the EMR. 
Women were routinely screened for gestational diabetes with an oral glucose 
tolerance test to diagnose gestational diabetes.  Typically, to make a diagnosis of 
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gestational diabetes two OGTT were done: a one-hour test and a three-hour test.  For the 
one-hour OGTT, women were given a 50-gram glucose drink to ingest and then a blood 
glucose reading was obtained one hour later.  The American Diabetes Association and the 
American College of Obstetricians and Gynecologists accept either value (130 mg/dL or 
140 mg/dL) as an abnormal value on the one-hour OGTT that indicates further testing for 
gestational diabetes by a three-hour OGTT (Turok, Ratcliffe, & Baxley, 2003).  The 
three-hour OGTT involves the ingestion of a 100-gram glucose drink followed by 
glucose testing at one, two, and three hours after the ingestion of the drink.  The results of 
the three-hour OGTT were used to determine a diagnosis of gestational diabetes based on 
criteria for abnormal results for the three-hour OGTT.  There are two sets of criteria that 
can be used to make a diagnosis of gestational diabetes.  The American Diabetes 
Association suggests the following criteria with two of the following values being met or 
exceeded: fasting 95 mg/dL; one hour 180 mg/dL; two hour 155 mg/dL; three hour 140 
mg/dL (American Diabetes Association, 2003).  However, in the current study, the 
following criteria were used, any two of the four blood glucose values being met or 
exceeded: fasting 90 mg/dL; one hour 165 mg/dL; two hour 145 mg/dL; three hour 125 
mg/dL (O'Sullivan, 1980; O'Sullivan & Mahan, 1964).   
For this study, if the one-hour test result was greater than 130 mg/dL , a three-
hour OGTT was typically done.  The result of the one-hour OGTT was recorded in the 
EMR for all patients who were screened for gestational diabetes.  If the result of the one-
hour OGTT is greater than 130 mg/dL, the glucose results of the three-hour glucose test 
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were also recorded in the EMR.  Therefore, almost all women had glucose results of the 
one-hour test documented in the EMR.  If a woman did not have a result for a gestational 
diabetes screen by a one-hour OGTT or a diagnosis of gestational diabetes, she was 
excluded from the sample, because it was impossible to classify her as a gestational 
diabetic or non-gestational diabetic.  Women who had an abnormal one-hour OGTT had 
results for the three-hour OGTT.  The results of the three-hour OGTT were used to define 
gestational diabetes in women for the present study.   
Anyone who had a one-hour OGTT result greater than 200 mg/dL was diagnosed 
with gestational diabetes without further testing.  In this study, women with a one-hour 
OGT result greater than 200 mg/dL, an ICD-9 code of gestational diabetes, a diagnosis of 
gestational diabetes written by the health care provider in the EMR, and/or abnormal 
results on the three-hour OGTT (as described above), were defined as having gestational 
diabetes.  The results of the glucose tests were extracted from the EMR. 
For maternal outcomes following delivery, the type of delivery, complications 
during pregnancy, and medications were assessed.  Deliveries were documented in the 
EMR using the following terms: Spontaneous Vaginal Delivery, Cesarean, Low-forceps 
Delivery, Mid-forceps Delivery, Forceps Outlet, Vacuum, Breech Assisted, or Breech 
Extraction.  This information was extracted from the EMR.  A history of cesarean section 
was also extracted.  For complications during delivery, the following were noted:  
shoulder dystocia, presence of meconium, nuchal cord, postpartum hemorrhage, 
chorioamnionitis, prolonged rupture of membranes, partial abruption, or maternal fever.  
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Presence of perineal tears were documented according to the degree of the tear (1st, 2nd, 
3rd, or 4th) and were extracted.  Although the use of a vacuum may be recorded when the 
type of delivery was recorded, the health care provider has the option of writing in the 
use of a vacuum as a complication.  If the health care provider chose to write in the use of 
a vacuum, it was classified as a vacuum delivery. 
For medication, participants were asked to list medications currently being taken 
in the self-report questionnaire.   The following medications were categorized for data 
analysis purposes:  insulin, oral diabetes medications, anti-depressants, and anti-anxiety 
medications. 
  For the infant outcomes, the Apgar scores, gestational age at delivery, and weight 
were used.  Apgar scores were routinely measured at one, five, and ten minutes after birth 
to reflect the health of the infant.  Apgar scores can range from zero to ten: a score of 
zero, one, or two are assigned to each of the five aspects of the score (Appearance, Pulse, 
Grimace, Activity, Respiration) and then summed to provide a total score.  Therefore, 
three Apgar scores were extracted for the study (scores at one, five, and ten minutes).  
Gestational age at delivery was extracted in “weeks” from the EMR.  Finally, infant birth 
weight was recorded in grams and was taken from the infant EMR.   
The sociological factors that were assessed included socioeconomic status, race, 
ethnicity, marital status, and planned pregnancy.  For socioeconomic status, a question 
regarding income was included on the demographic questionnaire administered in the 
self-report questionnaire booklet.  For race and ethnicity, participants were asked to 
66 
 
 
report their race as: Alaska Native, Native American, Asian, Black, White, Native 
Hawaiian or Other Pacific Islander, Preference not Indicated, or Other.  Non-Hispanic or 
Hispanic were the choices available for ethnicity in the self-report questionnaire.  This 
information was also extracted from the EMR.  For marital status, a question regarding 
marital status was included in the self-report questionnaire booklet.   Participants had to 
pick one of the following categories:  married, divorced, separated, single and not living 
with partner, and single and living with partner. For planned pregnancy, women were 
asked in the self-report questionnaire booklet if the pregnancy was planned or unplanned. 
Human Subjects Protection 
The involvement of human subjects involved the completion of the self-report 
questionnaires that were completed by the participant.  Also, medical data (maternal and 
infant) was collected from the EMR.  Characteristics of the sample were women older 
than 18 years of age who could read and speak English.  Women younger than 18 years 
of age were excluded from the sample due to the differences in depression symptom 
expression for adolescents.   It was necessary to study pregnant women, because it is not 
possible to conduct a study on gestational diabetes without including pregnant women. 
Sources of materials were the data collected from the self-report questionnaire 
booklet and the data extracted from the EMR.  These variables have been previously 
delineated.  
There were very few potential risks to this study.  However, upon completion of 
study tools, there was potential for participants to report feelings of anxiety and/or 
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depressive symptoms during the antepartum visit.  Since all prenatal patients are given 
the EPDS screening during their regular prenatal care visit and there is a protocol for 
treatment established at the institution where data collection occurred, patients were 
encouraged to discuss their feelings with their health care provider.  The consent stated 
that if the patient expressed “the thought of harming myself has occurred to me” on the 
EPDS, the health care provider was notified.  Data was also collected from the EMR and 
the informed consent stated that the medical record will be accessed and information 
obtained.   
To ensure adequate protection against risks to the participants, proper recruitment 
techniques and informed consent documents were obtained.  Participants were recruited 
from the outpatient obstetrics clinic.  Before recruitment began, permission for 
recruitment at the clinic was provided by Dr. John Gianapoulos.  Women attending the 
outpatient obstetric clinic for routine prenatal care between 24 and 40 weeks pregnant 
were approached for participation in the study by the investigator.  Informed consent was 
obtained by all participants (See Appendix D for a copy of the informed consent). 
In order to protect participants against risks, participants were informed of the 
possibility of experiencing depressive or anxious feelings while filling out the self-report 
questionnaires in the informed consent document.  If participants informed the 
investigator of feelings of depression or anxiety, they were encouraged to share these 
feelings with the health care provider they were seeing in the clinic.  If participants 
shared feelings of harming oneself on the EPDS questionnaire, this information was 
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shared with the health care provider of the participant.  Participants were informed of the 
possibility of sharing this information with the health care provider in the informed 
consent.  Loyola University has an established protocol for patients who report feelings 
of harming oneself on the EPDS.  The protocol was followed by informing the health 
care provider of the participant’s feelings. 
Collected data was kept in a locked file cabinet.  Only members of the research 
team had access to this data.  During data entry patient identifiers were not recorded, 
assuring participant anonymity.  Participants were informed that there were no identifiers 
recorded in the informed consent.  This research study involved pregnant women because 
pregnancy is necessary to study gestational diabetes.  However, because of the design of 
this study and information collected, there was no increased risk to the mother, fetus, or 
neonate.   
At this point there are no known benefits to human subjects or others.  However, 
if women with gestational diabetes were found to be at increased risk for depression, the 
care provided to them could be improved.  Also, with significant results, future studies to 
test an intervention that would improve depression symptoms in this population could be 
conducted which would provide benefit.   
Important knowledge may be gained at the completion of this study.  If women 
with gestational diabetes were found to be more at risk for depression, the care provided 
to this population would be improved.  Recognizing depression during pregnancy will 
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help improve the outcome of maternal and infant health and could decrease the effects of 
postpartum depression.  These benefits outweigh the minimal risk of this study.  
It was necessary to include women in the study; however, children were not 
included.  This study involved gestational diabetes and pregnancy, therefore only women 
were included.    Children and adolescents were not included because expression of 
symptoms of depression varies with developmental stage and some adolescents may have 
difficulty identifying and describing mood states (Bhatia & Bhatia, 2007).  The sample 
had a good representation of minority women: about 23% of the sample was African 
American, 33% was Hispanic, and 11% of the sample was of another minority group.  
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CHAPTER FOUR 
RESULTS 
 This chapter addresses the findings from the study.  First, the description of the 
sample and all study variables is provided.  Second, the results of the study aims are 
delineated.  As previously stated, there were three aims to this study.  The primary aim 
was to determine if women with gestational diabetes mellitus (GDM) had more 
depression than women without GDM.  The secondary aim was to determine if the 
factors predictive of depression in women with GDM were different than factors 
predictive of depression in women without GDM.  The exploratory aim was to determine 
if minority women were more at risk for prenatal depression than White women. 
Description of the Sample 
 One hundred and seventy two women were approached and asked to participate in 
the study (See Figure 2 for enrollment diagram).  Of these, 14 women refused and 
therefore 158 women were enrolled in the study.  Of the 158 women enrolled, 147 
women completed the self-report questionnaires.  Of those 147, eight had no results in the 
chart of their oral glucose tolerance test or a diagnosis of GDM, three had type 2 diabetes, 
and one had type 1 diabetes.  The final sample included a convenience sample of 135 
women (65 with gestational diabetes and 70 without gestational diabetes).   
 The majority of the sample was non-Hispanic (66.7%), married (65.2%), had an 
unplanned pregnancy (52.6%), had no history of depression (84.4%), and had an average 
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age of 29.7 years.  The average gestational age at the time participants completed the 
self-report questionnaire booklet was 31.3 weeks’ gestation.  The race of the sample was 
evenly distributed with 32.6% being White, 32.6% Hispanic, 23.0% Black, and 11.9% 
other (Table 3).  T-tests were done to determine if there were differences in age, and 
gestational age at when participants filled out the questionnaire booklet.  Women with 
GDM were significantly older (p<.001).  Chi-square tests were done to determine if there 
were differences between groups in marital status, income, and history of depression.  
Although women with GDM had higher incomes and more were married, these were not 
significantly different than women without GDM according to the chi-square results.   
Figure 2:  Enrollment Flow Diagram 
 
 
 
 
 
 
 
 
 
172 Approached 
158 Enrolled 
147 Participants 
14 refused 
9 never returned the 
questionnaires  
2 returned after the 
end of study 
65 
GDM 
70 
Non GDM 
3 Type 2 
1 Type 1 
8 missing 
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However, women with GDM were more likely to have a history of depression (χ2=5.40, 
p=.02).  See Table 3 for differences in the demographic variable between gestational 
diabetics and non-gestational diabetics.  The 12 women who were not included in the 
final sample because of missing results to an oral glucose tolerance test or a diagnosis of 
type 1 or type 2 diabetes had demographics similar to the women included in the sample 
(see Table 3).  The ethnic and racial makeup of the sample is representative of the 
population where the sample was collected. 
Table 3: Description of Sample 
Variable Total Sample 
N=135 (%) 
GDM 
N=65 (%) 
Non-GDM 
N=70 (%) 
Excluded 
Age*  Mean (SD) 
           Range 
29.7 (6.02) 
18-47 
32.12 (5.53) 
18-47 
27.36 (5.55) 
18-41 
26.25 
(7.65) 
18-36 
Gestational Age 
Mean (SD) 
Range 
 
31.3 (3.90) 
24.1-39.3 
 
31.8 (3.77) 
24.1-38.3 
 
30.86 (4.00) 
24.1-39.3 
 
31.63 
(4.08) 
26.5-39.3 
Gravida 
Mean (SD) 
Range 
 
3.0 (2.0) 
1-9 
 
3.0 (2.0) 
1-8 
 
3.0 (2.0) 
1-9 
 
3.0 (2.0) 
1-7 
Ethnicity 
Hispanic 
Non-Hispanic 
 
45(33.3%) 
90 (66.7%) 
 
25 (38.5%) 
40 (61.5%) 
 
20 (28.6%) 
50 (71.4%) 
 
4 (33.3%) 
8 (66.7%) 
Race 
White 
Black 
Hispanic 
Other 
 
44 (32.6%) 
31 (23.0%) 
44 (32.6%) 
16 (11.9%) 
 
20 (38.5%) 
11 (16.9%) 
25 (38.5%) 
9 (13.8%) 
 
24 (34.3%) 
20 (28.6%) 
19 (27.1%) 
7 (10%) 
 
1 (8.3%) 
6 (50%) 
4 (33.3%) 
1 (8.3%) 
Marital Status 
Married 
Divorced 
Separated 
Single, not living with 
partner 
 
88 (65.2%) 
3 (2.2%) 
2 (1.5%) 
15 (11.1%) 
 
 
48 (73.8%) 
2 (3.1%) 
1 (1.5%) 
6 (9.2%) 
 
 
40 (57.1%) 
1 (1.4%) 
1 (1.4%) 
9 (12.9%) 
 
 
5 (41.7%) 
1 (8.3%) 
N/A 
4 (33.3%) 
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Single, living with 
partner 
26 (19.3%) 7 (10.8%) 19 (27.1%) 2 (16.7%) 
Income  
Less than $5,000 
$5,000-$9,999 
$10,000-$19,999 
$20,000-$29,999 
$30,000-$39,999 
$40,000-$49,999 
$50,000-$59,999 
$60,000-$69,999 
Over $70,000 
 
23 (17.0%) 
4 (3.0%) 
16 (11.9%) 
23 (17.0%) 
19 (14.1%) 
10 (7.4%) 
9 (6.7%) 
9 (6.7%) 
15 (11.1%) 
 
9 (13.8%) 
1 (1.5%) 
8 (12.3%) 
9 (13.8%) 
9 (13.8%) 
5 (7.7%) 
5 (7.7%) 
4 (6.2%) 
12 (18.5%) 
 
14 (20%) 
3 (4.3%) 
8 (11.4%) 
14 (20.0%) 
10 (14.3%) 
5 (7.1%) 
4 (5.7%) 
5 (7.1%) 
3 (4.3%) 
 
5 (41.7%) 
N/A 
2 (16.7%) 
2 (16.7%) 
N/A 
N/A 
1 (8.3%) 
N/A 
1 (8.3%) 
Planned Pregnancy 
Yes 
No 
 
63 (46.7%) 
71 (52.6%) 
 
32 (49.2%) 
32 (49.2%) 
 
31 (44.3%) 
39 (55.7%) 
 
1 (8.3%) 
11 (91.7%) 
History of 
Depression* 
Yes 
No 
 
21 (15.6%) 
114 (84.4%) 
 
15 (23.1%) 
50 (76.9%) 
 
6 (8.6%) 
64 (91.4%) 
 
1 (8.3%) 
11 (91.7%) 
* Significant differences between GDM and non-GDM (p<.05) 
Data Entry 
 All data from the self-report questionnaires and EMR was de-identified and 
entered into a statistical software database (SPSS Windows Version 16.0, SPSS, Chicago, 
IL).  Data was then manually checked and corrected for any entry errors.  Once the raw 
data had been entered, only assigned ID numbers were used to analyze the data.  
Missing Data 
 After data entry was complete, data was assessed for missing data.  There was 
very limited missing data in the self-report questionnaires (see Appendix E).  This is 
because all booklets were examined upon completion for missing data.  If an item was 
missing, the participant was asked if the item was accidently skipped or left blank on 
purpose.  If the participant desired to leave an item blank it was accepted.  Missing data 
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on the self-report questionnaires was replaced with the individual mean for that specific 
instrument.  There was limited missing data from self-report questionnaires that could not 
be replaced with the individual mean (one marital status item, one pregnancy planned 
item, and seven income items).  Many participants when asked about income desired to 
leave this blank or were unsure of the annual income because the spouse was the primary 
wage earner.  
 There was also missing data from the EMR templates provided by the informatics 
expert.  When missing data was encountered on the template, the EMR was accessed and 
examined to see if missing information could be found (Appendix E).  This included 
reading through the following physician notes: the admission history and physical note, 
the delivery summary note, and the discharge summary note in the maternal EMR.  Also, 
the infant admission to the nursery and discharge summary notes were read.  When 
missing data was found, it was entered into the database.  There were six participants that 
did not deliver at the institution where data was collected and therefore all delivery data 
is missing from these six people.  See Appendix E for amount of missing data 
encountered from the EMR.  The variable with the most missing data was the Apgar 
score at ten minutes.  There were six participants with missing results for the one-hour 
OGTT gestational diabetes screen; however, all six of these participants had a diagnosis 
of gestational diabetes in their charts.  The most common reason for the missing one-hour 
OGTT results was because patients had transferred from other institutions and this data 
was not available. 
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Comparability of Data from Different Sources 
 Only information which could be documented as a discrete variable in a flow 
sheet was provided on the template.  Data such as the complications during delivery were 
only written in physician notes.  Therefore, physician notes were consulted to retrieve 
information not provided on the template and to find missing data.   Once the physician 
notes were read, discrepancies were found between the information retrieved using the 
EMR template and the physician notes in the EMR (Appendix F).  The physician notes 
from the maternal EMR that were reviewed included the following:  the history and 
physical note at the start of prenatal care, the history and physical note at the time of 
admission to the hospital for delivery, the delivery summary note, and the discharge 
summary note.  Physician notes from the infant EMR that were reviewed included the 
following: admission to the nursery and the discharge summary.  Usually, the information 
found in the physician note was entered into the database, because it was believed that the 
physician note would be more accurate than flow sheet documentation. 
Data Analyses of Key Study Variables 
 First, data was analyzed for normality and outliers.  Normality was assessed by 
examining histogram plots.  The outcome variables found to be positively skewed were 
the CES-D scores, the EPDS scores, the state anxiety scores, and the trait anxiety scores.  
Social support was found to be negatively skewed.  Lastly, perceived stress was found to 
be normally distributed.   Age and the gestational age when the self-report questionnaires 
were completed were also found to be normally distributed.  Although some variables 
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were skewed, the scores represent scores expected for this sample and consistent with the 
literature.  After consultation with the statistician and given that the distribution of scores 
was expected for this sample, transformation of scores was not done.  Normality is not an 
assumption for correlations and if dichotomous variables are used, normality is not a 
necessary assumption. 
 The next step in data analysis was to analyze the descriptive statistics and 
frequency distributions for all major outcome variables (gestational diabetes, depression, 
anxiety, stress, and social support).  A detailed analysis of each outcome variables is 
provided next, starting with gestational diabetes. 
Gestational Diabetes 
 For almost all participants (n=129), a one-hour OGTT test was done (as 
mentioned previously, six women had these results missing but had a diagnosis of GDM).  
These results are included in Table 4.  If the OGTT at one hour was abnormal, patients 
had further testing with a three-hour OGTT and these results are also presented in Table 
4.  The presence of gestational diabetes was determined based on the results of the three-
hour OGTT.  In order to make a diagnosis of gestational diabetes, two of the following 
four levels had to be abnormal: fasting>90 mg/dL, one hour >165 mg/dL, two hour >145 
mg/dL, and three hour >125 mg/dL.  The mean one-hour glucose for women with GDM 
was 170.46 mg/dL (SD±33.34) and for women without GDM was 113.16 mg/dL 
(SD±23.50), which were significantly different [t (127) = -11.40, p<.001].   
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Table 4: Oral Glucose Tolerance Results* 
Variable Mean (SD)  Range 
One-Hour OGTT (N=129) 139.36 (40.29) 65-300 
3-Hour OGTT: fasting 
(N=61) 
88.36 (9.56) 68-113 
3-Hour OGTT: 1 
hour(N=61) 
182.44 (28.70) 108-233 
3-Hour OGTT: 2 hour 
(N=61) 
159.75 (33.70) 67-249 
3-Hour OGTT: 3 hour 
(N=61) 
130.41 (30.72) 64-208 
*n=61 because four women had OGTT results missing but had a diagnosis of GDM in 
the chart 
 
Depression 
 There were two self-report instruments used to assess depression (the CES-D and 
the EPDS) and one question regarding history of depression.  The CES-D is a 20-item 
tool with four items (4, 8, 12, 16,) being reverse-coded before sum scores were 
calculated.  The EPDS is a 10-item tool with 7 items (3, 5, 6, 7, 8, 9, 10) being reverse-
coded before sum scores were calculated.  The question “Do you have a history of 
depression?” with response choices of “yes” or “no” was included in the self-report 
questionnaire booklet.   
For the CES-D the mean score for the entire sample was 12.73 (SD±9.8).  The 
women with GDM had a mean score of 12.97 (SD±10.66) and the women without GDM 
had a mean score of 12.5 (SD±9.0) (Table 5).  Using the recommended cutoff score of 16 
or greater to suggest depression, 28% of the entire sample had depression, 32% of the 
women with GDM had depression, and 24% of the women without GDM had depression.   
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Table 5: Mean Depression Scores 
 
Variable Entire Sample 
Mean (SD) 
GDM 
Mean (SD) 
Non-GDM 
Mean (SD) 
CESD 12.73 (9.80) 12.97 (10.66) 12.51 (9.00) 
EPDS 6.26 (5.72) 6.45 (6.21) 5.90 (5.25) 
 
For the EPDS the mean score for the entire sample was 6.26 (SD±5.72).  Women 
with GDM had a mean score of 6.65 (SD±6.2) and women without GDM had a mean 
score of 5.9 (SD±5.25) (Table 5).  Using the recommended cutoff score of 12 or greater 
to suggest depression, 16% of the entire sample had depression.  Also, 20% of women 
with GDM had depression, compared with 13% of women without GDM.  Table 7 
displays the individual item mean responses on the EPDS.  For women without GDM, the 
two items with the highest mean scores were numbers 4 and 6.  For women with GDM, 
the item with the highest mean score was number 4 followed by items 3 and 6 which both 
had the same mean.  Items 1 and 10 had the lowest mean scores for both women with and 
without GDM. 
Table 6 displays the mean item responses on the CES-D.  For both women with 
and without GDM, the two items with the highest mean were numbers 7 and 11 and the 
items with the lowest means were numbers 15 and 19.   
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Table 6: Item Means on the Center for Epidemiologic Studies Scale (CES-D) 
Item Sample 
Mean (SD) 
GDM 
Mean (SD) 
Non-GDM 
Mean (SD) 
1. I was bothered by things that 
usually don’t bother me .81(.88) .71(.84) .91(.91) 
2. I did not feel like eating; my 
appetite was poor .47(.74) .46(.81) .49(.68) 
3. I felt that I could not shake off 
the blues even with the help from 
my family or friends 
.45(.83) .46(.81) .44(.85) 
4. I felt I was just as good as other 
people* .87(1.13) .97(1.17) .79(1.09) 
5. I had trouble keeping my mind 
on what I was doing .76(.92) .68(.87) .84(.96) 
6. I felt depressed 
.52(.85) .55(.87) .49(.85) 
7. I felt that everything I did was 
an effort 1.24(1.10) 1.20(1.13) 1.29(1.08) 
8. I felt hopeful about the future* 
.87(1.05) .89(1.08) .84(1.03) 
9. I thought my life had been a 
failure .30(.66) .31(.61) .30(.71) 
10. I felt fearful 
.48(.74) .55(.71) .41(.77) 
11. My sleep was restless 1.31(.95) 1.29(1.00) 1.33(.91) 
12. I was happy* 
.66(.79) .74(.87) .59(.71) 
13. I talked less than usual 
.59(.84) .63(.88) .56(.81) 
14. I felt lonely 
.56(.85) .65(.86) .49(.85) 
15. People were unfriendly 
.29(.69) .29(.74) .29(.64) 
16. I enjoyed life* 
.59(.84) .66(.89) .51(.79) 
17. I had crying spells 
.59(.80) .52(.75) .64(.83) 
18. I felt sad 
.61(.79) .60(.79) .61(.80) 
19. I felt that people dislike me 
.18(.53) .20(.56) .16(.50) 
20. I could not get “going” 
.57(.74) .60(.75) .54(.74) 
* Reverse-coded items 
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Table 7: Item Means on the Edinburgh Postpartum Depression Scale (EPDS) 
 
Item Sample 
Mean (SD) 
GDM 
Mean (SD) 
Non-GDM 
Mean (SD) 
1. I have been able to laugh and see 
the funny side of things 
.30 (.59) .32 (.56) .27 (.61) 
2. I have looked forward with 
enjoyment to things 
.33 (.61) .37 (.65) .30 (.57) 
3. I have blamed myself 
unnecessarily when things went 
wrong* 
.91 (.88) .98 (.89) .84 (.88) 
4. I have been anxious or worried for 
no good reason 
.96 (.99) 1.05 (1.04) .87 (.95) 
5. I have felt scared or panicky for no 
very good reason* 
.74 (.87) .80 (.97) .70 (.77) 
6. Things have been getting on top of 
me* 
.92 (.81) .98 (.86) .86 (.77) 
7. I have been so unhappy that I have 
had difficulty sleeping* 
.61 (.84) .75 (.94) .49 (.72) 
8. I have felt sad or miserable* .77 (.79) .77 (.84) .77 (.75) 
9. I have been so unhappy that I have 
been crying* 
.64 (.79) .55 (.75) .73 (.82) 
10. The thought of harming myself 
has occurred to me* 
.07 (.37) .06 (.35) .07 (.39) 
* Reverse-coded items 
 
Anxiety 
 The Spielberger State-Trait Anxiety Index (STAI) was used to measure state and 
trait anxiety.  It is a 40-item tool which measures both a person’s current level of anxiety 
(state anxiety) and a person’s general and long standing anxiety (trait anxiety).  There are 
20 items (1-20) to measure state anxiety and 20 items (21-40) to measure trait anxiety.  
Nineteen of the items were reverse-coded when computing the sum score for state and 
trait anxiety.  These items included numbers: 1, 2, 5, 8, 10, 11, 15, 16, 19, 20, 21, 23, 26, 
27, 30, 33, 34, 36, and 39.  Higher scores on the STAI indicate higher anxiety.  
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 On the STAI, the mean score for state anxiety of the entire sample was 35.67 
(SD±11.62 and for trait anxiety the mean score was 36.25 (SD±11.57).  For women with 
GDM, the mean state anxiety score was 36.98 (SD±12.28) and for women without GDM 
the mean state anxiety score was 34.44(SD±10.93).  On trait anxiety, women with GDM 
had a mean score of 38.22(SD±12.77) and women without GDM had a mean score of 
34.43(SD±10.08) (Table 8).  Table 9 and Table 10 display the means for individual items 
for both state and trait anxiety. Due to copyright regulations, only the first five items are 
written completely while the rest of the items are abbreviated to not violate the copyright 
laws.  For state anxiety, the items with the highest mean for the entire sample were 
numbers 5 and 19.  For women without GDM, items 5 and 15 had the highest means.  For 
women with GDM, items with the highest means were 5 and 16.  Items 13 and 18 had the 
lowest means for everyone (entire sample, women with GDM, and women without 
GDM).  Regarding trait anxiety, items 26 and 34 had the highest mean scores for the 
entire sample and women with GDM.  For women without GDM, items 26 and 27 had 
the highest mean scores.  For all groups (the entire sample, women with and without 
GDM) the lowest mean scores were items 25 and 31.   
Table 8: Mean Anxiety Scores 
Variable Entire Sample 
Mean (SD) 
GDM 
Mean (SD) 
Non-GDM 
Mean (SD) 
State Anxiety 35.67 (11.62) 36.98 (12.28) 34.44 (10.93) 
Trait Anxiety 36.25 (11.57) 38.22 (12.77) 34.43 (10.08) 
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Table 9: Item Means on the State Anxiety Scale 
Item Sample 
Mean (SD) 
GDM 
Mean (SD) 
Non-GDM 
Mean (SD) 
1. I feel calm* 1.73 (.80) 1.82 (.75) 1.64 (.83) 
2. I feel secure* 1.61 (.78) 1.63 (.70) 1.59 (.86) 
3. I am tense 1.87 (.85) 1.94 (.85) 1.80 (.87) 
4. I feel strained 1.77 (.88) 1.80 (.91) 1.74(.86) 
5. I feel at ease* 2.11 (.98) 2.18 (.95) 2.06 (1.02) 
6. Upset 1.52 (.85) 1.51 (.83) 1.53 (.86) 
7. I am presently worrying  1.78 (.92) 1.92 (.91) 1.64 (.92) 
8. Satisfied* 1.97 (.95) 2.08 (.94) 1.87 (.95) 
9. Frightened 1.53 (.76) 1.51 (.71) 1.54 (.81) 
10. Comfortable* 1.98 (.97) 1.98 (1.00) 1.97 (.95) 
11. Self-confident* 1.87 (.90) 1.91 (.91) 1.83 (.90) 
12. Nervous 1.87 (.90) 1.92 (.94) 1.83 (.87) 
13. Jittery 1.33 (.67) 1.40 (.66) 1.27 (.68) 
14. Indecisive 1.52 (.82) 1.62 (.82) 1.43 (.81) 
15. Relaxed* 2.07 (.96) 2.11 (.94) 2.04 (.98) 
16. Content* 2.04 (.95) 2.20 (.97) 1.89 (.91) 
17. Worried 1.78 (.90) 1.88 (.91) 1.69 (.89) 
18. Confused 1.39 (.72) 1.45 (.77) 1.34 (.68) 
19. Steady* 2.09 (.92) 2.17 (.91) 2.01 (.92) 
20. Pleasant* 1.84 (.85) 1.97 (.88) 1.72 (.81) 
* Items that were reverse-coded when computing the sum score 
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Table 10: Item Means on the Trait Anxiety Scale 
Item Sample 
Mean (SD) 
GDM 
Mean (SD) 
Non-GDM 
Mean (SD) 
21. Pleasant* 1.84 (.87) 1.92 (.91) 1.77 (.82) 
22. Nervous, restless 1.86 (.81) 2.02 (.78) 1.71 (.82) 
23. Satisfied with self* 1.83 (.91) 1.92 (.89) 1.74 (.93) 
24. Happy as others  1.86 (.96) 2.03 (1.00) 1.70 .(89) 
25. Like a failure 1.36 (.65) 1.40 (.68) 1.31 (.63) 
26. Rested* 2.51 (.96) 2.62 (.98) 2.41 (.94) 
27. “calm, cool, and 
collected.”* 
2.10 (.92) 2.18 (.92) 2.03 (.93) 
28. Difficulties are 
piling up 
1.62(.79) 1.71 (.82) 1.54 (.76) 
29. Worry too much  1.80 (.88) 1.88 (.93) 1.73 (.83) 
30. Happy* 1.74 (.86) 1.88 (.91) 1.61(.80) 
31. Disturbing thoughts 1.41 (.74) 1.45 (.73) 1.37 (.77) 
32. Self-confidence 1.53 (.84) 1.65 (.86) 1.41 (.81) 
33. Secure* 1.81 (.89) 1.92 (.92) 1.70 (.86) 
34. Decisions easily* 2.13 (.88) 2.26 (.96) 2.00 (.80) 
35. Inadequate 1.45 (.68) 1.49 (.69) 1.41 (.67) 
36. Content* 2.00 (.95) 2.11 (.97) 1.90 (.93) 
37. Unimportant 
thoughts 
1.81 (.87) 1.88 (.88) 1.74 (.86) 
38. Disappointments 1.88 (.91) 1.97 (.95) 1.80 (.86) 
39. Steady person* 1.96 (.91) 2.06 (.98) 1.87 (.83) 
40. State of tension 1.76 (.84) 1.88 (.86) 1.64 (.82) 
* Items that were reverse-coded when computing the sum score 
 
Stress 
 Stress was measured using the Cohen Perceived Stress Scale (PSS).  It had a total 
of ten items scored on a scale of 0-4.  Four items were reverse-coded when computing the 
sum score (items 4, 5, 7, 8).  Higher scores on the instrument indicate higher levels of 
stress.  The mean score for the entire sample was 15.07 (SD±8.40). The women with 
GDM had a mean score of 16.11 (SD±8.49) and women without GDM had a mean score 
of 14.11 (SD±8.25) (Table 11). 
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Table 11: Mean Perceived Stress Scores 
Variable Entire Sample 
Mean (SD) 
GDM 
Mean (SD) 
Non-GDM 
Mean (SD) 
Perceived Stress  15.07 (8.40) 16.11 (8.49) 14.11 (8.25) 
 
    Table 12 displays the means for individual items on the PSS.  For the entire 
sample and women with and without GDM, items 1 and 3 had the highest mean scores.  
For the entire sample the items 4 and 5 had the lowest mean scores.  For women without 
GDM, items 4 and 10 had the lowest mean scores.  For women with GDM, items 4 and 7 
had the lowest mean score. 
Table 12: Item Means on the Perceived Stress Scale 
Item Sample 
Mean (SD) 
GDM 
Mean (SD) 
Non-GDM 
Mean (SD) 
1. Have you been upset because of 
something that happened unexpectedly? 
1.81 (1.06) 1.94 (1.09) 1.69 (1.03) 
2. Have you felt that you were unable to 
control the important things in your life? 
1.48 (1.21) 1.62 (1.21) 1.36 (1.20) 
3. Have you felt nervous or “stressed”? 2.04 (1.10) 2.20 (1.11) 1.89 (1.07) 
4. Have you felt confident about your 
ability to handle your personal 
problems?* 
1.19 (1.09) 1.17 (.96) 1.20 (1.21) 
5. Have you felt that things were going 
your way?* 
1.29 (1.02) 1.37 (.99) 1.21 (1.05) 
6. Have you found that you could not 
cope with all things you had to do? 
1.51 (1.19) 1.62 (1.10) 1.41 (1.21) 
7. Have you been able to control 
irritations in your life?* 
1.30 (1.02) 1.32 (.94) 1.27 (1.02) 
8. Have you felt that you were on top of 
things?* 
1.37 (1.02) 1.45 (1.12) 1.30 (.92) 
9. Have you been angered because of 
things that were outside of your control? 
1.73 (1.11) 1.86 (1.09) 1.60 (1.12) 
10. Have you felt difficulties were 
piling up so high that you could not 
overcome them? 
1.37 (1.24) 1.57 (1.25) 1.19 (1.21) 
* Items that were reverse-coded when computing the sum score 
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Social Support 
 Social support was measured by the Multidimensional Scale of Perceived Social 
Support (MSPSS).  The tool consisted of 12 items and contained three subscales.  The 
three subscales included the following: significant other support, family support, and 
friend support.  Items in the significant other subscale included numbers 1, 2, 5, and 10.  
The family support subscale consisted of numbers 3, 4, 8, and 11.  Lastly, the friend 
support subscale included items, 6, 7, 9, and 12.  Each item is scored on a seven point 
Likert scale ranging from “very strongly disagree” (1) to “very strongly agree” (7).  
There were no items that were reverse-coded for this tool.  The items are averaged to 
compute a sum score.  Higher scores suggest higher levels of social support.  The mean 
score for overall social support in the entire sample was 6.00 (SD±1.10), the mean was 
6.30(SD±1.18) for significant other support, 6.11(SD±1.16) for family support, and 
5.59(SD±1.55) for friend support.  For women with GDM the means for the total and 
subscales were as follows:  for overall social support 6.03(SD±1.03), for significant other 
support 6.27(SD±1.10), for family support 6.06(SD±1.11), and for friend support 
5.77(SD±1.38).  For women without GDM the means were as follows: 5.97(SD±1.17) for 
overall support, 6.27(SD±1.26) for significant other support, 6.15(SD±1.20) for family 
support and 5.42(SD±1.69) for friend support (Table 13).  Table 14 displays the item 
means for the MSPSS.  For the entire sample and the women without GDM, items 1 and 
10 had the highest means, and items 6 and 7, the lowest means.  For women with GDM, 
items 3 and 10 had the highest means and items 7 and 8 had the lowest means. 
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Table 13: Mean Overall Social Support and Subscale Scores 
Variable Entire Sample 
Mean (SD) 
GDM 
Mean (SD) 
Non-GDM 
Mean (SD) 
Overall Support 6.00 (1.10) 6.03 (1.03) 5.97 (1.17) 
Significant Other 
Support 
6.30 (1.18) 6.27 (1.10) 6.32 (1.26) 
Family Support 6.11 (1.16) 6.06 (1.11) 6.15 (1.20) 
Friend Support 5.59 (1.55) 5.77 (1.38) 5.42 (1.69) 
 
Table 14: Item Means on the Multidimensional Perceived Social Support Scale 
Item Entire Sample 
Mean (SD) 
GDM 
Mean (SD) 
Non-GDM 
Mean (SD) 
1. There is a special person who is 
around when I am in need 
6.22 (1.39) 6.12 (1.41) 6.31 (1.37) 
2. There is a special person with whom I 
can share my joys and sorrows 
6.27 (1.24) 6.25 (1.24) 6.30 (1.24) 
3. My family really tries to help me 6.26 (1.23) 6.29 (1.17) 6.23 (1.30) 
4. I get the emotional help and support I 
need from my family 
6.17 (1.24) 6.14 (1.26) 6.20 (1.22) 
5. I have a special person who is a real 
source of comfort to me 
6.25 (1.29) 6.26 (1.16) 6.24 (1.41) 
6. My friends really try to help me 5.61 (1.66) 5.86 (1.44) 5.39 (1.83) 
7. I can count on my friends when 
things go wrong 
5.45 (1.69) 5.60 (1.60) 5.31 (1.77) 
8. I can talk about my problems with my 
family 
5.90 (1.49) 5.74 (1.55) 6.04 (1.43) 
9. I have friends with whom I can share 
my joys and sorrows 
5.67 (1.56) 5.85 (1.35) 5.50 (1.73) 
10. There is a special person in my life 
who cares about my feelings 
6.44 (1.14) 6.45 (.97) 6.43 (1.29) 
11. My family is willing to help me 
make decisions 
6.10 (1.31) 6.06 (1.16) 6.14 (1.45) 
12. I can talk about my problems with 
my friends. 
5.62 (1.63) 5.77 (1.46) 5.49 (1.77) 
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Medication Use and Chronic Conditions 
 
 In the self questionnaire booklet, participants were asked to list any medications 
they were taking.  These medications were coded into the following groups: (1) 
antidepressant, (2) anti-anxiety, (3) insulin, (4) oral diabetes medication, (5) 
antidepressant and anti-anxiety, (6) oral diabetes medication and antidepressant, and (7) 
oral diabetes medication and insulin.  There were only 25 women taking medications 
according to these categories (Table 15).  Only five women were taking antidepressants 
and 22 were taking medications to treat their GDM.  As for chronic conditions, 
participants were asked if they had been diagnosed with asthma, diabetes, hypertension, 
bipolar disorder, or schizophrenia (Table 16).  No women had bipolar disorder or 
schizophrenia, only 10 (7.4%) had hypertension, and 14 (10.4%) had asthma.   
Table 15: Medication Use 
Medication Category N (%) 
Antidepressant 2 (1.5%) 
Anti-anxiety 0 (0%) 
Insulin 2 (1.5%) 
Oral Diabetes Medication 16 (11.9%) 
Antidepressant and Anti-anxiety 1 (0.7%) 
Oral Diabetes Medication and Antidepressant 2 (1.5%) 
Oral Diabetes Medication and Insulin 2 (1.5%) 
 
Table 16: Chronic Conditions 
 
Chronic Condition N (%) 
Asthma 14 (10.4%) 
Diabetes 42 (31.1%) 
Hypertension 10 (7.4%) 
Bipolar Disorder 0 (0%) 
Schizophrenia 0 (0%) 
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Interestingly, out of the 65 women who had a diagnosis of gestational diabetes, only 42 
marked down that they had diabetes. This may be due to the fact that the question asked 
about “diabetes” and not “gestational diabetes”.   
Correlations 
 The relationships between the variables (GDM, age, race, marital status, planned 
pregnancy, income, gravida, BMI, depression, anxiety, stress, and social support) were 
analyzed using Pearson correlations (r).  Gestational diabetes was found to be 
significantly related to age (r =.397, p<.001), marital status (r =-.217, p=.01), income (r 
=.197, p=.03), gravida (r =.174, p=.04), and BMI (r =.265, p<.001).  The relationship 
between marital status and GDM was negative, meaning that more people with GDM 
were married.  Income and gravida were positively correlated with GDM, meaning that 
women with GDM had higher incomes and more pregnancies.  Depression was correlated 
with marital status (r = .182, p = .04), if the pregnancy was planned (r = .227, p <.001), 
and with income (r = -.177, p = .05).—indicating that women who were not married, had 
an unplanned pregnancy, and had lower incomes had more depression.  Regarding the 
self-report instruments, the expected relationships were found with a positive correlation 
between depression, anxiety, and stress.  Also, a negative relationship was found between 
social support, depression, anxiety and stress (Table 17).  The strongest relationship was 
found between state and trait anxiety (r =.871, p<.001), as expected.  The weakest 
relationship was found between gravida and GDM (r = .174, p<.04).  The two depression 
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measures (CES-D and EPDS) were also found to be strongly positively correlated 
(r=.791, p<.001), as would be expected.
  
Table 17: Correlations between Key Variables 
 Age Race Marital 
Status 
Plan Income Gravida BMI CESD Social 
Support 
State 
Anxiety 
Trait 
Anxiety 
Stress EPDS 
GDM .397** .109 -.217* -.057 .197* .174* .266** .023 .030 .110 .164 .119 .065 
Age  -.037 -.429** -.266** .610** .343** .178* -.078 .023 -.056 .012 .007 -.026 
Race   -.129 -.007 -.029 .098 .095 .082 -.060 .166 .140 .122 .133 
Marital 
Status 
   -.490* -.482** -.047 -.135 .182* -.101 .026 .054 .125 .092 
Plan     -.365** .127 .064 .227** -.188* .132 .176* .218* .178* 
Income      -.021 -.004 -.177* .191* -.204* -.185* -.130 -.206* 
Gravida       .331** .103 -.245** .109 .191* .199* .134 
BMI        -.038 .061 .031 .045 .042 .102 
CESD         -.556** .712** .805** .757** .791** 
Social 
Support 
         -.520** -.599** -.577** -
.587** 
State 
Anxiety 
          .871** .769** .805** 
Trait 
Anxiety 
           .855** .861** 
Stress             .844** 
**Significant correlations at the p<.001 level, *Significant correlations at the p<.05 level.
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Data Analysis for Study Aims 
 The primary aim of this study was to determine if women with GDM had more 
depression than women without GDM.  The secondary aim was to determine if the 
factors predictive of depression in women with GDM were different than factors 
predictive of depression in women without GDM.  The third aim was to determine if 
minority women were more at risk for prenatal depression than White women.  In the 
next section, the analysis for each aim will be described. 
Data Analysis: Aim 1 
 The first aim of the study was to determine if women with GDM have more 
depression than women without GDM.  The analysis for this aim was done three ways:  
one-tailed Fisher’s exact test, an independent t-test, and logistic regression.  To present 
the results of the data for the primary aim, the assumptions of each analysis will be 
discussed followed by the results.   
A Fisher’s exact test is done to test the relationship between two categorical 
variables.  The Fisher’s exact test is usually done when there are two variables and both 
variables are dichotomous so a 2 x 2 table can be created (A. Field, 2009).  There are two 
assumptions associated with the Fisher’s exact test: (1) there must be independence of 
data and (2) the expected frequency of each variable must be greater than five (A. Field, 
2009).  In this analysis, both of these assumptions were met.  The variables of presence of 
GDM and presence of depression were independent of each other and there were more 
than five cases present in each category.  
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The one-tailed Fisher’s exact test was done (since the hypothesis was directional) 
to assess the difference in the proportion of depressed women (with and without GDM) 
using the recommended cutoff score on the CES-D ≥ 16 and on the EPDS ≥ 12 to 
indicate women who had depression.  The results shown in Table 18 display that there 
were no significant differences in the frequency of depression between women with and 
without GDM when using the CES-D (p=.199).  Similarly, there were no significant 
differences in the frequency of depression found among women with and without GDM 
when the EPDS was used (p=.187) (Table 19). 
Table 18: Fisher’s Exact Test for Depression (CES-D) 
 CES-D<16 (Not Depressed) 
N (%) 
CES-D≥ 16 (Depressed) 
N (%) 
GDM  44 (67.7%) 21 (32.3%) 
No GDM 53 (75.7%) 17 (24.2%) 
p value for Fisher’s Exact test =.199 
Table 19: Fisher’s Exact Test for Depression (EPDS) 
 EPDS<12 (Not Depressed) 
N (%) 
EPDS≥ 12 (Depressed) 
N (%) 
GDM  52 (80%) 13 (20%) 
No GDM 61 (87.1%) 9 (12.9%) 
p value for Fisher’s Exact test =.187 
Independent t-tests compared mean depression scores between women with and 
without GDM.  There are four assumptions made when performing independent t-tests: 
(1) the sampling distribution is normal, (2) data is measured at the interval level or 
greater, (3) there is homogeneity of variance, and (4) scores are independent of each other 
(scores come from separate people) (A. Field, 2009).  Three of the four assumptions were 
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met for this analysis (Appendix G).  Data was collected at the interval level or greater, 
depression scores between women with GDM and without GDM were independent of 
each other, and there was homogeneity of variance among the two groups.  The normal 
distribution of the sample was the only assumption not met (Appendix F); however, the 
scores generated were consistent with what has been published in the literature.  Also, 
both independent t-tests and regression analyses are relatively robust to moderate 
deviations from the normal distribution; therefore, transformation of the data was not 
done (Box & Watson, 1962).   
 Independent t-tests indicated that mean scores on the CES-D were slightly higher 
for women with GDM (M=12.97, SE=1.32) when compared with women without GDM 
(M=12.51, SE=1.08), but not statistically significant [t (133) = .269, p =.789 (Table 20)].  
Similarly on the EPDS, women with GDM (M=6.65, SE=.77) had slightly more 
depression than women without GDM (M=5.90, SE= .63), which was also not 
statistically significant [t(133)= .755, p = .451 (Table 20)].     
Table 20: Independent T-Tests for Depression Measures  
Variable Group Mean Standard 
Error 
Df t statistic p value 
CES-D GDM 12.97 1.32 133 .269 .789 
Non-
GDM 
12.51 1.07 
EPDS GDM 6.65 .771 133 .755 .451 
Non-
GDM 
5.90 .628 
 
Although independent t-tests are robust, a Mann-Whitney analysis (non-
parametric test of comparison of means) was done to determine if the non-normality of 
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the data impacted the findings (A. Field, 2009).   This test was also not significant for 
both depression measures.  Results for the CES-D (U=2212.00, p = .781) and for the 
EPDS (U=2206.50, p = .762)  indicated that the non-normality of the data did not affect 
the ability to detect significant findings.  
Logistic regression is done to predict which group a participant is likely to belong 
to, based on known information (A. Field, 2009).  In the logistic regression analysis, the 
outcome variable must be dichotomous.   In the current study, the outcome variable of 
depression was dichotomized in two ways.  The first was done using a score on the CES-
D≥ 16 to classify women as depressed and a score <16 to classify women as not 
depressed.  The second analysis was done using a score on the EPDS≥ 12 to classify 
women as depressed and an EPDS score <12 to classify women as not depressed.  In 
logistic regression, covariates may be at the nominal to ratio level of measurement 
(Munro, 2005).  In the analysis age, income, and marital status were used as covariates 
because these have been demonstrated in the literature to be related to depression.  The 
assumptions associated with logistic regression include the following: (1) linearity, (2) 
independence of errors, and (3) multicollinearity.  The assumption of linearity assumes 
that there is a linear relationship between the continuous predictors and the logit of the 
outcome variable.  There was one covariate which was continuous in this analysis (age), 
and to test this assumption, the logistic regression was run using the interaction between 
the variable and the log of itself (A. Field, 2009).  When the model was run this way the 
interaction terms were not significant, therefore this assumption was met.  The second 
assumption of independence of errors is the same as the independence assumption 
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discussed with the independent t-test.  As mentioned previously, the assumption has been 
met.  The last assumption of multicollinearity indicates that predictor variables should not 
be highly correlated (correlation coefficient>.8).  To test this assumption, a linear 
regression was done with the analysis of the collinearity diagnostics option (A. Field, 
2009).  These results indicate that relationships between age, income, marital status, and 
GDM were not highly correlated and this assumption was met. 
To continue the analysis between groups of women with and without GDM, 
logistic regression analysis was done.  According to the CES-D, there was not a 
significant relationship between depression and GDM when controlling for age, income, 
and marital status.  Although women with GDM were more likely to have depression, it 
was not statistically significant (OR=2.00, 95% CI, .84, 4.75, p=.115) (Table 21).    
Table 21: Gestational Diabetes Predicting Depression (CES-D)* 
 95% CI for Odds Ratio 
 b (SE) Lower Odds Ratio Upper 
Constant -2.16 (1.27)    
GDM .69 (.44) .84 2.00 4.75 
*Covariates were age, marital status, and income 
 
Similar results were found for the second logistic regression using the EPDS.  
When controlling for age, income, and marital status, women with GDM were more 
likely to have depression but the findings were not statistically significant (OR=2.33, 
95% CI, .80, 6.81, p=.12) (Table 22). 
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Table 22: Gestational Diabetes Predicting Depression (EPDS)* 
 95% CI for Odds Ratio 
 b (SE) Lower Odds Ratio Upper 
Constant -2.59 (1.51)    
GDM .85 (.55) .80 2.33 6.81 
*Covariates were age, marital status, and income  
Depression has been found to be related to higher BMI in women (Keddie, 2011; 
Zhao et al., 2009).  Although no articles were found on BMI and prenatal depression, 
BMI has been found to be related to postpartum depression (LaCoursiere, Baksh, 
Bloebaum, & Varner, 2006; LaCoursiere, Barrett-Connor, O'Hara, Hutton, & Varner, 
2010).  Also, a relationship between gravida and depression has been documented 
(Larsson, Sydsjo, & Josefsson, 2004; Lindgren, 2001; Records & Rice, 2007).  The 
logistic model was run to include these covariates.  After controlling for age, income, 
marital status, BMI, and gravida, women with GDM were 2.7 times more likely to have 
depression (OR=2.72, 95% CI, 1.04, 7.13, p =.041) using the CES-D (Table 23).  Using 
the EPDS and controlling for age, income, marital status, BMI, and gravida, although 
women with GDM were 2.36 times more likely to have depression (OR=2.36, 95% CI, 
.79, 7.06, p = .126), it was not statistically significant (Table 24).   
Table 23: Gestational Diabetes Predicting Depression (CES-D)*   
 95% CI for Odds Ratio 
 b (SE) Lower Odds Ratio Upper 
Constant -1.09 (1.73)    
GDM 1.00 (.49) 1.04 2.72 7.13 
*Covariates were age, marital status, income, BMI, and gravida  
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Table 24: Gestational Diabetes Predicting Depression (EPDS)*  
 
 95% CI for Odds Ratio 
 b (SE) Lower Odds Ratio Upper 
Constant -2.59 (1.51)    
GDM .86 (.56) .79 2.36 7.06 
*Covariates were age, marital status, income, BMI, and gravida  
When analyzing the descriptive statistics, more women with GDM were found to 
have a history of depression than women without GDM (Table 4).  To analyze these 
differences further, a chi-square analysis and a logistic regression analysis were done.  
Chi-square results indicated that women with a history of depression were significantly 
more likely to have GDM (χ2=5.40 (1), p=.02).  In the logistic regression analysis, when 
controlling for age, marital status, and income, women with a history of depression were 
also significantly more likely to have GDM (OR=2.95, 95% CI, .98, 8.82, p=.05) (Table 
25).  Results suggest that women with GDM are about three times as likely to have a 
history of depression.  Once the covariates of gravida and BMI were added, they were 
3.07 times as likely to have a history of depression (OR=3.07, 95% CI, 1.01, 9.49, p = 
.05) (Table 26). 
Table 25: History of Depression Predicting Gestational Diabetes 
 95% CI for Odds Ratio 
 b (SE) Lower Odds Ratio Upper 
Constant -2.49 (1.57)    
GDM 1.08 (.56) .98 2.95 8.82 
*Covariates were age, marital status, income 
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Table 26: History of Depression Predicting Gestational Diabetes 
 
 95% CI for Odds Ratio 
 b (SE) Lower Odds Ratio Upper 
Constant -3.07 (2.09)    
GDM 1.12 (.57) 1.01 3.07 9.36 
*Covariates were age, marital status, income, BMI, and gravida 
The results for the primary aim of this study indicate that women with GDM do 
have higher depression scores as measured by both the CES-D and the EPDS; however, 
the differences between groups were not statistically significant (using Fisher’s exact test 
and the independent t-tests).  However, logistic regression indicated that women with 
GDM were two times more likely to have depression on both the CES-D and the EPDS 
when controlling for age, marital status, and income.  Gravida and BMI were found to be 
related to depression in the literature, therefore, these variables were added into the 
analysis.  Once controlling for age, marital status, income, BMI, and gravida, women 
with GDM were 2.7 times likely to have depression (when the CES-D was used) and this 
was statistically significant.  In addition, this is a clinically significant finding.  Also, as 
discussed in the descriptive statistics section, there was a significant difference between 
women with and without GDM and a history of depression.  Logistic regression also 
indicated that women with a history of depression were 3.07 times more likely to have 
GDM when controlling for age, marital status, income, gravida, and BMI.    
Data Analysis: Aim 2 
 The second aim of this study was to determine the predictive factors of depression 
and to determine if these factors differ between women with and without GDM.  The 
following variables:  state anxiety scores, trait anxiety scores, age, marital status, and 
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socioeconomic status which were based upon the literature were used as the predictors 
for the multiple linear regression analyses.  
Multiple regression is done to predict an outcome variable from several predictor 
variables (A. Field, 2009).  In the current study, depression is the outcome variable, while 
anxiety, stress, gestational diabetes, age, marital status, and socioeconomic status were 
predictor variables.  There are nine assumptions associated with multiple regression.  
These include the following: (1) variable types, (2) non-zero variance, (3) 
multicollinearity, (4) predictors which are not correlated with external variables, (5) 
homoscedasticity, (6) independent errors, (7) normally distributed errors, (8) 
independence, and (9) linearity.  These assumptions were met to allow for the testing to 
be done (Appendix G).  
First, the predictive factors (state anxiety, trait anxiety, GDM, age, marital status, 
and socioeconomic status) were entered into the model using the forced entry method.  In 
the forced entry method, all predictors are entered into the model at the same time (A. 
Field, 2009).  Predictor variables are chosen based on theory and published research; 
however, the order in which the predictor variables are entered into the model is not 
determined.  In the first analysis, the CES-D score was the outcome variable and in the 
second analysis the EPDS score was the outcome variable.  The analysis was also run 
using social support as a predictor variable instead of marital status because the analysis 
suggested that the effect of the marital status and social support were very similar.  Only 
the models using marital status are displayed because marital status had a greater effect 
when analyzing the interaction effects between the variables.  First, the regression 
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analyses using the CES-D score as the outcome variable will be presented followed by 
the regression analyses using the EPDS as the outcome variable. 
The predictors (state anxiety, trait anxiety, GDM, age, marital status, and 
socioeconomic status) explained 71% of the variance in depression as measured by the 
CES-D [R2= .71, Adjusted R2=.69, F (7, 119) = 40.87, p < .001, Table 27].  Trait anxiety 
was the only statistically significant predictor, b=.61 (SE=.11), t=4.73, p<.001.  This 
finding suggested that for every one unit increase in trait anxiety score there is a .61 
increase in the depression score.  Although this is a small increase, this finding was 
statistically significant.  Perceived stress and marital status were two other predictors 
trending toward significance (Table 27). 
Table 27: Multiple Regression with Depression (CES-D) as Outcome  
Variable B SE B β t p value 
State 
Anxiety 
.08 .09 .09 .86 .394 
Trait 
Anxiety 
.51 .11 .61 4.73 <.001 
Perceived 
Stress 
.20 .12 .17 1.72 .088 
GDM 1.21 1.06 .06 1.14 .258 
Age -.04 .11 -.02 -.36 .723 
Marital 
Status 
.64 .35 .10 1.83 .070 
Income .21 .26 .06 .79 .429 
 
 To determine if women with GDM had different predictors of depression, 
multiple regression analyses were done including the predictor variables (state anxiety, 
trait anxiety, GDM, age, marital status, and socioeconomic status) and interaction effects.  
An interaction occurs when the influence of one predictor variable depends on the level 
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of another predictor variable.  In the current study, the predictor variables of state 
anxiety, trait anxiety, perceived stress, age, marital status, and income may have an 
influence on the predictor variable of GDM.  Therefore, regression analyses were run 
with the predictor variables and the interaction effects of the predictor variables for both 
depression measures (CES-D and EPDS).   
Table 28: Multiple Regression with Interaction Terms for Depression (CES-D) as 
Outcome 
 
Variable B SE B β t p value 
State 
Anxiety 
.018 .12 .02 .15 .883 
Trait 
Anxiety 
.44 .15 .53 3.02 .003 
Perceived 
Stress  
.40 .14 .35 2.77 .077 
GDM -8.76 6.84 -.45 -1.28 .203 
Age -.18 .17 -.11 -1.05 .294 
Marital 
Status 
.08 .42 .01 .20 ..519 
Income .28 .43 .07 .65 .249 
GDM X 
State 
Anxiety  
.12 .18 .25 .68 .496 
GDM X 
Trait 
Anxiety 
.20 .22 .44 .92 .362 
GDM X 
Perceived 
Stress 
-.53 .24 -.54 -2.21 .029 
GDM X Age .21 .23 .36 .95 .346 
GDM X 
Marital 
Status 
-5.32 2.26 -.26 -2.36 .020 
GDM X 
Income 
.20 .55 .07 .36 .718 
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In the model with predictor variables and interaction effects, 73% of the variance 
in depression measured by the CES-D was explained [R2= .73, Adjusted R2=.70, F (13, 
113) = 23.41, p < .001].  In this model, there were two significant interaction terms: the 
interaction between GDM and perceived stress [b= -.54 (SE=.24), t= -2.21, p=.029] and 
the interaction between GDM and marital status [b= -.26 (SE=2.26), t= -2.33, p=.020] 
(Table 28).   A significant interaction term indicates that the influence of the predictor 
variable on the outcome variable may depend on another predictor variable.  According 
to these findings, the interaction effects of perceived stress and GDM and of marital 
status and GDM were significant, suggesting that perceived stress and marital status 
depend on the GDM variable.  This means that the relationship between perceived stress 
and depression and the relationship between marital status and depression depend on 
whether women have GDM or not.  Therefore, the predictor variables of perceived stress 
and marital status may differ for women with and without GDM.  To further investigate 
these differences, a third regression analysis was done.  To determine where these 
differences occurred, the file was split to compare women with and without GDM.  In 
this model, only the predictor factors (state anxiety, trait anxiety, GDM, age, marital 
status, and socioeconomic status) were entered (no interaction effects were used). For 
women with GDM, the factors explained 75% of the variance in depression measured by 
the CES-D [R2= .75, Adjusted R2=.72, F (6, 54) = 27.18, p < .001] (Table 29).  For 
women with GDM, trait anxiety [b=.81 (SE=.18), t=3.79, p=.001] and marital status 
[b=.29 (SE=.60), t=3.53, p=.001] were the significant predictors of depression.  Also, for 
women without GDM, the factors explained 73% of the variance in depression measured 
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by the CES-D [R2= .73, Adjusted R2=.70, F (6, 59) = 26.21, p < .001] (Table 29).  
However, for women without GDM, trait anxiety [b=.50 (SE=.13), t=3.35, p=.001] and 
perceived stress [b=.40 (SE=.13), t=3.28, p=.002] were significant predictors of 
depression (Table 29). Thus, trait anxiety was a significant predictor for women with and 
without GDM.  However, marital status was only a significant predictor for women with 
GDM and perceived stress was only a significant predictor for women without GDM.  
Table 29: Predictors of Depression (CES-D) for Women with and without Gestational 
Diabetes 
 
Group Variable B SE B Β t p value 
GDM State Anxiety .15 .14 .18 1.09 .282 
Trait Anxiety .67 .18 .81 3.79 <.001 
Perceived 
Stress  
-.17 .20 -.13 -.82 .416 
Age .08 .16 .04 .50 .619 
Marital Status 2.10 .60 .29 3.53 .001 
Income .55 .37 .14 1.51 .137 
No 
GDM 
State Anxiety .01 .11 .01 .06 .955 
Trait Anxiety .44 .13 .50 3.35 .001 
Perceived 
Stress  
.42 .13 .40 3.28 .002 
Age -.19 .15 -.12 -1.28 .206 
Marital Status -.25 .39 -.05 -.65 .521 
Income .19 .38 .05 .49 .629 
 
When using the EPDS as the outcome variable, the predictive factors (state 
anxiety, trait anxiety, GDM, age, marital status, and socioeconomic status) explained 
81% of the variance [R2=.81, Adjusted R2=.80, F (7, 119) = 73.04, p < .001, Table 30].  
In this model, trait anxiety [b=.42 (SE=.051), t=4.05, p<.001] and perceived stress [b=.40 
(SE=.06), t=4.96, p<.001] were statistically significant predictors of depression.  These 
findings suggest that for every one unit increase in trait anxiety score, there is a .42 
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increase in the depression score.  Also, for every one unit increase in perceived stress, 
there is a .40 increase in the depression score.  Again, although small, these findings are 
statistically significant. 
Table 30: Multiple Regression for Depression (EPDS) as Outcome  
Variable B SE B β t p value 
State 
Anxiety 
.06 .04 .12 1.41 .16 
Trait 
Anxiety 
.21 .05 .42 4.05 <.001 
Perceived 
Stress 
.27 .06 .40 4.96 <.001 
GDM .69 .50 .06 1.37 .17 
Age .03 .05 .03 .61 .54 
Marital 
Status 
-.01 .17 -.01 -.11 .91 
Income -.14 .13 -.06 -1.14 .26 
 
Once again the next regression analysis was done to determine if women with 
GDM had different predictors of depression than women without GDM.  This was done 
by a regression analysis with the predictor variables (state anxiety, trait anxiety, GDM, 
age, marital status, and socioeconomic status) and interaction effects.   In this analysis, 
the factors explained 82% of the variance in depression measured by the EPDS [R2=.82, 
Adjusted R2=.80, F (13, 113) = 40.62, p < .001].  In this model, trait anxiety (b= .39 
(SE=.07), t=2.74, p<.007] and perceived stress [b= .42 (SE=.07), t=4.20, p<.001] were 
statistically significant predictor variables (Table 31).  However, unlike in the CES-D 
analysis there were no significant interaction effects.  This suggests that there were no 
differences in predictor variables between women with and without GDM.  In order to 
confirm this, a third regression analysis was done with a split file to compare women with 
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and without GDM.  This analysis also indicates that significant predictive factors were 
the same for women with and without GDM.  The significant predictor variables were 
trait anxiety and perceived stress for both women with and without GDM (Table 32).  For 
women with GDM, the factors explained 89% of the variance in depression [R2=.89, 
Adjusted R2=.87, F (6, 54) = 70.57, p < .001].  For women without GDM the factors 
explained 74% of the variance in depression measured by the EPDS [R2 = .74, Adjusted 
R2=.71, F (6, 59) = 27.28, p < .001].    
Table 31: Multiple Regression with Interaction Terms and Depression (EPDS) as 
Outcome  
 
Variable B SE B Β t p value 
State Anxiety .05 .06 .09 .80 .43 
Trait 
Anxiety 
.19 .07 .39 2.74 .007 
Perceived 
Stress  
.29 .07 .42 4.20 <.001 
GDM -.82 3.27 -.07 -.25 .802 
Age .00 .08 .00 .03 .979 
Marital Status -.20 .20 -.06 -1.00 .322 
Income .02 .20 .01 .12 .908 
GDM X State 
Anxiety  
.05 .09 .16 .55 .587 
GDM X Trait 
Anxiety 
-.01 .11 -.03 -.08 .941 
GDM X 
Perceived 
Stress 
-.00 .11 -.01 -.03 .975 
GDM X Age .04 .11 .11 .36 .720 
GDM X 
Marital 
Status 
-1.81 1.08 -.15 -1.68 .095 
GDM X 
Income 
-.23 .26 -.13 -.88 .380 
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Table 32: Predictors of Depression (EPDS) for Women with and without Gestational 
Diabetes 
 
Group Variable B SE B Β t p value 
GDM State Anxiety .09 .06 .18 1.69 .097 
Trait Anxiety .19 .07 .39 2.70 .009 
Perceived 
Stress  
.28 .08 .39 3.51 .001 
Age .05 .06 .05 .80 .425 
Marital Status .35 .24 .08 1.49 .143 
Income -.22 .15 -.09 -1.51 .136 
No 
GDM 
State Anxiety .05 .06 .10 .71 .482 
Trait Anxiety .19 .08 .37 2.48 .016 
Perceived 
Stress  
.29 .08 .46 3.84 <.001 
Age .00 .09 .00 .01 .992 
Marital Status -.23 .23 -.08 -.99 .327 
Income .02 .22 .01 .07 .944 
 
There were a total of six multiple regression analyses done to determine the 
predictor factors of depression in women with and without GDM.  The first set of models 
determined predictive factors of depression in general.  These models determined that 
when using the CES-D as the outcome variable, trait anxiety was the only significant 
predictive factor.  However, when using the EPDS, only trait anxiety and perceived stress 
were significant predictors of depression.   
The next set of analyses was done using interaction effects to determine if there 
were differences in predictive factors of depression between women with and without 
depression.  In these models, it is the interaction effects that will determine what 
differences exist between groups.  When using the CES-D, there were two interaction 
effects which were significant: the interaction effect between GDM and perceived stress 
and between GDM and marital status.   This indicates that there are differences in stress 
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and marital status for women with and without GDM.  To further investigate this, another 
regression model was done splitting the file into groups (women with and without GDM) 
to compare them.  This regression analysis indicated that for women with GDM, trait 
anxiety and marital status were significant predictors.  However, for women without 
GDM, trait anxiety and perceived stress were significant.  Therefore, trait anxiety is a 
significant predictor regardless of whether a woman has GDM or not.  Marital status is 
only a significant predictor if a woman has GDM.  Women with GDM had significantly 
higher depression scores if they were not married.  However, perceived stress was only a 
significant predictor for women without GDM where higher stress was related to higher 
depression scores.   
 The same analysis was done using the EPDS as the outcome variable.  Similar to 
the CES-D model, there were two main effects which were significant; the trait anxiety 
and perceived stress.  However, in this analysis there were no interaction effects which 
were statistically significant.   Therefore according to the EPDS, there are no differences 
in predictors of depression regardless if a woman has GDM or not.  The regression 
analysis that was done with the file split between women with and without GDM to 
compare the two groups confirms that the regression analysis done with the interaction 
terms.   Therefore, both trait anxiety and perceived stress were significant predictors of 
depression for women with and without GDM. 
Data Analysis: Exploratory Aim 
 The exploratory aim of this study was to determine if minority women were more 
at risk for depression than White women.  To determine this, a chi-square analysis was 
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done.   Women were classified into four groups: White, Black, Hispanic, and Other 
(included American Indian, Asian, and women who did not state a specific race).  Two 
chi-square analyses were done: one using the recommended cutoff score on the CES-D ≥ 
16 to categorize women as depressed and the second one using the EPDS ≥ 12 to indicate 
women who had depression.  To further explore the impact of race on depression, two 
independent t-tests were done.  In the t-test analyses the sample was grouped into White 
or non-White.  In one analysis, the continuous CES-D score was used as the outcome 
variable and in the second analysis, the continuous EPDS score was used.  The 
assumptions of the Pearson’s chi-square test and the independent t-tests have been 
discussed previously.  
 According to the results with the CES-D, there was no significant relationship 
between race and depression (χ2 (3) =2.231, p=.526).   Also, no significant relationship 
was found when using the EPDS (χ2 (3) =4.515, p=.211).  
 The independent t-tests also indicated no significant difference between race and 
depression. According to mean scores on the CES-D, White women (M=10.95, SE=1.38) 
had slightly less depression than non-White women (M=13.59, SE=1.05).  However, this 
difference was not statistically significant [t (133) = -1.47, p =.143].  Similarly on the 
EPDS, White women (M=5.30, SE=.75) had slightly less depression than non-White 
women (M=6.73, SE= .63).  Again, this difference was not statistically significant [t 
(133)= -1.36, p = .175] (Table 33).   
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Table 33: Independent T-Tests for Race (CES-D and EPDS) 
Variable Group Mean Standard 
Error 
Df t statistic p value 
CES-D White 10.95 1.38 133 -1.47 .143 
Non-
White 
13.59 1.05 
EPDS White 5.30 .75 133 -1.36 .175 
Non-
White 
6.73 .63 
 
 To determine if there were differences in depression between race, both Pearson’s 
chi-square and independent t-tests were done.  Although the results indicated that White 
women had less depression, the differences between the groups were not statistically 
significant. 
Data Analysis of Maternal and Infant Health Outcomes 
 Although not a specific aim of this study, the reviewed literature indicated that 
women with depression and gestational diabetes are more at risk for complications during 
delivery.  Therefore, some delivery information was analyzed to determine if women 
with gestational diabetes were more at risk for complications and if women with 
depression were more at risk for complications.  The variables analyzed were as follows: 
gestational age at delivery, type of delivery (vaginal, c-section, or instrument delivery), 
presence of lacerations during vaginal delivery, delivery complications (shoulder 
dystocia, presence of meconium, nuchal cord, maternal fever, postpartum hemorrhage, 
chorioamnionitis, prolonged rupture of membrane, and partial abruption), Apgar scores at 
one, five, and ten minutes, and infant birth weight.  In order to analyze this, descriptive 
statistics and frequency tables were done for women with and without GDM (Table 34).  
The descriptive statistics and frequency tables were also completed for women with and 
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without depression according to the CES-D score (≥ 16 being categorized as depressed) 
and the EPDS score (≥ 12 being categorized as depressed) (Table 35).  As mentioned in 
the Missing Data section, there are six women for whom delivery data is missing.  These 
women delivered at an outside hospital where delivery information was unavailable. 
Unfortunately, most of the women with the missing data were in the GDM group, which 
may be a limitation in examining this data.  Also, women with a twin pregnancy were 
excluded from this analysis because of their increased risk of a cesarean section, 
complications, and the inability to include more than one infant in the categories of birth 
weight and Apgar scores. 
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Table 34: Delivery Outcomes for Women with and without Gestational Diabetes 
Variable GDM  
N (%) 
No GDM 
N (%) 
Type of Delivery 
Vaginal 
C-section 
Instrument 
VBAC 
N=56 N=65 
27 (48%) 49 (72%) 
26 (46%) 13 (20%) 
1 (2%) 4 (6%%) 
2 (4%) 1 (2%) 
Lacerations 
None 
1st degree 
2nd degree 
3rd degree 
4th degree 
Sulcus Tear 
N=56 N=65 
40 (71%) 23 (35%) 
6 (11%) 15 (23%) 
8 (14%) 24 (37%) 
N/A 1 (2%) 
1 (2%) N/A 
1 (2%) 2 (3%) 
Complications* 
None 
Shoulder dystocia 
Meconium present 
Nuchal cord 
Maternal fever 
Postpartum hemorrhage 
Chorioamnionitis 
Prolonged ROM 
Partial abruption 
N=56 N=65 
38 (68%) 48 (74%) 
1 (2%) 2 (3.1%) 
7 (13%) 11 (16.9%) 
9 (16%) 6 (9.2%) 
2 (4%) 2 (3.1%) 
2 (4%) 1 (1.5%) 
3 (5%) 3 (4.6%) 
3 (5%) 5 (7.7%) 
N/A 1 (1.5%) 
 GDM 
Mean (SD) 
No GDM 
Mean (SD) 
Gestational Age at Delivery 38.2 (1.67) 39.0 (1.25) 
Apgar: 1 min 8.07 (1.32) 8.09 (1.58) 
Apgar: 5 min 8.75 (.58) 8.83 (.45) 
Apgar: 10 min 8.87 (.45) 8.93 (.31) 
Birth Weight (grams) 3.42 (.62) 3.32 (.48) 
 *Complication category will not total 100% because some women experience more than 
one complication. 
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Table 35: Delivery Outcomes for Women with and without Depression 
Variable Depressed 
CES-D ≥ 16 
N (%) 
Not Depressed  
CES-D < 16 
N (%) 
Depressed 
EPDS ≥ 12 
N (%) 
Non-Depressed 
EPDS <12 
N (%) 
Type of Delivery 
Vaginal 
C-section 
Instrument 
VBAC 
N=36 N=85 N=21 N=100 
19 (52%) 55 (65%) 8 (38%) 66 (66%) 
15 (42%) 24 (28%) 12 (57%) 27 (27%) 
1 (3%) 4 (5%) 1 (5%) 4 (4%) 
1 (3%) 2 (2%) N/A 3 (3%) 
Lacerations 
None 
1st degree 
2nd degree 
3rd degree 
4th degree 
Sulcus Tear 
    
24 (67%) 39 (46%) 15 (72%) 48 (48%) 
7 (19%) 14 (16%) 3 (14%) 18 (18%) 
4 (11%) 28 (33%) 3 (14%) 29 (29%) 
N/A 1 (1%) N/A 1 (1%) 
1 (3%) N/A N/A 1 (1%) 
N/A 3 (4%) N/A 3 (3%) 
Complications* 
None 
Shoulder dystocia 
Meconium present 
Nuchal cord 
Maternal fever 
Postpartum 
hemorrhage 
Chorioamnionitis 
Prolonged ROM 
Partial abruption 
    
26 (72%) 60 (71%) 17 (81%) 65 (65%) 
3 (8%) N/A N/A 3 (3%) 
5 (14%) 13 (15%) 2 (10%) 16 (16%) 
4 (11%) 11 (13%) 2 (10%) 13 (13%) 
N/A 4 (5%) N/A 4 (4%) 
1 (3%) 2 (2%) 1 (5%) 2 (2%) 
N/A 6 (7%) N/A 6 (6%) 
2 (6%) 6 (7%) N/A 8 (8%) 
N/A 1 (1%) 1 (5%) N/A 
 Depressed 
CES-D ≥ 16 
Mean (SD) 
Not Depressed  
CES-D < 16 
Mean (SD) 
Depressed 
EPDS ≥ 12 
Mean (SD) 
Non-Depressed 
EPDS <12 
Mean (SD) 
Gestational Age at 
Delivery 
38.2 (1.98) 38.8 (1.21) 38.5 (1.18) 38.6 (1.56) 
Apgar: 1 min 8.39 (.87) 7.95 (1.63) 8.10 (1.33) 8.08 (1.49) 
Apgar: 5 min 8.86 (.35) 8.76 (.57) 8.90 (.30) 8.77 (.55) 
Apgar: 10 min 9.00 (.27) 8.87 (.40) 9.00 (.00) 8.89 (.40) 
Birth Weight 
(grams) 
3.38 (.58) 3.36 (.53) 3.48 (.45) 3.34 (.56) 
*Complication category will not total 100% because some women experience more than one 
complication. 
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 To determine if there were any significant differences between groups (women 
with and without GDM and women with and without depression), independent t-tests 
were done for the continuous variables of the following: gestational age at delivery, 
Apgar at 1, 5, and 10 minutes, and birth weight.  In order to do chi-square analyses, type 
of delivery was made a dichotomous variable where only vaginal delivery and cesarean 
section delivery were analyzed.  The lacerations variable was also made dichotomous 
where no tears was considered a group and the presence of a tear (first degree, second 
degree, third degree, fourth degree, and sulcus tear) was considered a group. 
According to the chi-square results, there was a significant difference in the type 
of delivery between women with and without GDM [χ2 (1) =11.63, p=.001].  Women 
with GDM had significantly more cesarean sections than women without GDM.  There 
was also a significant difference between groups in the presence of tears [χ2 (1) =15.66, 
p<.001].  Women with GDM had significantly fewer tears than women without GDM.  
However, given that the women with GDM had more cesarean sections (and you can 
only have a vaginal tear if you deliver vaginally), it is not surprising that women with 
GDM had fewer vaginal tears. 
 Assumptions for the independent t-test analysis have also been discussed 
previously.  The results of the independent t-tests indicate there are no differences in 
Apgar scores or birth weight between women with and without GDM (Table 36).  
However, there was a significant difference in gestational age at delivery: women with 
GDM delivered earlier.  According to the mean gestational age at delivery, women with 
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GDM (M=38.23, SE=.22) delivered slightly earlier than women without GDM 
(M=38.97, SE=.16).  This difference was significant [t (119) = 2.81, p =.006, Table 36]. 
Table 36: Independent T-Tests for Infant Outcomes in Women with and without 
Gestational Diabetes 
 
Variable Group Mean Standard 
Error 
Df t statistic p value 
Gestational 
Age  
GDM 38.23 .22 119 2.81 .006 
Non-
GDM 
38.97 .16 
1 min 
Apgar 
GDM 8.07 .18 119 .08 .938 
Non-
GDM 
8.09 .20 
5 min 
Apgar 
GDM 8.75 .08 103 .84 .401 
Non-
GDM 
8.83 .06 
10 min 
Apgar 
GDM 8.87 .07 105 .88 .381 
Non-
GDM 
8.93 .04 
Birth 
Weight 
GDM 3.42 .09 115 -1.04 .302 
Non-
GDM 
3.32 .06 
 
 The same chi-square analyses were done for women with and without depression.  
Women were classified as depressed based on their CES-D score (≥16 as depressed) and 
their EPDS score (≥12 as depressed).  Type of delivery and presence of lacerations were 
also dichotomized as in the previous analysis.  According to the CES-D there was no 
difference in the type of delivery between women with and without depression [χ2 (1) 
=2.31, p=.129].  However, there was a significant difference in the presence of vaginal 
tears [χ2 (1) =4.38, p=.036], where women without depression had more vaginal tears.  
When using the EPDS, there was a significant difference in the type of delivery between 
women with and without depression [χ2 (1) =4.01, p=.045], where women with 
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depression had more cesarean sections.  There were also significantly more vaginal tears 
in women without depression [χ2 (1) =3.82, p=.051].  Again, because more women 
without depression had vaginal deliveries, they are more likely to have vaginal tears.          
Independent t-tests were also done to analyze differences in gestational age at 
delivery Apgar scores (1, 5, and 10 minutes), and birth weight between women who were 
and were not depressed.   Two separate independent t-test analyses were done: one with 
women who had a score ≥16 on the CES-D categorized as depressed and a second with 
women who had a score ≥12 on the EPDS categorized as depressed.  According to the 
CES-D, there were no differences in gestational age at delivery, Apgar scores, or birth 
weight between women with and without depression (Table 37).  Gestational age at 
delivery was trending towards significance where women with depression delivered 
slightly earlier than women without depression.  There was also a trend toward 
significance with depressed women having an infant with a slightly higher ten minute 
Apgar score than women without depression.   
 When the EPDS was used to classify women as depressed or not depressed, 
similar results were found.  In this analysis, the equality of variances was not met for 
Apgar scores at five and ten minutes.  However, there were significant differences in the 
ten minute Apgar score between babies born to women who were and were not 
depressed.  Babies born to women with depression (M=9.00, SE=.00) had higher Apgar 
scores at ten minutes than babies born to women without depression (M=8.89, SE=.04).  
This difference was significant [t (92) = -2.58, p =.012].  The adjusted degrees of 
freedom, t statistic, and p value have been reported in Table 38. 
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Table 37: Independent T-Tests for Infant Outcomes in Women with and without 
Depression (CES-D) 
 
Variable Group Mean Standard 
Error 
Df t statistic p value 
Gestational 
Age  
Depressed 38.21 .33 46.50 1.69 .097 
Non-
Depressed 
38.81 .13 
1 min 
Apgar 
Depressed 8.39 .15 119 -1.51 .133 
Non-
Depressed 
7.95 .18 
5 min 
Apgar 
Depressed 8.86 .06 103 -1.13 .26 
Non-
Depressed 
8.76 .06 
10 min 
Apgar 
Depressed 9.00 .05 70.72 -1.84 .069 
Non-
Depressed 
8.87 .05 
Birth 
Weight 
Depressed 3.38 .10 115 -.21 .837 
Non-
Depressed 
3.36 .06 
 
Table 38: Independent T-Tests results for Infant Outcomes for Women with and without 
Depression (EPDS) 
 
Variable Group Mean Standard 
Error 
Df t statistic p value 
Gestational 
Age  
Depressed 38.53 .26 119 .32 .752 
Non-
Depressed 
38.65 .16 
1 min 
Apgar 
Depressed 8.10 .29 119 -.04 .965 
Non-
Depressed 
8.08 .15 
5 min 
Apgar 
Depressed 8.90 .07 52 -1.58 .12 
Non-
Depressed 
8.77 .06 
10 min 
Apgar 
Depressed 9.00 .00 92 -2.58 .012 
Non-
Depressed 
8.89 .04 
Birth 
Weight 
Depressed 3.48 .10 115 -1.12 .266 
Non-
Depressed 
3.33 .06 
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 The results of the independent t-tests indicate that there are few very differences 
in maternal and infant health outcomes between women with and without GDM.  In fact, 
only gestational age at delivery was significantly different with women with GDM 
delivering earlier than women without GDM.  When comparing women with and without 
depression according to the CES-D there were no differences in delivery outcomes.  
However, when comparing women with and without depression on the EPDS, women 
with depression had more cesarean sections and babies born to women with depression 
had higher Apgar scores at ten minutes.  These differences were significant, but it is 
important to note that there was very little difference between the means.  In fact, the 
small difference does not suggest a clinical significance between ten minute Apgar 
scores.  A larger sample size may produce different findings regarding differences 
between women with and without GDM and women with and without depression. 
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CHAPTER FIVE 
DISCUSSION 
 This chapter discusses the study findings, implications for nursing, and 
recommendations for future research.  Prenatal depression and gestational diabetes are 
common complications during pregnancy.   Although evidence suggested that a potential 
relationship between prenatal depression and gestational diabetes exists, further research 
was needed.  This study found that women with GDM had higher rates of depression as 
well as higher mean depression scores, but the results were not statistically significant.  
However, it was determined that women with GDM were 2.7 times more likely to suffer 
from depression than women without GDM when controlling for age, marital status, 
income, BMI, and gravida.  This finding was both statistically significant and clinically 
significant.  Also, women with a history of depression were 3.07 times more likely to 
have GDM (when controlling for age, marital status, income, BMI, and gravida).   Trait 
anxiety was found to be a predictive factor of depression for both women with and 
without GDM.  There were no differences in depression between races, suggesting that 
pregnant minority women were not at greater risk for depression.  It was also determined 
that gestational diabetes had little impact on delivery outcomes although women with 
GDM delivered slightly earlier than women without GDM.  There were very few  
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differences in delivery outcomes between women who did and did not have depression.  
When using the EPDS, women with depression had more cesarean sections and the ten 
minute Apgar score was found to be slightly higher. Also, for both measures (CES-D and 
the EPDS); women without depression were more likely to have vaginal tears.  
 The biopsychosocial model guided this study.  This is a holistic model, in which 
the biological, psychological, and sociological components of a person are all equally 
important when treating an illness (Engel, 1977).  The biopsychosocial model allows the 
researcher or clinician to consider many factors such as quality of life, social role 
performance, and emotional status during evaluation of a patient (Fava & Sonino, 2008). 
 There is a known relationship between depression and type 2 diabetes.  
Depression is more commonly found in women with type 2 diabetes (28%) than in men 
with type 2 diabetes (18%) (R. Anderson et al., 2001).  Both hyperglycemia and insulin 
resistance which occur in type 2 diabetes have been related to depression.  
Hyperglycemia and insulin resistance are also present during gestational diabetes.  
However, the relationship between gestational diabetes and depression has not been 
extensively studied.  This study was conducted to further investigate the possible 
relationship between gestational diabetes and depression. 
Description of the Sample 
 This convenience sample had a mean age of 29.7 years and was ethnically diverse 
(33% White, 23% Black, 33% Hispanic, and 11% Other), which was representative of the 
population where the data was collected.  The average age of a woman giving birth for 
the first time was 25 years in 2006 (Martin et al., 2009).  The mean age in this sample 
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may be older due to the inclusion of multiparous women and the trend in the United 
States of older women having children (Martin et al., 2009).   For the current study, 
participants were enrolled during routine prenatal care visits and the average gestational 
age at which participants filled out the self-report questionnaires was 31.1 weeks.  
Women with GDM were found to be significantly older (Mean= 32.12 years) compared 
with women without GDM (Mean=27.36 years).  Advanced maternal age is a known risk 
factor for developing GDM, therefore these findings were not surprising (Casey et al., 
1997; Jovanovic & Pettitt, 2001).  In the current study, more women with GDM were 
married and had higher incomes than women without GDM; however, these differences 
were not statistically significant.  Other studies have also not found significant 
differences in marital status and income between women with and without GDM (Casey 
et al., 1997; Jovanovic & Pettitt, 2001).  The current study did not find differences in the 
prevalence of GDM between races.  This is contradictory to other studies which have 
reported that GDM is more common in Black and Hispanic women (Getahun et al., 2008; 
Lawrence, Contreras, Chen, & Sacks, 2008).  Both of these studies had very large sample 
sizes (over 100,000).  The small sample size of the current study may be the reason that 
GDM was not more common in minority women.   
Discussion of the Variables 
Depression 
In the current study, two tools were used to measure depression (the CES-D and 
the EPDS).  To this researcher’s knowledge, this is the first study to use both tools and to 
explore the relationship between the two commonly used prenatal depression measures.  
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Results varied depending upon which tool was used.  Using the CES-D, 28% of women 
had depression when the recommended cutoff score of 16 was used.  Thirty two percent 
of women with GDM were found to have depression compared with 24% of women 
without GDM.  The items with the highest means on the CES-D for women with and 
without GDM were question 7 (“I felt that everything I did was an effort”) and question 
11 (“My sleep was restless”).  This indicates that regardless of GDM, women during 
pregnancy felt that they had to use a lot of effort in their everyday lives and that they had 
problems with sleep. Other studies have reported that sleep deprivation and sleep 
disturbances are common for women during pregnancy (Da Costa et al., 2010; Facco, 
Kramer, Ho, Zee, & Grobman, 2010; Hall et al., 2009).   
 Rates of depression in this sample were compared with rates in studies examining 
prenatal depression  (Chazotte et al., 1995; Davis et al., 2007; Davis et al., 2004; Diego et 
al., 2005; T. Field et al., 2002; Glazier et al., 2004; Holzman et al., 2006; C. Kim et al., 
2005; Lindgren, 2001; Marcus et al., 2003; S. Orr et al., 2007; S. T. Orr et al., 2006; 
Records & Rice, 2007; Westdahl et al., 2007).  In studies that used the CES-D in 
pregnant populations, rates of depression ranged from 7.8% to 70% (Table 39).  
Consistent with previous research, the women in this study (with and without GDM) 
were found to have rates of depression within this range.  When comparing the mean 
scores on the CES-D from this study (12.73 for the entire sample, 12.97 for women with 
GDM, and 12.51 for women without GDM), they were within the range cited in previous 
work (6.5 to 21.9) (Table 39).  
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Table 39: Prenatal Depression Research (CES-D) 
 
Author Sample 
Size 
Sample 
Characteristics 
Percentage 
Depressed 
Mean (SD) Range 
Chazotte, 
Freda, 
Elovitz, & 
Youchah 
(1995) 
90 (30 
GDM, 30 
healthy, 
30 
preterm) 
Average age 
25.1 years 
44% Black, 
50% Hispanic, 
6% White. 
56.7% GDM, 
70% at risk for 
preterm labor, 
33.3% healthy 
GDM-17.0 
(9.1) 
PTL-20.9 
(9.4) 
Healthy- 
13.7 (7.5) 
Unknown 
Davis et al. 
(2007) 
247 Age unknown 
49% White, 
20% Hispanic, 
11% African 
American, 
9% Asian. 
12.7%-17.8% 
(measured 3 
times during 
pregnancy) 
6.5 (4.8)-7.3 
(5.5) 
0-27 
Davis et al. 
(2004)  
22 Average age 
28.0 years 
68% White, 
27% Hispanic, 
5% Other. 
42% 14.9 (10.2) 2-34 
Diego, Field, 
& 
Hernandez-
Reif, 2005 
80 Average age 
27 years 
46% Hispanic, 
27% Black, 
16% White, 
11% Asian. 
Unknown 21.9 (6.34) Unknown 
Field et al. 
(2002) 
112 Average age 
30.7 years 
54% Hispanic, 
46% African 
American. 
Unknown 11.5 (8.39) Unknown 
Glazier et al. 
(2004) 
2,052 Average age 
30.7 years 
Racial Distr. 
unknown. 
Unknown Unknown Unknown 
Holzman et 
al. (2006) 
1,321 Average age 
unknown 
69% White, 
25% African 
American, 
6% Other. 
46% of teens 
47% 
disadvantaged 
23% 
advantaged 
Teens-17.0 
(10.3) 
Disad-17.3 
(11.0) 
Advan-10.7 
(8.7) 
Unknown 
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Kim, C, et 
al. (2005) 
1,445 (64 
GDM, 
148 PIH, 
1,233 
healthy) 
Average age 
unknown 
In women 
with GDM 
50% Hispanic, 
25% White, 
17% Black, 
8% 
Asian/Other. 
7.8% of GDM 
10.1% 
Pregnancy 
Induced HTN 
11.6% healthy 
Unknown Unknown  
Lindgren, 
2001 
252 Average age 
29.5 years 
77% White, 
13% Black, 
10% Other. 
44.4% 14.37 (9.62) 0-48 
Marcus, et 
al. (2003) 
3,742 Average age 
28.6 years 
73% White, 
13% Black.   
20.4% Unknown Unknown 
Orr et al. 
(2006) 
1163 Average age 
24.1 
70% Black, 
30% White. 
Unknown 16.2 0-55 
Orr et al. 
(2007) 
1163 Average age 
24.7 
70% Black, 
30% White.   
44%  16.2 0-55 
Records & 
Rice, 2007 
139  Average age 
27 years 
89% White, 
1% African 
American,  
4% Hispanic.   
38% Unknown Unknown 
Westdahl et 
al. (2007) 
1,047 Average age 
20.4 years 
80% Black, 
13% Hispanic, 
7% White.   
33% 12.74 (8.45) 1-43 
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According to the EPDS, 16% of this sample had depression using the 
recommended cutoff score of 12.  For women with GDM, 20% were found to have 
depression compared with 13% of women without GDM.  On the EPDS, items 4 and 6 
had the highest mean scores for both women with and without GDM.  Item 4 is “I have 
been anxious or worried for no good reason.”  Therefore, both women with and without 
GDM were feeling worried and anxious during their pregnancy.  Item 6 is “things have 
been getting on top of me,” suggesting that women with and without GDM are feeling 
like things are building up and may suggest feelings of stress during pregnancy.  Other 
studies have reported that pregnant women have high amounts of daily stressors and 
feelings of anxiety (Hall et al., 2009; Reid, Power, & Cheshire, 2009).  
In previous research, rates of depression ranged from 9% to 39% using the EPDS 
in pregnant women (C. Anderson et al., 2002; Dayan et al., 2006; Deave et al., 2008; Hart 
& McMahon, 2006; Heron et al., 2004; Larsson et al., 2004; Mautner et al., 2009; 
Rubertsson et al., 2005) (Table 40).  In the current study, women with and without GDM 
had rates of depression within this range.  In addition, the mean EPDS scores for this 
sample was 6.26 for the entire sample, 6.45 for women with GDM, and 5.9 for women 
without GDM, consistent with other studies which have reported scores ranging from 6.0 
to 10.4 (C. Anderson et al., 2002; Dayan et al., 2006; Deave et al., 2008; Hart & 
McMahon, 2006; Heron et al., 2004; Larsson et al., 2004; Mautner et al., 2009; 
Rubertsson et al., 2005) (Table 40).  
125 
 
 
Table 40: Prenatal Depression Research (EPDS) 
 
Author Sample 
Size 
Sample 
Characteristics 
Percentage 
Depressed 
Mean (SD) Range 
Anderson, 
Roux, & 
Pruitt, 2002 
31 Average age 
31.7 years 
84% White, 
10% Black, 
3% Hispanic, 
3% Other. 
29% 8.71 
(Unknown) 
1-25 
Dayan et al. 
(2006) 
681 Average age 
28.5 years 
Racial 
distribution 
unknown.   
14.5% (>14) 7.2 (5.6) 0-28 
Deave et al. 
(2008) 
11,098 Average age 
28 years 
96% White. 
14.1% (>12) Unknown Unknown 
Hart & 
McMahon, 
(2006) 
53 Average age 
31.24 years 
Racial 
distribution 
unknown. 
9% (>13) 6 (3.93) 0-16 
Heron et al. 
(2004) 
8,323 *   11% (>13) Unknown Unknown 
Larsson et al. 
(2004) 
518 * 17.4% Unknown Unknown 
Mautner et al. 
(2009) 
90 Average age 
31.2 years 
Racial 
distribution 
unknown. 
39% (>10) GDM-7.55 
(5.48) 
HTN-9.06 
(5.33) 
Preterm 
Labor-
10.41(4.79) 
Healthy-
6.41(4.37) 
Unknown 
Rubertsson et 
al. (2005) 
2,674 * 14.9% Unknown Unknown 
* Average age and racial distribution unknown. 
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In the general population, 10% of women have depression (Center for Disease 
Control and Prevention, 2010).  Therefore, pregnant women in this sample had higher 
rates of depression than the general population, but did have rates consistent with 
previous studies using the CESD and EPDS to measure depression in pregnant women.  
The results of the current study were also consistent with another study which reported 
that pregnant women had significantly higher depression scores when compared to non-
pregnant women (Breitkopf et al., 2006). 
 When comparing the CES-D and the EPDS, the rates of depression and mean 
scores were higher when using the CES-D in both the current study and in previous 
research.  Since the CES-D includes items that measure somatic symptoms of pregnancy 
such as restless sleep and appetite, this may be the reason for the increased rate of 
depression (Blaney et al., 2004; Holzman et al., 2006; S. T. Orr et al., 2006; Westdahl et 
al., 2007).  Because one of the items with the highest mean score was “restless sleep”, 
this most likely contributed to the higher depression scores on the CES-D for the current 
study.   
 At the site for data collection, women are informed that depression screening is 
part of prenatal care and that the EPDS is used around 28 weeks’ gestation to screen for 
prenatal depression.  When women were enrolled into this study, they were informed that 
the study was investigating moods during pregnancy.  Thus, women may have recognized 
the EPDS as a depression screen when filling it out for the current study.  It is possible 
that their familiarity with the tool may have impacted how they responded. It should be 
noted that for all women, the CES-D was administered first, with the EPDS administered 
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as one of the last questionnaires.  Thus the ordering of the questionnaires may have 
contributed to the difference in the rates of depression and the mean depression scores. 
History of depression was assessed in the self-report questionnaires with “Have 
you ever been diagnosed with depression?”  A significant difference was found in that 
women with a history of depression were more likely to have GDM .  This is a clinically 
significant finding because women with a history of depression may need to be screened 
earlier and monitored more closely for GDM.  Depression as a risk factor for type 2 
diabetes has been proposed in three meta-analyses (Lustman et al., 2000; Lustman et al., 
2007; Musselman et al., 2003).  It has been suggested that depression-induced changes in 
neurotransmitter functions may negatively affect glycemic control by causing 
hyperglycemia.  This may be the physiological reason for depression predisposing a 
person to diabetes (Von Kanel et al., 2001).  Also, depression has been found to be 
significantly related to hyperglycemia in both type 1 and type 2 diabetes (Lustman et al., 
2000).  The current study supports the importance and clinical significance of a history of 
depression being a risk factor for developing GDM. 
Anxiety 
In working women between the ages of 19 and 39, normal state anxiety scores 
have been reported with a mean of 36.17 (SD±10.96) and trait anxiety scores with a mean 
of 36.15 (SD±9.53) (Spielberger, Gorsuch, Jacobs, Lushene, & Vagg, 1983).  For the 
current study, the state anxiety scores (M=35.67) and trait anxiety scores (M=36.25) were 
within 0.5 points of the normative scores.  Women with GDM had about the same state 
anxiety scores (M=36.98); however, they had higher trait anxiety scores (M=38.22).  
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Lastly, women without GDM were found to have slightly lower state anxiety (M=34.44) 
and trait anxiety (M=34.43) scores when compared to the documented norm.  Two 
studies using the STAI to measure anxiety reported that state and trait levels were about 
equal (Allister et al., 2001; Bergant et al., 1997).  However, two other studies examining 
depression and anxiety using the STAI have found trait anxiety to be higher than state 
anxiety as was noted in the present study (Dayan et al., 2006; Hart & McMahon, 2006).   
The findings of the current study are consistent with previous research which found that 
women with GDM had higher state and trait anxiety scores shortly after diagnosis of 
GDM compared to women without GDM (Daniells et al., 2003).  
Anxiety has been associated with prenatal depression (Allister et al., 2001; 
Breitkopf et al., 2006; Glazier et al., 2004; Hart & McMahon, 2006).  The current study 
also found a relationship between depression and anxiety.   State anxiety was correlated 
with both CES-D scores (r=.712, p<.001) and EPDS scores (r=.805, p<.001).  Trait 
anxiety was also correlated with both CES-D scores (r=.805, p<.001) and EPDS scores 
(r=.861, p<.001).  Therefore, the current study was consistent with previous research.    
Stress 
The perceived stress scale had a reported mean score of  16.14 (SD±7.73)  in a 
large sample of  women aged 40 and older (n=1032)  (Cohen & Janicki-Deverts, in 
press).  It was also reported that women had higher levels of  stress than men and that 
stress was higher in younger people as well as individuals with lower income (Cohen & 
Janicki-Deverts, in press).  In the current study, women with GDM (M= 16.11) reported 
similar stress levels.  However, the sample as a whole (M=15.07) and women without 
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GDM (M=14.11) had slightly lower levels of stress than the documented norms.   
Although the current study noted that women with GDM were older, they had higher 
stress which was most likely due to the diagnosis of gestational diabetes.  Another study 
found that women with GDM were found to have higher stress shortly after the diagnosis 
of GDM when compared to women without GDM (Daniells et al., 2003).  Also, one 
study which used the PSS in a sample of pregnant women (n=247) reported much higher 
means on the scale (M= 26.7).  However, that study used a different version of the scale 
(12 items) (Davis et al., 2007), making comparisons to the current study difficult. 
 The highest mean scores on the stress scale were the same for women with and 
without GDM.  Item 1 (“Have you been upset because of something that happened 
unexpectedly?”) and item 3 (“Have you felt nervous or “stressed”?”) had the highest 
mean scores.  Literature has reported that it is common for women to experience stress 
during pregnancy (Reid et al., 2009; Zust, Natwick, & Oldani, 2010).   
Social Support 
The mean overall social support in the current study was 6.0, which suggests that 
the women had high levels of social support.   Similar findings have been documented in 
pregnant women (n=265) where the mean score on this tool was 6.01 (SD±.90) (Zimet et 
al., 1990).  This tool included three subscales: significant other support, family support, 
and friend support.  The mean scores in the current study for the three subscales were 6.3 
for significant other support, 6.11 for family support, and 5.59 for friend support; 
findings consistent with the research by Zimet et al. (1990) (significant other support 
=6.39, family support=6.02, and friend support=5.64).  
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For women with GDM, item 3 (“My family really tries to help me.”) and item 10 
(“There is a special person in my life who cares about my feelings.”) had the highest 
mean scores.  Women without GDM also had item 10 as one of the highest mean item 
scores and item 1 (“There is a special person who is around when I am in need”).  
Because women with GDM had item 3 regarding help from family as a high item mean it 
appears that they get more assistance from their family than women without GDM.  
However, women without GDM had two items regarding their significant other which 
indicates most of the support for women without GDM comes from the significant other.  
The diagnosis of gestational diabetes may mean women require more support and 
therefore these women look to family in addition to their significant other to support them 
during their pregnancy.  Other research has shown that women with gestational diabetes 
have greater compliance with their management of diabetes if they have more social 
support and fewer stressors (Ruggiero, Spirito, Bond, Coustan, & McGarvey, 1990).  
Medications 
Nineteen percent of women in the study were taking antidepressants, anti-anxiety, 
insulin, and oral diabetes medication.  Four percent of women were taking an anti-
depressant medication which is consistent with a large study (n=6,582) reporting that 
4.5% of women used antidepressants during three months prior to pregnancy or until 
delivery (Alwan, Reefhuis, Rasmussen, Friedman, & National Birth Defects Prevention 
Study, 2011).  For the current study, 66% of women were not taking medications for their 
diabetes.  However, of those taking medication (35%), only two (1%) were taking insulin 
while the others were taking oral medication (glyburide).   For the current study, the use 
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of medications for glycemic control was consistent with a previous study where 63% of 
women with gestational diabetes were diet controlled and 37% were treated with either 
oral medications or insulin (Kremer & Duff, 2004). 
Discussion of Study Aims 
Aim 1: Difference in Depression between Women with and without GDM 
 The primary aim of this study was to determine if women with GDM had more 
depression than women without GDM.  Findings indicated that there were no statistically 
significant differences between women with GDM and without GDM in terms of the 
frequency of depression as well as the mean depression scores (both the CES-D and the 
EPDS).  Although more women with GDM reported depression (32.3%) compared to 
women without GDM (24.2%), it was not statistically significant.  Chazotte et al. (1995), 
also reported no differences in depression between healthy women without GDM (37%) 
and with GDM (57%) using the CESD-D).  Although their study had higher rates of 
depression, the sample was much smaller (n=30 per group), and the participants were 
younger (M=26.6 years) and limited to women of 34 to 36 weeks’ gestation.  Both 
younger age (Glazier et al., 2004; Lindgren, 2001; S. T. Orr et al., 2006; Rubertsson et 
al., 2005) and the third trimester (Records & Rice, 2007) have been associated with 
higher levels of depression.   
Although the current study reported that women with GDM had higher mean 
depression scores than women without GDM on the CES-D (12.97 vs. 12.51) and the 
EPDS (6.65 vs. 5.90), these findings were not statistically significant.  Mautner et al. 
(2009), also reported that women with GDM had higher mean EPDS scores (M= 7.55) 
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when compared to women without GDM (M=6.41), but these differences were not 
statistically significant.  Limitations of this study were the small number of gestational 
diabetics (n=11) and that the data was collected in Germany where generalizability to the 
current study may be difficult.  Chazotte et al. (1995), also reported that women with 
GDM had a higher depression scores (mean CES-D=17) compared to women without 
GDM (mean CES-D=13.7) which was also not statistically significant.  The possible 
reasons for the higher mean differences between the current study and Chazotte et al. 
(1995), have been previously addressed.  The lack of statistically significant findings in 
all three studies may be attributed to the small sample sizes and inadequate power to 
detect statistically significant findings. 
For the current study, logistic regression did reveal that after controlling for age, 
marital status, income, BMI, and gravida, women with GDM were 2.7 times more likely 
to have depression than women without GDM when using the CES-D.   A similar 
analysis with the EPDS indicated that women with GDM were 2.3 times more likely to 
have depression when controlling for age, marital status, income, BMI, and gravida, but 
these findings were not statistically significant.  The non-significant results with the 
EPDS may be attributed to the difference in the measurement tools.  As discussed 
previously, the CES-D includes items which are somatic symptoms of pregnancy which 
may increase the depression scores on the CES-D and the percentage of depressed 
women in the sample, therefore impacting the logistic regression results.  
The results of the current study are consistent with a research study with a sample 
of over 11,000 which reported that women with diabetes during pregnancy were 1.85 
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times more likely to have depression than women without diabetes (Backes Kozhimannil 
et al., 2009).  The findings of the current study are clinically significant.  Since women 
with GDM were at least two times more likely to be depressed than women without 
GDM, health care providers may want to screen women with GDM more frequently for 
depression during prenatal care visits.    
Aim 2: Difference in Predictive Factors of Depression between  
Women with and without GDM 
 The second aim of this study was to determine predictive factors of depression 
and to examine whether women with GDM had different predictive factors of depression 
than women without GDM.  The first regression analysis was done to determine which 
factors (state anxiety, trait anxiety, stress, GDM, age, marital status, and income) were 
predictive of depression in the entire sample.  When using the CES-D, it was found that 
the model explained 71% of the variance in the depression scores and that trait anxiety 
was the only significant predictor of depression.  Perceived stress and marital status were 
trending toward significance and also contributed to the amount of variance explained by 
the model.  Anxiety (Leigh & Milgrom, 2008) and marital status (Marcus et al., 2003) 
have been found to be predictive of prenatal depression in previous research.  Also, 
anxiety (C. T. Beck, 2001; Heron et al., 2004), stress (C. T. Beck, 2001), and marital 
relationships have been reported as significant predictors of postpartum depression (C. T. 
Beck, 2001).   
It was also interesting that the other factors entered into the model (state anxiety, 
GDM, age, and income) were not significant predictors of depression.  Some of the 
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reviewed literature has reported that age (Glazier et al., 2004; Holzman et al., 2006; 
Lindgren, 2001; S. T. Orr et al., 2006; Rubertsson et al., 2005; Steer et al., 1992; 
Westdahl et al., 2007), marital status (H. G. Kim et al., 2006; Lindgren, 2001; Marcus et 
al., 2003; S. T. Orr et al., 2006; Rubertsson et al., 2005; Westdahl et al., 2007), and 
income (Glazier et al., 2004; Holzman et al., 2006; Lindgren, 2001) impact depression.  
Studies had sample sizes ranging from 154 to 3,472 (Appendix H).  Age, income levels, 
and marital status were varied in these studies.  Other research has not found significant 
relationships between depression and age (Dayan et al., 2006; Diego et al., 2005; Hart & 
McMahon, 2006; Marcus et al., 2003) and marital status (Dayan et al., 2006; Diego et al., 
2005).  The sample sizes (53 to 3,472), ages, and marital status were also varied in these 
studies.  However, two of these studies had smaller samples (<100) (Diego et al., 2005; 
Hart & McMahon, 2006).  Although age, income, and marital status were associated with 
depression in most studies, there were some studies that indicated these factors were not 
related to depression, but these studies tended to have smaller samples.  Therefore, the 
sample size may dictate whether a significant relationship between age, marital status, 
and income is found.    
Regression was used to determine if predictive factors of depression were 
different in women with GDM when compared to women without GDM.  Trait anxiety 
was a significant predictor for both groups.  Trait anxiety is relatively stable and 
reflective of long-term anxiety levels.  People with high trait anxiety have been reported 
to perceive stressful events as more unsafe (Spielberger et al., 1983).  Previous research 
has reported a positive correlation between depression and anxiety when using the STAI 
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(Allister et al., 2001; Bergant et al., 1997; Davis et al., 2007; Davis et al., 2004; Dayan et 
al., 2006; Glazier et al., 2004; Hart & McMahon, 2006).  One study examined the 
relationship between depression and anxiety, but only the state anxiety portion of the 
STAI was used (Breitkopf et al., 2006).  Findings indicated that depression scores 
(measured by the Beck Depression Inventory) were predictive of state anxiety scores.  
However, the current study found that trait anxiety was predictive of depression which is 
consistent with longstanding anxiety as compared with state anxiety which is more 
temporary.  A high state anxiety score would indicate that a person is anxious at the time, 
whereas a high trait anxiety score indicates that a person is more anxious over the long 
term.  Because the depression measures asked how women felt in the past week (and not 
at the present time), it would be expected that the trait anxiety score would be the one that 
is predictive of depression compared to the state anxiety score.  In addition, clinical 
practice has indicated that both anxiety and depression occur more often together rather 
than in isolation (Ballenger, 1999).  
When using the CES-D differences in predictive factors of depression were found.  
Marital status was a significant predictor of depression for women with GDM and 
perceived stress was significant for women without GDM.  Married women with GDM 
had lower depression scores than single women with GDM.    The finding that married 
women had lower depression scores is consistent with previous research (Kelly et al., 
1999; H. G. Kim et al., 2006; Lindgren, 2001; Marcus et al., 2003; S. T. Orr et al., 2006; 
Rubertsson et al., 2005; Westdahl et al., 2007).  Still, being married did not have an 
impact of depression scores for women without GDM.  This finding was consistent with 
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the research which did not show a relationship between marital status and depression 
(Dayan et al., 2006; Diego et al., 2005).  Also, women without GDM had higher 
depression scores if they had higher stress scores.  Two previous studies reported a 
positive relationship between prenatal depression and stress (Davis et al., 2007; Glazier et 
al., 2004).  As discussed previously, marital status (Marcus et al., 2003), stress (C. T. 
Beck, 2001), and anxiety (C. T. Beck, 2001; Heron et al., 2004; Leigh & Milgrom, 2008) 
are known predictors of depression.   
Regression was also used to determine predictive factors of depression using the 
EPDS.   The first model showed that the factors explained 81% of the variance in 
depression.  In this model, trait anxiety and perceived stress were the significant 
predictors of depression.  As discussed previously, state anxiety, GDM, age, marital 
status, and income were not significant predictors of the model.  Unlike the CES-D which 
found that marital status was predictive of depression for women with GDM and stress 
was predictive in women without GDM, the EPDS found that trait anxiety and perceived 
stress were significant predictors of depression for women with and without GDM.   
 Trait anxiety is a constant and significant predictor of depression when using the 
CES-D and the EPDS.  If the patient has a diagnosis of an anxiety disorder or a history of 
an anxiety disorder, clinicians may want to screen for prenatal depression frequently 
during prenatal care.   
 There were differences in predictor variables based on which outcome variable 
(the CES-D or the EPDS) was used.  This may be due to the fact that more women had 
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higher scores on the CES-D than on the EPDS.  As discussed earlier, this may be related 
to the somatic symptoms of pregnancy items included on the CES-D. 
Aim 3: Race and Depression 
The third aim of this study was to determine if minority women were more at risk 
for depression than White women.  Although this study had a good representation of 
minority women (32.6% White, 32.6% Hispanic, 23% Black, 11.9% Other), results 
indicated that race was not associated with depression.  Other studies have reported 
similar findings (Diego et al., 2005; Marcus et al., 2003; Sleath et al., 2005; Westdahl et 
al., 2007) (Appendix H).  Two studies, however, have reported that race is related to 
depression (Lindgren, 2001; S. T. Orr et al., 2006).  Lindgren (2001) reported that non-
White women had higher depression scores, but did not indicate if these differences were 
statistically significant.  Orr et al. (2006), did indicate that Black women had significantly 
higher depression scores than White women.  However, Blacks were more likely to be on 
Medicaid so the difference found in depression scores between races may be more 
attributable to socioeconomic factors than race.  Other studies did not report the racial 
distribution of the sample or did not indicate if race was related to depression scores, 
making it difficult to compare the current study results to these studies (Glazier et al., 
2004; Hart & McMahon, 2006; Rubertsson et al., 2005; Steer et al., 1992).  The current 
study has results consistent with most research on prenatal depression and race which 
suggests that minority women do not appear to be at increased risk for depression (Diego 
et al., 2005; Marcus et al., 2003; Sleath et al., 2005; Westdahl et al., 2007). 
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Other Findings:  Maternal and Infant Health Outcomes 
 Delivery and infant health information were extracted from the EMR to determine 
the impact of GDM on delivery complications and infant health.  This was also analyzed 
in terms of depression status. The outcomes analyzed were as follows: gestational age at 
delivery, type of delivery, presence of lacerations, delivery complications (shoulder 
dystocia, presence of meconium, nuchal cord, maternal fever, postpartum hemorrhage, 
chorioamnionitis, prolonged rupture of membrane, and partial abruption), Apgar scores at 
one, five, and ten minutes, and infant birth weight. 
 When comparing women with and without GDM in terms of gestational age at 
delivery, it was found in that women with GDM delivered earlier (38.1 weeks) compared 
to women without GDM (38.8 weeks).  Although this was statistically significant, it was 
not clinically significant.  Women with GDM may have delivered slightly earlier because 
they are at greater risk for macrosomia, and induction at 38 weeks may reduce the rate of 
macrosomia (Nicholson et al., 2008).  It should be noted that women with GDM had 
significantly more cesarean sections than women without GDM, which is consistent with 
previous research (Casey et al., 1997).  Women without GDM were more likely to have 
vaginal tears; which would make sense, since they were more likely to deliver vaginally.   
Women were also compared according to whether they had depression or not.  
This was done using the recommended cut scores for both tools (CESD-D and EPDS).   
A significant difference was found using the EPDS where infants born to depressed 
women had higher Apgar scores at 10 minutes (9.0) compared to non-depressed women 
(8.91).  However, this was not a clinically significant finding.  Also, when using the 
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EPDS, women with depression were significantly more likely to have cesarean sections 
than women without depression.  This finding is consistent with previous research 
(Larsson et al., 2004).  The last significant difference was found when using both the 
CES-D and the EPDS: women without depression were more likely to have vaginal tears; 
which would make sense, since they were more likely to deliver vaginally.   
Data Quality of the Electronic Medical Record 
There is an immense amount of information in the EMR that can be extracted and 
used for research purposes.  However, when using the EMR for research purposes there 
are some aspects that are important to keep in mind.  Hayrinen, Saranto, & Nykanen 
(2008) have reported that information found in the EMR should be complete, accurate, 
and reliable when compared to a paper medical chart.  The current study did not compare 
information from the EMR to a paper chart, so it is impossible to determine if the EMR 
was more or less accurate, complete, and reliable than a paper chart.  However, there 
were some variables extracted from the EMR which had missing data (Appendix E), 
suggesting that data from the EMR is not always complete.  In the current study, it was 
often found that the data missing on the provided template was located in the physician 
notes.  Information was not always consistent throughout the chart, which raises concerns 
of accuracy.  There were differences found between information provided in the template 
and in the physician notes (Appendix F).  For example, the gestational age at delivery 
was documented differently between the template and the physician notes and this made 
it difficult to determine which information was accurate and reliable.  In the current 
study, when contradictory information was found between the template and physician 
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note, the information written in the note was used in the analysis, since the investigator 
believed this information would be more accurate and reliable than information 
documented in a flow sheet.   
The current study also identified instances when data would have been missed or 
mis-classified based on the information provided in the template.  For example, there 
were six participants for whom a diagnosis of GDM was written in a note in the chart but 
was not listed in the active problem list.  The active problem list was provided on the 
template and was the list of active diagnoses the patient had at the time of delivery and a 
way to identify women with GDM.  Had the lab results and notes not been accessed, the 
six women without GDM on the active problem list would never have been identified as 
GDM or they would have been classified as non-GDM, resulting in an error in analysis.  
Missing information on the template was also identified as a problem in a study which 
compared the amount of prescribed medication to the elderly between two data sources 
(Vandenberghe et al., 2005).  This study compared a semi-automatic data extraction 
system from the EMR (similar to the template in the current study) to the amount of 
prescribed medication on the EMR to a paper chart (Vandenberghe et al., 2005).   This 
study found that the proportion of patients who were prescribed drugs to treat 
osteoarthritis was almost twice as high for the general practitioners recording data on 
paper sheets (64%) when compared with the general practitioners using EMR (36%).  
Researchers in that study had two possible explanations for the difference in findings: (1) 
the general practitioners wrote the prescriptions on paper and did not record them in the 
EMR or (2) the prescriptions were recorded in a different place in the EMR and the semi-
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automatic extraction was not able to capture the total number of patients on medications 
(Vandenberghe et al., 2005).  The current study also found that information could be 
missing on the template, but was often recorded in a place in the chart which the template 
used for data retrieval was not able to capture.  Although most data could be found when 
accessing the notes, checking all the information in the template against the notes in the 
chart was time-intensive and future studies may find it beneficial to develop a systematic 
approach to extract data from the EMR in order to decrease the amount of time it takes 
for data extraction.  In the current study, a system was developed by the investigator.  
First, lab results were extracted to determine which women had a diagnosis of GDM and 
to ensure accurate classification of women with GDM.  Next the information provided by 
the informatics specialist on the template was compared to the information written in the 
chart.  To do the comparison, five notes in the chart were read.  Three notes were read in 
the maternal EMR: the admission note at the start of prenatal care, the admission note at 
the time of delivery, and the discharge note.  Two notes were read in the infant chart: the 
admission to the nursery note and the discharge summary note.  The investigator found 
that by reading these five notes, most missing data could be retrieved and any inaccurate 
data on the template could be captured in one of these physician notes.  The utilization of 
this systematic approach allowed for the information extracted from the EMR to be 
complete, accurate and reliable.   
Summary of Major Findings 
 When analyzing the scores on the self-report questionnaires, the mean scores on 
the scales were similar to the normative scores.  However, the standard deviations were 
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large and may be a reason that statistically significant differences were not found.  
Although women with GDM were found to have higher depression scores on both the 
CES-D and the EPDS and the rates of depression were higher among these women, it was 
not statistically significant.  However, after controlling for age, marital status, income, 
BMI, and gravida, women with GDM were 2.7 times more likely to have depression 
(when measured by the CES-D), which was statistically and clinically significant.  When 
using the EPDS, women with GDM were 2.4 times more likely to have depression (when 
controlling for age, marital status, income, BMI, and gravida), but the findings were not 
statistically significant.   Another important finding was that women with a history of 
depression were more likely to have GDM.  This finding suggests that a history of 
depression is a risk factor in development of GDM.   
When determining predictive factors of depression, trait anxiety was the one 
factor that was significant in every analysis.  Other significant predictive factors in some 
of the models were stress and marital status.  No significance difference was found 
between race and depression in the current sample of women.  When delivery outcomes 
were compared between women with and without GDM, women with GDM had more 
cesarean sections and were found to deliver earlier than women without GDM (but this 
was not clinically significant).  When comparing delivery outcomes in women with and 
without depression, women with depression (on the EPDS) had more cesarean sections.  
Women with depression (as measured by the EPDS) had infants with slightly higher ten-
minute Apgar scores, but again this was not clinically significant.  Women without 
depression had more vaginal tears (when measured by both the CES-D and the EPDS).  
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The interpretation of these delivery outcomes must also be interpreted with caution 
because a Bonferroni correction was not utilized.   
Study Limitations 
 There were limitations in this study based on threats to internal and external 
validity.   The first threat to internal validity was selection bias.  A convenient, non-
random sample was used.  Because of the sampling techniques, a significant difference in 
age was noted in that women with GDM were older.  This difference in groups was 
accounted for in the analyses to address this impact of this limitation.  The next threat to 
internal validity was the use of self- report questionnaires as the measure for depression.  
Depression self- report questionnaires do not always generate the same results as a 
clinical diagnosis of depression (Murray & Cox, 1990).  Therefore, some women may 
have been classified as depressed based on the recommended cutoff score for the CES-D 
and the EPDS, but they may not have been clinically depressed based on the diagnostic 
criteria.  The last threat to internal validity was the missing data.  There was a limited 
amount of missing data from the self-report questionnaires.  In order to reduce missing 
data, questionnaires were reviewed after they were completed by participants to reduce 
this error.  In cases where data was missing, a conservative method was used for 
replacement where the individual’s mean score was used.    
 There were also two external validity threats which pose limitations to the study.  
The first is that the study excluded non-English-speaking women and pregnant women 
less than 18 years of age.   Results and conclusions may not be generalizable to teenagers 
and non-English-speaking women.  Also, the sample size was small and was obtained 
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from the greater Chicagoland area.  The results are not generalizable beyond the 
institution where data was collected.  In addition, because women were recruited for the 
study at prenatal care visits, all study participants were receiving prenatal care at some 
point during their pregnancy.  Therefore, women who did not receive prenatal care and 
who may be at more risk for depression and delivery complications were not represented 
in the study. 
Nursing Implications  
 Nurses have a great deal of contact with patients during their prenatal care visits.   
It is important for nurses to know and understand the prevalence and symptoms of 
antenatal depression.  Nurses need to be sensitive to women with prenatal depression and 
provide care to treat them appropriately.  Often nurses provide education to the women 
diagnosed with gestational diabetes.   It is imperative that nurses are aware that women 
with GDM are more likely to have a history of depression and are at least two times more 
likely to have antenatal depression.  It may be desirable to include a depression screen in 
the diabetic teaching session.  A psychosocial screen (such as a depression screen), is 
recommended for people with diabetes (American Diabetes Association, 2010a).  
However, a depression screen is not included in the recommended guidelines for 
treatment of gestational diabetes (American Diabetes Association, 2010b).  Gestational 
diabetes education could include the symptoms of depression which may develop during 
pregnancy and the postpartum period.  Also, involved family members or supportive 
people in the pregnant woman’s life should be educated on the risk of depression and 
symptoms of depression.  Women with prenatal depression may need some help in 
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identifying their depression and encouragement to seek help.  If the family and support 
system of the woman are educated on depression, they may be more likely to help and 
encourage the woman to seek depression help and treatment.  An Illinois Public Health 
Act (Public Act 095-0469), indicates that depression education should provided to all 
women receiving prenatal care.  The act also encourages the inclusion of families in the 
education.  The act does not mandate a prenatal depression screen, but does recommend 
that all women receiving prenatal care be given the option to complete a depression 
screen.  At the data collection site, the recommendations of this act were followed and 
women were routinely screened for depression during prenatal care using the EPDS.  The 
number of women with prenatal depression found in the current study supports the 
recommendations provided in the public act.  Health care providers who are not currently 
screening for depression during routine prenatal care visits, should implement a 
depression screen in order detect and address depressive symptoms in pregnant women. 
Women need to be reassured by nurses that depression is common and there is 
treatment in order to help them deal with the symptoms.  Nurses should strive to provide 
understanding and sympathetic care while instilling hope that the depression symptoms 
will improve.  Antidepressant medication is a possible treatment option for women with 
antenatal depression.  Although there is research to suggest that antidepressants may be 
associated with an increased risk of fetal anomalies, there is also research to indicate that 
there is no association (Wisner et al., 2009).  One study of  pregnant women (n=238) 
between 20 and 36 weeks’ gestation reported that although antidepressant use and 
untreated depression were not related to an increased risk of physical anomalies in the 
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infants, they were related to premature births (Wisner et al., 2009).  Therefore, depression 
should be assessed and evaluated for treatment in the antenatal period because of the 
impact on the mother as well as on the unborn baby.   
 Another major finding of this study is that women with a history of depression 
were three times more likely to develop GDM.  Therefore, a history of depression was 
found to be a risk factor in development of GDM.  All health care providers should be 
aware of the relationship between the history of depression and GDM.  Health care 
providers may want to consider earlier screening for GDM in women with a history of 
depression. 
Future Research 
 Because many of the findings in the current study were trending toward 
significance, a larger study may be needed to determine if there are additional statistically 
significant differences in depression between women with and without GDM.  This study 
indicated that 28% of women had depression according to the CES-D and 16% had 
depression using the EPDS.  Because the CES-D includes items which are somatic 
symptoms of pregnancy, future research may want to use the EPDS or another 
measurement which does not include somatic symptoms of pregnancy. 
Future intervention studies should be done to decrease the amount of depression 
and the depressive symptoms which occur during pregnancy.  A meta-analysis paper 
reviewed 11 studies which included the treatment of prenatal and postpartum depression 
(Bledsoe & Grote, 2006).  Of the 11 studies, only four were done during the prenatal 
period.  Three of these four studies used interpersonal therapy (IPT) and one study used 
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an education intervention.  Interpersonal therapy treats depression by addressing 
interpersonal problems related to the current depressive symptoms (Bledsoe & Grote, 
2006).  The meta-analysis paper did not indicate if the depression treatments during 
pregnancy were done on an individual basis or in groups (Bledsoe & Grote, 2006).  
Cognitive behavioral therapy (CBT) was used to treat postpartum depression in three of 
the studies and focuses on improving cognitive skills and changing negative thoughts 
(Bledsoe & Grote, 2006).  The current study found that stress and anxiety were common 
symptoms which occurred with depression.  Future intervention studies may want to use 
IPT or CBT to treat depression, stress, and anxiety at the same time.  The successful 
treatment of prenatal depression, stress, and anxiety may improve the quality of life and 
health outcomes of the mother and baby.  
Group CBT has been used to successfully treat depression and anxiety in women 
with type 2 diabetes (Penckofer et al., 2010).  However, the use of group CBT has not 
been done during pregnancy.  Group therapy may provide an economical approach to 
antenatal depression treatment.  Also, pregnant women may like the aspect of a group 
treatment during pregnancy because they could provide support for each other during all 
the changes which occur in pregnancy.  
 Because women with GDM were more likely to have a history of depression and 
twice as likely to have antenatal depression, future studies may want to test an 
intervention that includes depression treatment incorporated into the gestational diabetic 
teaching.  Similar to the CBT treatments described above, these could be specific to 
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women with GDM and could include treatment of depression and educational 
information on how to manage gestational diabetes. 
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Center for Epidemiologic Studies Depression Scale (CES-D) 
Below is a list of ways you might have felt or behaved.  Please tell me how often you 
have felt this way during the past week. 
 
 Rarely or 
none of the 
time 
(less than 1 
day) 
Some or 
a little of 
the time 
 (1-2 
days) 
Occasionally 
or a 
moderate 
amount of 
time  
(3-4 days) 
Most or 
all of the 
time 
 (5-7 days) 
1. I was bothered by things 
that usually don’t bother me 
 
1 2 3 4 
2. I did not feel like eating; 
my appetite was poor 
 
1 2 3 4 
3. I felt that I could not shake 
off the blues even with help 
from my family or friends 
1 2 3 4 
4. I felt I was just as good as 
other people 
 
1 2 3 4 
5. I had trouble keeping my 
mind on what I was doing 
 
1 2 3 4 
6. I felt depressed 
 
1 2 3 4 
7. I felt that everything I did 
was an effort 
 
1 2 3 4 
8. I felt hopeful about the 
future 
 
1 2 3 4 
9. I thought my life had been 
a failure 
 
1 2 3 4 
10. I felt fearful 
 
1 2 3 4 
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11. My sleep was restless 1 2 3 4 
12. I was happy 
 
1 2 3 4 
13. I talked less than usual 
 
1 2 3 4 
14. I felt lonely 
 
1 2 3 4 
15. People were unfriendly 
 
1 2 3 4 
16. I enjoyed life 
 
1 2 3 4 
17. I had crying spells 
 
1 2 3 4 
18. I felt sad 
 
1 2 3 4 
19. I felt that people dislike 
me 
 
1 2 3 4 
20. I could not get “going” 
 
1 2 3 4 
 
152 
 
 
Multidimensional Scale of Perceived Social Support 
 
Instructions:  We are interested in how you feel about the following statements.  Read 
each statement carefully.  Indicate how you feel about each statement. 
 
 Very 
Strongly 
Disagree 
Strongly 
Disagree 
Mildly  
Disagree 
Neutral Mildly  
Agree 
Strongly  
Agree 
Very  
Strongly  
Agree 
1.  There is a special  
      person who is  
      around when I  
     am in need 
1 2 3 4 5 6 7 
2.  There is a special  
      person with whom 
      I can share my  
       joys and sorrows 
1 2 3 4 5 6 7 
3.  My family really   
      tries to help me 1 2 3 4 5 6 7 
4.  I get the emotional  
     help and support I  
     need from my 
     family 
1 2 3 4 5 6 7 
5.  I have a special  
     person who is a  
     real source of  
     comfort to me 
1 2 3 4 5 6 7 
6.  My friends really  
     try to help me 1 2 3 4 5 6 7 
7.  I can count on  
     my friends when  
     things go wrong 
1 2 3 4 5 6 7 
8.  I can talk about  
     my problems with  
     my family 
1 2 3 4 5 6 7 
9.  I have friends with  
     whom I can share  
     my joys and 
     sorrows 
1 2 3 4 5 6 7 
10.  There is a special  
       person in my life  
       who cares about 
       my feelings 
1 2 3 4 5 6 7 
11.  My family is 
       willing to help  
       me make   
      decisions 
1 2 3 4 5 6 7 
12.  I can talk about  
       my problems with  
       my friends 
1 2 3 4 5 6 7 
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Spielberger State-Trait Anxiety Scale (Only the first five items are printed so as not to 
violate copy right laws). 
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Perceived Stress Scale 
 
The questions in this scale ask you about your feelings and thoughts during the 
last month. In each case, you will be asked to indicate by circling how often you 
felt or thought a certain way. 
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Edinburgh Postnatal Depression Scale (EPDS) 
Are you pregnant or have recently had a baby?  We would like to know how you are 
feeling.  Please check the answer that comes closest to how you have felt in the past 7 
days, not just how you feel today. 
 
In the past 7 days: 
 
1.  I have been able to laugh and see the 
funny side of things 
__As much as I always could 
__Not quite so much now 
__Definitely not so much now 
__Not at all 
 
2.  I have looked forward with 
enjoyment to things 
__As much as I ever did 
__Rather less than I used to 
__Definitely less than I used to 
__Hardly at all 
 
3.  I have blamed myself unnecessarily 
with things went wrong 
__Yes, most of the time 
__Yes, some of the time 
__Not very often 
__No, never 
 
4.  I have been anxious or worried for no 
good reason 
__No, not at all 
__Hardly ever 
__Yes, sometimes 
__Yes, very often 
 
5.  I have felt scared or panicky for no 
very good reason 
__Yes, quite a lot 
__Yes, sometimes 
__No, not much 
__No, not at all 
 
 
 
6.  Things have been getting on top of 
me. 
__Yes, most of the time I haven’t been 
able to cope at all 
__Yes, sometimes I haven’t been coping 
as well as usual 
__No, most of the time I have coped 
quite well 
__No, I have been coping as well as ever 
 
7.  I have been so unhappy that I have 
had difficulty sleeping 
__Yes, most of the time 
__Yes, sometimes 
__Not very often 
__No, not at all 
 
8.  I have felt sad or miserable 
__Yes, most of the time 
__Yes, quite often 
__Not very often 
__No, not at all 
 
9.  I have been so unhappy that I have 
been crying 
__Yes, most of the time 
__Yes, quite often 
__Only occasionally 
__No, never 
 
10.  The thought of harming myself has 
occurred to me 
__Yes, quite often 
__Sometimes 
__Hardly ever 
__Never 
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Demographic and Health History Information 
 
 
ID #____________  MRN#__________________   Date_________________ 
 
Please fill out the information below. 
 
1.   Age:  _______________ 
 
 
2. Ethnicity: (please circle one)         
1.  Hispanic                          
2.   Non-Hispanic 
  
 
3. Race: (please circle one)   
1. Alaska Native       
2. American Indian          
3. Asian             
4. Black             
5. White 
6. Native Hawaiian or Other Pacific Islander         
7. Preference not indicated         
8. Other 
 
 
 
4. Marital Status: (please circle one) 
1. Married                
2.  Divorced                     
3.  Separated  
4. Single, and not living with partner   
5. Single, and living with partner 
 
 
 
5.   Estimated Due Date: __________________ 
 
 
 
6.   Was your current pregnancy planned? YES   NO 
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7.   Please list any medications you are currently taking: 
 
______________________     ____________________  
 
______________________     ____________________  
 
______________________     ____________________  
 
______________________     ____________________  
 
 
 
8.   Have you ever been diagnosed with depression? YES   NO 
 
9.   Please circle any of the following conditions you have been diagnosed with: 
 
1. Asthma 
2. Diabetes 
3. High Blood Pressure 
4. Depression 
5. Bipolar Disorder 
6. Schizophrenia 
7. Other: _____________________________________ 
 
 
 
10.   How many times have you been pregnant? _______________ 
 
 
11.   How many of those pregnancies did you deliver a full term (after 37 weeks) 
baby?              ___________ 
 
12.   How many of those pregnancies did you deliver a preterm (between 20 and 37 
weeks) baby?             ____________ 
 
13.   How many miscarriages have you had? ___________________ 
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14.  How many abortions have you had? _______________ 
 
 
15.   How many living children do you have? ____________________ 
 
 
16.   Have you ever had a cesarean section?  YES   NO 
 
 
17.   What is your annual income? 
 
1. Less than $5,000 _____ 
2. $5,000 to $9,999 ______ 
3. $10,000 to $19,999 ______ 
4. $20,000 to $29,999 ______ 
5. $30,000 to $39,999_______ 
6. $40,000 to $49,999_______ 
7. $50,000 to $59,999______ 
8. $60,000 to $69,999______ 
9. Over $70,000____  
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Variables to be Collected From the EMR 
 
ID # _____________      Date ___________ 
 
 
PREGNANCY DATA: 
 
Maternal Date of Birth ______________________ 
 
Result of One Hour Glucose Tolerance Test _____________   Date of test ____________ 
 
Result of 3-hour Glucose Tolerance Test (only if 1 hour is greater than 130 mg/dl) 
 
Fasting ______1___________   2___________  3__________  Date of test _________ 
 
Gestational Diabetes                         YES                       NO 
 
Pre-pregnancy Weight ____________lbs.         Date of weight ___________ 
 
Weight at appointment when questionnaire completed: _____________lbs. 
 
Height ____________in 
 
BP at appointment when questionnaire completed: _________ 
 
 
Gravida __________ 
 
Parity __________ 
 
 
EPDS SCORE @ 28 weeks gestation ___________________ 
 
 
 
DATA TAKEN FROM CHART AT TIME OF DELIVERY: 
 
Weight at Delivery admission ___________lbs. 
 
History of abuse:  YES                                 NO 
If yes: what (physical, emotional, sexual) and when  __________________________ 
 
History of tobacco use:  YES                          NO 
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If yes: how much (packs per day) ___________________________ 
 
History of alcohol use:  YES                         NO 
If yes: how much ______________________________________ 
 
History of illicit drug use:  YES                     NO 
If yes: what drug and how much________________________________________ 
 
Active Patient Problem List ___________________________________ 
 
Past medical History (including history of depression) _________________________ 
 
Current 
medications_____________________________________________________________ 
 
DELIVERY DATA: 
Gestational age at delivery ________________weeks 
Sex of infant:  Male                             Female 
Infant weight ____________________ounces 
Infant length____________________inches 
 SGA                                       AGA                                  LGA 
Induction of Labor:                        YES                NO 
Type of Delivery:        
Spontaneous Vaginal Delivery    Cesarean            Low Forceps Delivery 
Mid Forceps Delivery          Forceps Outlet                Vacuum             
 Breech Assisted               Breech Extraction     
History of Previous C-section:        YES                     NO 
Shoulder Dystocia:         YES                            NO                   UNKNOWN  
Delivery complications _______________________ 
Episiotomy:   YES                                       NO 
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Perineal Tear:   YES                                        NO 
If yes, degree of laceration:   1                               2                                3                          4  
APGARS:  1 min _______________      5 min_____________  10 min_______________ 
Infant Blood Glucose (from heel stick): 
 #1_________________     #2___________________     #3__________________ 
EPDS Score at Delivery _______________ 
Breastfeeding:    YES                        NO 
 
POSTPARTUM DATA: 
EPDS Score at 2 weeks postpartum ______________________ 
EPDS Score at 6 weeks postpartum ___________________ 
Maternal weight at 6 weeks postpartum ________________kg 
Fasting Blood Glucose at 6 weeks postpartum ________________mg/dL 
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IRB NUMBER: 202019121609 
 
LOYOLA UNIVERSITY HEALTH SYSTEM  
MAYWOOD, ILLINOIS 
NIEHOFF SCHOOL OF NURSING 
STRITCH SCHOOL OF MEDICINE  
 
INFORMED CONSENT 
(a copy of consent must be inserted in participant's file) 
 
Participant's Name:_________________________________ 
 
Project Title:  “Pregnancy and Mood Study”    
 
The project will undergo re-review on or before 6/16/2011. 
 
 Patient Information 
PRINCPLES CONCERNING RESEARCH:  You are being asked to take part in a 
research project.  It is important that you read and understand the principles that apply to 
all individuals who agree to participate in the research project described below: 
 
1. Taking part in the research is entirely voluntary. 
 
2. You may not benefit from taking part in the research but the knowledge obtained 
may help health professionals understand the experiences of women with 
diabetes.  
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3. You may withdraw from the study at any time without anyone objecting and 
without penalty or loss of any benefits to which you are otherwise entitled. 
 
The purpose of the research, how it is to be done, and your part in the research is 
described below.  Also described are the risks, inconveniences, discomforts and other 
important information which you need to make a decision about whether or not you wish 
to participate.  You are urged to discuss any questions you have about this research with 
the staff members. 
PURPOSE OF RESEARCH:  You are being asked to participate in this research 
because you are having a baby.  There is evidence to indicate that pregnant women may 
experience hormonal fluctuations and have mood alterations during pregnancy.  There is 
also evidence to indicate that fluctuations in blood sugar are associated with mood 
alterations.  We are interested in studying whether the alterations in mood during 
pregnancy are greater in women who have gestational diabetes.  Gestational diabetes is 
when a woman has high blood sugars that start or are first diagnosed during pregnancy.  
Thus, we will be comparing the health and well-being of women who have gestational 
diabetes with those who do not have gestational diabetes. The purpose of this study is to 
find out if women with gestational diabetes experience more mood alterations than 
women who do not have gestational diabetes.    
Approximately 120 pregnant women will participate in this study.  The information 
obtained from this study will be used to develop future research projects on pregnant 
women.   
DESCRIPTION AND EXPLANATION OF PROCEDURES:  If you agree to 
participate in this research you will be asked to complete a questionnaire booklet that will 
take about 20 to 30 minutes.  The questionnaire booklet will ask you about your moods 
(depression, anxiety, and stress), your support systems, and your demographic and health 
history.  We will also be obtaining information from your medical record that is part of 
your routine care during your pregnancy and delivery.  In addition, we will be obtaining 
information from the medical record of your baby once it is delivered. . 
POTENTIAL RISKS AND DISCOMFORTS:  Because you will be filling out 
questionnaires related to your moods, you may experience feelings of sadness or anxiety.  
If you experience these feelings you should talk with the healthcare provider you are 
seeing at your appointment.   
It is important that you understand that if you need assistance with the management of 
your emotions such as medication or counseling, you should talk to your health care 
provider about this. If you report feelings of harming yourself on the questionnaire, this 
information will be shared with your healthcare provider at the clinic.  
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All information taken from your medical record will be kept confidential.  There will be 
no identifying information (name, birth date, or social security number).    
POTENTIAL BENEFITS:  We do not know if you will benefit from participating in 
this study.  The information learned in this study may help others in the future.  
ALTERNATIVES:  You do not have to participate in this project if you do not want to.  
Your decision about participation will not affect your care in any way.  If you are an 
employee of Loyola University, your decision about participation will not affect your 
evaluations or career or career opportunities in any way.   
FINANCIAL INFORMATION:  There are not costs associated with your participation 
in this research.  You will be responsible for all costs associated with your care and 
treatment at Loyola.   
You will be given a $10 gift card for participating in the study. 
INFORMATION COLLECTED AND WHAT WILL HAPPEN TO IT:  In order to 
meet the goals of the research study (see Purpose of Research section of this consent), we 
will collect information on you.  The information will be collected by Mary Byrn, RN.  
All data will be stored in a locked file cabinet in the researcher’s office.  Only the 
research team will have access to those files.  
 
The results of this research study may be published in a journal for the purpose of 
advancing medical knowledge.  You will not be identified by name or by any other 
identifying information in any publication or report about this research. 
 
The information we will collect includes:  
X_DEMOGRAPHIC INFORMATION (E.G., NAME, ADDRESS, PHONE 
NUMBER) 
 
X_QUESTIONNAIRES ABOUT YOUR MENTAL HEALTH INCLUDING MOOD 
AND  FEELINGS  
 
X_INFORMATION TAKEN FROM YOUR MEDICAL RECORD (E.G., HEIGHT, 
WEIGHT, ORAL GLUCOSE TOLERANCE TEST RESULTS, DEPRESSION 
SCREENING SCORES, DELIVERY INFORMATION, SUBSTANCE ABUSE 
HISTORY, PLANS TO BREASTFEED) 
This authorization expires when the sponsor has collected all of the data and the analysis 
is complete. 
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Consent for Loyola University Health System (LUHS) to use and disclose your 
information is required in order for you to participate in the study.   
Withdrawal of Consent: Your consent to use and disclose your information for the 
purpose of this research study is completely voluntary.  You can withdraw your consent for 
LUHS to use and disclose your information and your consent to participate in this study at 
any time without affecting your ability to receive care and treatment at LUHS unrelated to 
the research study.  Withdrawal means that all study procedures and follow-up will stop 
and we will not send any more information about you.  However, information already used 
and disclosed to the researcher prior to the time of your withdrawal from this study may 
continue to be used and disclosed by LUHS.  
If you withdraw from the study we will ask that you sign the form attached to this consent 
and send it to Mary Byrn, RN.  Your withdrawal from the study will not have any affect on 
any actions by LUHS taken before the attached form is received by LUHS. 
Your study doctor, the Institutional Review Board/Independent Ethics Committee, the 
regulatory authorities, or Loyola University Chicago may terminate the study at any time 
with or without your consent.  
CONSENT 
I have fully explained to ____________________________ the nature and purpose of the 
above described procedure and the risks that are involved in its performance.  I have 
answered and will answer all questions to the best of my ability.  I may be reached at 708-
216-9304, Mary Byrn, RN. 
________________________________              _________________ 
(Signature)      Date 
Mary Byrn, RN, principal investigator for this study, will be available to answer any 
questions you may have.  Sue Penckofer, PhD, RN can be reached at:  708-216-9303.   
If you ever feel that you have been injured by participating in this study or if you have any 
questions concerning your rights as a research participant, you may contact Dr. Kenneth 
Micetich, Chairman, Institutional Review Board for the Protection of Human Subjects-
Medical Center (708-216-4608).   
 
You will receive a signed copy of this informed consent document. 
 
You have been fully informed of the above-described research program with its possible 
benefits and risks.  Your signature below indicates that you are willing to participate in this 
research study and agree to the use and disclosure of information about you as described 
above.   
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You do not give up any of your legal rights by signing this consent document.   
_________________________________________________Date:_____________ 
(Signature: Patient) 
_________________________________________________Date:_____________ 
(Signature: Witness) 
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REVOCATION OF AUTHORIZATION TO RELEASE 
PROTECTED HEALTH INFORMATION (PHI) 
 
 
 
 I, _____________________________________, hereby revoke my consent to 
participate  
in the “Pregnancy and Mood Study” at Loyola University Health System.  I also revoke 
my consent to release information I provided to LUHS or allowed LUHS to use and 
disclose my information to Loyola University Chicago as outlined in the consent form, 
which I signed on _______________.  I understand that this revocation does not apply to 
any action LUHS has taken in reliance on the consent I signed earlier.   
 
___________________________________   ______________________ 
Patient Name or Personal Representative   Date 
 
 
 
 
 
 
Please return this form to: 
 
Mary Byrn, RN  
Professor, School of Nursing 
Building 105, Room 2840 
Loyola University Health System  
2160 South First Avenue 
Maywood, Illinois 60153 
mbyrn@luc.edu  
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Self-Report Questionnaire Missing Data 
ID# Tool and Item Individual Mean Group Mean Replaced 
142 CESD #4 2.5 3.11 3 
68 CESD #10 1.5 1.45 2 
56 MDPSS #5 5.09 6.25 5 
68 STAI #16 2.33 2.97 2 
125 STAI #16 2.56 2.97 3 
73 STAI #35 2.38 1.44 2 
56 STAI #36 2.1 3.01 2 
54 PSS #1 1.56 1.81 2 
102 PSS #2 2.44 1.5 2 
135 PSS #4 3 2.78 3 
87 PSS #7 2 2.64 2 
91 PSS #10 2.33 1.36 2 
 
EMR Missing Data 
 Variable Number of Missing Items 
Height 1 
One hour OGTT 6 
Status of ruptured membranes 18 
Apgar score at 1 min 6 
Apgar score at 5 min 6 
Apgar at 10 min 20 
Infant birth weight 10 
Infant birth length 18 
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ID Notes 
2 Induction of Labor (IOL) said no on template and yes in note, entered yes. 
3 Operative note says 1st  degree perineal tear, template says 2nd  degree, entered 1st 
degree. 
11 LMP: 5/2/10 on template and 7/8/09 in note.  Used the one in note.  Delivery on 
template said vaginal, note said vacuum.  Entered vacuum. 
16 IOL said no on template and yes in note, entered yes. 
36 Template says cesarean section delivery and clear membranes and note says vacuum 
and meconium membranes.  Vacuum and meconium entered.  Laceration says none 
on template and 2nd degree in note.  Entered 2nd degree. 
39 Templates says no to induction, note says yes.  Entered yes for induction. 
56 No diagnosis of GDM in list, but diagnosis in note.  Entered GDM has a diagnosis. 
58 No diagnosis of GDM in list, but diagnosis in note.  Entered GDM has a diagnosis. 
64 Template has induction as yes, but note says no.  Entered no (patient was only 34 
weeks). 
70 Template has no for induction, but note says yes.  Entered yes.  Template has 
epidural, note has combined spinal/epidural.  Entered combined spinal/epidural. 
72 Note has preeclampsia, but not in diagnosis list.  Entered it has a diagnosis. 
74 Note has combined spinal/epidural, but template has epidural.  Entered combined 
spinal/epidural.  Note has no LMP and has pregnancy due to IVF.  IVF entered in 
diagnosis list. 
76 Oligohydramnios entered in note but not in template, put it in the diagnosis list. 
78 Template has vaginal delivery, but note has Vaginal Birth after Cesarean (VBAC). 
VBAC entered. 
82 Template has no tears, note has bilateral labial tears.  Labial tears entered. 
90 Template has G:2, note has G5.  Entered G5 because on self-report patient wrote G5. 
91 Template has G:3, note has G2.  Entered G3 because on self-report patient wrote G3.  
Anesthesia on template had spinal/epidural, note had epidural.  Entered epidural. 
93 Anesthesia on template had epidural, note had spinal/epidural.  Entered 
spinal/epidural 
95 Template says NSVD, note says vacuum.  Entered vacuum. 
99 Diagnosis of GDM in chart, but not on active problem list.  Entered GDM has a 
diagnosis.  Also, epidural in template but spinal/epidural in note.  Entered 
spinal/epidural. 
101 Diagnosis of GDM in chart, but not on active problem list.  Entered GDM has a 
diagnosis. 
105 Diagnosis of GDM in chart, but not on active problem list.  Entered GDM has a 
diagnosis. 
106 Diagnosis of pre-eclampsia in note but not in active problem list.  Entered it into 
active problem list. 
107 Induction says no on template, yes in note.  Entered yes. 
110 Template has epidural and note has combined spinal/epidural.  Combined 
spinal/epidural entered. 
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111 Diagnosis of GDM in chart, but not on active problem list.  Entered GDM has a 
diagnosis. 
114 Diagnosis of pre-eclampsia in chart but in active problem list.  Entered preeclampsia 
as diagnosis. 
124 Note has c-section with vacuum assist and template only has c-section.  C-section 
with vacuum entered.  Also, template has epidural and note has combined 
spinal/epidural.  Entered combined spinal/epidural. 
126 Template has yes for induction, note does not have induction.  Entered no for 
induction. 
135 Delivery weight missing.  Looked in anesthesia note at time of delivery.  Note says 
patient current weight is 262, however last weight on flow sheet was 164.  Entered 
164 as weight at delivery.  Diagnosis of depression in note but not in diagnosis list, 
entered depression in diagnosis list. 
139 Template has no for induction, note says yes.  Entered yes. 
141 Template has LMP as 4/10/11, this date is incorrect since we have not had this date 
yet.  LMP in the note says uncertain, possibly 4/7/10 and therefore it was left blank. 
145 Template has spinal and note has spinal/epidural.  Entered spinal/epidural. 
146 Template has NSVD, note has VBAC.  VBAC entered. 
149 Depression and oligohydramnios in note not in diagnosis list, entered them into 
active problem list. 
150 Template has spinal, note has spinal/epidural for anesthesia type.  Entered 
spinal/epidural.  Note has G4, P2002.  Note has G3.  G3 entered because that makes 
sense with P2002. 
151 No diagnosis of GDM in active problem list, but diagnosis in note.  Entered GDM as 
diagnosis in APL.  Epidural in template, combined spinal/epidural in note.  Entered 
spinal/epidural. 
152 Template has 1st degree tear, note says no tears.  No tears entered. 
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Assumptions for Independent t-tests 
Assumption Description 
Normal distribution The sampling distribution is normal. 
Interval data Data should be measured at the interval level, at least. 
Homogeneity of 
variance 
The outcome variable (depression) should be the same for each 
group (GDM vs no GDM).   
Independence Data from groups (GDM vs no GDM) are independent of each 
other. 
  
Normal Distribution Tests 
Test Description CES-D 
Result 
EPDS 
Result 
Skewness Measure of symmetry.  In a normal sample this score 
is zero. 
1.32 1.11 
Kurtosis Degree to which scores group together at either end.  
In a normal sample this score is zero 
1.67 .80 
Kolmogorov-
Simirnov 
To determine if the distribution deviates from a 
similar normal distribution.  These tests compare the 
scores to a sample with normally distributed scores 
(with the same mean and standard deviation).  If the 
test is significant (p < .05) the distribution is different 
from a normal distribution and the assumption of 
normality is not met. 
p < 
.001 
p < 
.001 
Shapiro-Wilk p < 
.001 
p < 
.001 
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Multiple Regression Assumptions 
Assumption Description Assumption Met 
Variable types Quantitative means the variables 
should be measured at the interval 
level, at least.  Unbounded is 
defined as the variability having 
no constraints (the range of scores 
spans the entire scale for that 
measure).  
Met based on the description. 
Non-zero variance Predictor variables should have 
variation (do not have a variance 
of zero).  
Met after review of 
descriptive statistics. 
Multicollinearity Predictor variables should not be 
highly correlated. 
Met after review of 
correlation matrix, there 
were no variables highly 
correlated (r>.90) and all 
variance inflation factors less 
than ten. 
Predictors 
uncorrelated with 
external variables 
External variables are variables 
that have not been included in the 
analysis but are related to the 
outcome variable.  Therefore 
external variables should not be 
correlated with predictor 
variables. 
Met after review of the 
literature and correlation 
results did not suggest other 
variables to be correlated to 
depression. 
Homoscedasticity Residuals of each predictor 
variable should have the same 
variance. 
Met after review of Levene’s 
test. 
Independent errors Residuals between two 
participants should be 
uncorrelated 
Met based on the Durbin 
Watson statistic.  Durbin 
Watson value was 1.94 and a 
value less than one or greater 
than three indicates this 
assumption has not been met. 
Normally distributed 
errors 
Residuals are random, normally 
distributed, and have a mean of 
zero.   
Met; the means of the 
residuals equals zero.  
Independence All values of the outcome variable 
come from separate participants, 
and therefore are independent of 
each other. 
Met based on data collected 
from separate participants at 
one time point 
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Linearity The relationship in the model is 
linear. 
Met based on definition of 
assumption. 
Note: Assumptions and descriptions are from Field, 2009. 
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APPENDIX H 
PRENATAL DEPRESSION AND DEMOGRAPHIC RISK FACTORS 
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Author Sample 
Size 
Mean Age Ethnicity/ Race  Income Marital Status Findings 
Dayan et al. 
(2006) 
681 28.5  
 
Unknown Unknown 89% married Age and marital status not related to 
depression. 
Diego, Field, 
& 
Hernandez-
Reif (2005) 
80 27  46% Hispanic 
27% Black 
16% White 
11% Asian 
Unknown 64% married Age, marital status, and race not 
related to depression. 
Glazier et 
al., (2004) 
2,052 30.7 Unknown 35.6% 
>$70,000 
89.7% married Age and income related to 
depression. 
Hart & 
McMahon, 
(2006) 
53 31.24  Unknown Unknown 94% married Age not related to depression. 
Holzman et 
al. (2006) 
1,321 15% <20 
56% 20-29 
29% >30 
69% White 
25% African 
American 
6% Other 
54% 
Medicaid 
52% married Teens and disadvantaged more likely 
to be depressed.   
Kim et al. 
(2006) 
154 25 32% African 
American 
31% Hispanic 
15% White 
10% African 
7% Native 
American 
Unknown 62% married Marital status related to depression. 
Lindgren, 
(2001) 
252 29.5 77% White 
13% Black 
10% Other 
 
44% < 
$30,000 
56% 
>$30,001 
72% married Age, marital status, and income 
related to depression.  Minority 
women had higher depression scores 
(not indicated if significant). 
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Marcus et al. 
(2003) 
3,742 28.6 73% White 
13% African 
American 
6% Asian 
American 
2% Hispanic 
3% Other 
Unknown 74% married Marital status related to depression, 
age and race not related to 
depression. 
Orr et al. 
(2006) 
1163 20% <20 
years 
70% Black 
30% White 
68% 
Medicaid 
6% 
Uninsured 
44% married Age, race, and marital status related 
to depression. 
Rubertsson 
et al. (2005) 
2,674 Unknown Unknown Unknown Unknown Age and marital status related to 
depression. 
Steer et al. 
(1992) 
712 323 teens 
(mean age 
15.0) 
389 adults 
(mean age 
21.59) 
62.2% Black 
28.6% Hispanic 
18.5% White 
Unknown 11% married Age related to depression. 
Sleath et al. 
(2005) 
73 23.6 25% White 
25% African 
American 
23% Hispanic 
Unknown Unknown Race not related to depression. 
Westdahl et 
al.  (2007) 
1,047 20.42 80% African 
American 
13% Hispanic 
7% White 
Unknown 70% in 
relationship 
Age and marital status related to 
depression. 
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